T Stamp (IDAI) S-1 27 Jan 25 IPO registration Financial data

Document and Entity Information

Document and Entity Information	9 Months Ended
	Sep. 30, 2024
Cover [Abstract]
Document Type	S-1
Entity Registrant Name	T STAMP INC.
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Central Index Key	0001718939
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)		Sep. 30, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents		$ 598,031	$ 3,140,747
Accounts receivable, net (includes unbilled receivables of $4,463 and $143,219 as of September 30, 2024 and December 31, 2023, respectively)		375,732	686,327
Related party receivables		23,781	44,087
Prepaid expenses and other current assets		1,213,924	826,781
Total Current Assets		2,211,468	4,697,942
Capitalized internal-use software, net		1,532,357	1,472,374
Goodwill		1,248,664	1,248,664
Intangible assets, net		193,304	223,690
Property and equipment, net		39,825	56,436
Operating lease right of use assets		198,634	164,740
Investment		5,100,000	0
Other assets		35,375	29,468
Total Assets		10,559,627	7,893,314
Current Liabilities:
Accounts payable		1,107,276	1,232,118
Related party payables		48,235	82,101
Accrued expenses		1,670,260	1,143,890
Deferred revenue		95,750	10,800
Income tax payable		0	1,975
Loans payable		645,536	0
Short-term operating lease liabilities		95,367	81,236
Short-term financial liabilities		0	162,130
Total Current Liabilities		3,662,424	2,714,250
Warrant liabilities		250,694	256,536
Notes payable, including accrued interest of $45,383 and $40,317, as of September 30, 2024 and December 31, 2023, respectively		1,007,213	953,877
Long-term operating lease liabilities		70,555	53,771
Total Liabilities		4,990,886	3,978,434
Commitments, Note 11
Stockholders' Equity:
Common stock $0.01 par value, 50,000,000 shares authorized, 18,819,750 and 9,198,089 shares issued, and 18,819,750 and 9,143,355 outstanding at September 30, 2024 and December 31, 2023, respectively	[1]	12,547	6,096
Treasury stock, at cost: 0 and 54,734 shares held as of September 30, 2024 and December 31, 2023, respectively	[1]	0	0
Additional paid-in capital	[1]	60,755,010	54,460,960
Accumulated other comprehensive income		86,436	139,670
Accumulated deficit		(55,446,691)	(50,853,285)
Total T Stamp Inc. Stockholders' Equity		5,407,302	3,753,441
Non-controlling interest		161,439	161,439
Total Stockholders' Equity		5,568,741	3,914,880
Total Liabilities and Stockholders' Equity		$ 10,559,627	$ 7,893,314
[1] After giving effect to the 15 for 1 reverse stock split effected on January 6, 2025.

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)		9 Months Ended
	Jan. 06, 2025	Sep. 30, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Jul. 06, 2023 shares	Dec. 31, 2022 USD ($) $ / shares shares
Unbilled receivables | $		$ 4,463	$ 143,219		$ 109,475
Non-convertible notes payable, current accrued interest | $		$ 45,383	$ 40,317		$ 16,458
Common stock, par value (in dollars per share) | $ / shares		$ 0.01	$ 0.01		$ 0.01
Common stock, shares authorized (in shares)		50,000,000	50,000,000	50,000,000	50,000,000
Common stock, shares issued (in shares)		1,254,650	613,206		327,389
Common stock, shares outstanding (in shares)		1,254,650	609,557		323,621
Treasury stock, at cost, shares held (in shares)		0	3,649		3,768
Stock split		0.20
Subsequent Events
Stock split	15

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Net revenue		$ 511,081	$ 3,065,804	$ 1,585,153	$ 3,985,242
Operating Expenses:
Cost of services (exclusive of depreciation and amortization shown separately below)		254,892	239,313	796,925	660,199
Research and development		569,506	605,196	1,586,085	1,811,962
Selling, general, and administrative		2,181,907	2,053,524	6,805,995	5,900,715
Depreciation and amortization		181,472	189,655	547,467	596,109
Total Operating Expenses		3,187,777	3,087,688	9,736,472	8,968,985
Operating Loss		(2,676,696)	(21,884)	(8,151,319)	(4,983,743)
Non-Operating Income (Expense):
Interest expense, net		(114,320)	(9,759)	(149,644)	(29,753)
Change in fair value of warrant liability		974	(2,142)	5,842	3,473
Other income		5,000,563	0	5,235,417	261,217
Other expense		(1,526,997)	(1,377)	(1,533,702)	(4,174)
Total Other Expense (Income), Net		3,360,220	(13,278)	3,557,913	230,763
Net Income (Loss)		683,524	(35,162)	(4,593,406)	(4,752,980)
Deemed dividend		(1,939,439)	0	(1,939,439)	0
Net loss before non-controlling interest		(1,255,915)	(35,162)	(6,532,845)	(4,752,980)
Net loss attributable to non-controlling interest		0	0	0	0
Net loss attributable to T Stamp Inc.		$ (1,255,915)	$ (35,162)	$ (6,532,845)	$ (4,752,980)
Basic net loss per share attributable to T Stamp Inc. (in dollars per share)	[1]	$ (1.06)	$ (0.06)	$ (7.33)	$ (10.71)
Diluted net loss per share attributable to T Stamp Inc. (in dollars per share)	[1]	$ (1.06)	$ (0.06)	$ (7.33)	$ (10.71)
Weighted-average shares used to compute basic net loss per share (in shares)	[1]	1,181,150	543,708	891,211	443,880
Weighted-average shares used to compute diluted net loss per share (in shares)	[1]	1,181,150	543,708	891,211	443,880
[1] After giving effect to the 15 for 1 reverse stock split effected on January 6, 2025.

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)		9 Months Ended
	Jan. 06, 2025	Sep. 30, 2024
Stock split		0.20
Subsequent Events
Stock split	15

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Net loss including non-controlling interest	$ (1,255,915)	$ (35,162)	$ (6,532,845)	$ (4,752,980)	$ (7,637,642)	$ (12,091,540)
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(88,623)	18,204	(53,234)	(30,842)	(97,582)	53,352
Total Other Comprehensive Income (Loss)	(88,623)	18,204	(53,234)	(30,842)	(97,582)	53,352
Comprehensive loss	(1,344,538)	(16,958)	(6,586,079)	(4,783,822)	(7,735,224)	(12,038,188)
Comprehensive loss attributable to non-controlling interest	0	0	0	0	0	0
Comprehensive loss attributable to T Stamp Inc.	$ (1,344,538)	$ (16,958)	$ (6,586,079)	$ (4,783,822)	$ (7,735,224)	$ (12,038,188)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)		Common Stock		Additional Paid-In Capital		Treasury Stock		Stockholders' Notes Receivable	Accumulated Other Comprehensive Income	Accumulated Deficit	Non-controlling Interest	Total
Beginning balance (in shares) at Dec. 31, 2021	[1]	273,002
Beginning balance at Dec. 31, 2021		$ 2,730	[1]	$ 32,024,100	[1]			$ (130,267)	$ 183,900	$ (27,208,186)	$ 161,439	$ 5,033,716
Beginning balance (in shares) at Dec. 31, 2021	[1]					3,768
Beginning balance at Dec. 31, 2021	[1]					$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of warrants to common stock, including inducement (in shares)	[1]	32,700
Exercise of warrants to common stock, including inducement		$ 327	[1]	3,383,435	[1]							3,383,762
Exercise of options to common stock (in shares)	[1]	931
Exercise of options to common stock		$ 9	[1]	95,107	[1]							95,116
Issuance of common stock (in shares)	[1]	14,056
Issuance of common stock		$ 141	[1]	1,023,504	[1]							1,023,645
Issuance of common stock warrants				667,290	[1]							667,290
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)	[1]	2,932
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary		$ 30	[1]	(51,010)	[1]							(50,980)
Repayment of shareholders loan through in-kind services								111,720				111,720
Stock-based compensation				2,399,063	[1]							2,399,063
Currency translation adjustment									53,352			53,352
Ending balance (in shares) at Dec. 31, 2022	[1]	323,621
Ending balance at Dec. 31, 2022		$ 3,237	[1]	39,541,489	[1]	$ 0	[1]	(18,547)	237,252	(39,299,726)	161,439	$ 625,144
Ending balance (in shares) at Dec. 31, 2022						3,768	[1]					3,768
Ending balance at Dec. 31, 2022	[1]					$ 0						$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of warrants to common stock, including inducement (in shares)	[1]	121,550
Exercise of warrants to common stock, including inducement		$ 1,216	[1]	621,338	[1]							622,554
Exercise of options to common stock (in shares)	[1]	116
Exercise of options to common stock		$ 1	[1]	1,999	[1]							2,000
Issuance of common stock (in shares)	[1]	87,498
Issuance of common stock		$ 875	[1]	7,463,437	[1]							7,464,312
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)	[1]	16,532				(2,796)
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary		$ 165	[1]	(24,821)	[1]							(24,656)
Reverse stock split rounding (in shares)	[1]	318
Reverse stock split rounding	[1]	$ 3		(3)
Repayment of shareholders loan through in-kind services								18,547				18,547
Stock-based compensation				305,350	[1]							305,350
Currency translation adjustment									(30,842)			(30,842)
Net income (loss) attributable to T Stamp Inc.										(4,752,980)		(4,752,980)
Ending balance (in shares) at Sep. 30, 2023	[1]	549,635
Ending balance at Sep. 30, 2023		$ 5,497	[1]	47,908,789	[1]	$ 0	[1]	0	206,410	(44,052,706)	161,439	4,229,429
Ending balance (in shares) at Sep. 30, 2023	[1]					972
Ending balance at Sep. 30, 2023	[1]					$ 0
Beginning balance (in shares) at Dec. 31, 2022	[1]	323,621
Beginning balance at Dec. 31, 2022		$ 3,237	[1]	39,541,489	[1]	$ 0	[1]	(18,547)	237,252	(39,299,726)	161,439	$ 625,144
Beginning balance (in shares) at Dec. 31, 2022						3,768	[1]					3,768
Beginning balance at Dec. 31, 2022	[1]					$ 0						$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of warrants to common stock, including inducement (in shares)	[1]	182,750
Exercise of warrants to common stock, including inducement		$ 1,828	[1]	2,853,886	[1]							$ 2,855,714
Exercise of options to common stock (in shares)		116	[1]									82
Exercise of options to common stock		$ 1	[1]	1,999	[1]							$ 2,000
Issuance of common stock (in shares)	[1]	1,403				(1)
Issuance of common stock		$ 14	[1]	(14)	[1]							0
Issuance of common stock warrants				3,915,917	[1]					(3,915,917)		0
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)	[1]	13,853				(118)
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary		$ 139	[1]	(79,040)	[1]							(78,901)
Reverse stock split rounding (in shares)	[1]	316
Reverse stock split rounding		$ 3	[1]	(3)	[1]							0
Repayment of shareholders loan through in-kind services								18,547				18,547
Stock-based compensation				763,288	[1]							763,288
Currency translation adjustment									(97,582)			(97,582)
Ending balance (in shares) at Dec. 31, 2023	[1]	609,557
Ending balance at Dec. 31, 2023		$ 6,096	[1]	54,460,960	[1]	$ 0	[1]	0	139,670	(50,853,285)	161,439	$ 3,914,880
Ending balance (in shares) at Dec. 31, 2023						3,649	[1]					3,649
Ending balance at Dec. 31, 2023	[1]					$ 0						$ 0
Beginning balance (in shares) at Jun. 30, 2023	[1]	531,485
Beginning balance at Jun. 30, 2023		$ 5,315	[1]	47,141,784	[1]				188,206	(44,017,544)	161,439	3,479,200
Beginning balance (in shares) at Jun. 30, 2023	[1]					1,122
Beginning balance at Jun. 30, 2023	[1]					$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of warrants to common stock, including inducement (in shares)	[1]	18,000
Exercise of warrants to common stock, including inducement		$ 180	[1]	620,820	[1]							621,000
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)	[1]	150				(150)
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary		$ 2	[1]	(1,855)	[1]							(1,853)
Stock-based compensation				148,040	[1]							148,040
Currency translation adjustment									18,204			18,204
Net income (loss) attributable to T Stamp Inc.										(35,162)		(35,162)
Ending balance (in shares) at Sep. 30, 2023	[1]	549,635
Ending balance at Sep. 30, 2023		$ 5,497	[1]	47,908,789	[1]	$ 0	[1]	0	206,410	(44,052,706)	161,439	4,229,429
Ending balance (in shares) at Sep. 30, 2023	[1]					972
Ending balance at Sep. 30, 2023	[1]					$ 0
Beginning balance (in shares) at Dec. 31, 2023	[1]	609,557
Beginning balance at Dec. 31, 2023		$ 6,096	[1]	54,460,960	[1]	$ 0	[1]	$ 0	139,670	(50,853,285)	161,439	$ 3,914,880
Beginning balance (in shares) at Dec. 31, 2023						3,649	[1]					3,649
Beginning balance at Dec. 31, 2023	[1]					$ 0						$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of warrants to common stock, including inducement (in shares)	[1]	158,800
Exercise of warrants to common stock, including inducement		$ 1,588	[1]	(1,588)	[1]							0
Termination of common stock warrant agreement				(483,560)	[1]							$ (483,560)
Exercise of options to common stock (in shares)		125,333	[1]									0
Exercise of options to common stock		$ 1,253	[1]	3,476,534	[1]							$ 3,477,787
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)												3,649
Deemed dividend related to inducement transactions				(1,939,439)	[1]							$ (1,939,439)
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees		$ 211	[1]	(57,203)	[1]							(56,992)
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees (In shares)	[1]	21,113				(3,649)
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary		$ 3,399	[1]	4,342,703	[1]							4,346,102
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)	[1]	339,847
Stock-based compensation				956,603	[1]							956,603
Currency translation adjustment									(53,234)			(53,234)
Net income (loss) attributable to T Stamp Inc.										(4,593,406)		(4,593,406)
Ending balance (in shares) at Sep. 30, 2024	[1]	1,254,650
Ending balance at Sep. 30, 2024		$ 12,547	[1]	60,755,010	[1]	$ 0	[1]		86,436	(55,446,691)	161,439	$ 5,568,741
Ending balance (in shares) at Sep. 30, 2024						0	[1]					0
Ending balance at Sep. 30, 2024	[1]											$ 0
Beginning balance (in shares) at Jun. 30, 2024	[1]	758,943
Beginning balance at Jun. 30, 2024		$ 7,590	[1]	56,697,964	[1]	$ 0	[1]		175,059	(56,130,215)	161,439	911,837
Increase (Decrease) in Stockholders' Equity
Exercise of prefunded warrants to common stock (in shares)	[1]	63,860
Exercise of prefunded warrants to common stock		$ 639	[1]	(639)	[1]							0
Exercise of warrants to common stock, including inducement (in shares)	[1]	125,333
Exercise of warrants to common stock, including inducement		$ 1,253	[1]	3,476,534	[1]							3,477,787
Termination of common stock warrant agreement				(483,560)	[1]							$ (483,560)
Exercise of options to common stock (in shares)												0
Issuance of common stock (in shares)	[1]	306,514
Issuance of common stock		$ 3,065	[1]	2,652,557	[1]							$ 2,655,622
Deemed dividend related to inducement transactions				(1,939,439)	[1]							(1,939,439)
Stock-based compensation				351,593	[1]							351,593
Currency translation adjustment									(88,623)			(88,623)
Net income (loss) attributable to T Stamp Inc.										683,524		683,524
Ending balance (in shares) at Sep. 30, 2024	[1]	1,254,650
Ending balance at Sep. 30, 2024		$ 12,547	[1]	$ 60,755,010	[1]	$ 0	[1]		$ 86,436	$ (55,446,691)	$ 161,439	$ 5,568,741
Ending balance (in shares) at Sep. 30, 2024						0	[1]					0
Ending balance at Sep. 30, 2024	[1]											$ 0
[1] After giving effect to the 15 for 1 reverse stock split effected on January 6, 2025.

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)		9 Months Ended
	Jan. 06, 2025	Sep. 30, 2024
Stock split		0.20
Subsequent Events
Stock split	15

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income (loss) attributable to T Stamp Inc.	$ (4,593,406)	$ (4,752,980)
Net loss attributable to non-controlling interest	0	0
Adjustments to reconcile net loss to cash flows used in operating activities:
Depreciation and amortization	547,467	596,109
Stock-based compensation	956,603	305,350
Change in fair value of warrant liability	(5,842)	(3,473)
Repayment of shareholder loan through in-kind services	0	18,547
Impairment of capitalized internal-use software	23,595	16,819
Gain on sale of property and equipment	0	(216,189)
Non-cash interest	133,146	28,958
Non-cash lease expense	109,700	151,001
Non-cash write off of mobile hardware	(162,130)	(15,775)
Loss on retirement of equipment	3,751	17,589
Loss on inducement agreements	360,307	0
Loss on termination of warrant agreement	1,166,440	0
Non-cash investment gain	(5,000,000)	0
Changes in assets and liabilities:
Accounts receivable	310,595	467,129
Related party receivables	20,306	396
Prepaid expenses and other current assets	(387,143)	40,220
Other assets	(5,907)	(20,442)
Accounts payable	(124,842)	(258,376)
Accrued expense	526,370	(238,431)
Related party payables	(33,866)	(145,274)
Deferred revenue	84,950	(1,724,202)
Income tax payable	(1,975)	(5,616)
Operating lease liabilities	(111,277)	(145,483)
Net cash flows from operating activities	(6,183,158)	(5,884,123)
Cash flows from investing activities:
Proceeds from sale of property, plant and equipment	0	377,360
Investment	(100,000)	0
Capitalized internally developed software costs	(502,206)	(478,338)
Patent application costs	(71,883)	(78,169)
Purchases of property and equipment	(12,617)	(538)
Net cash flows from investing activities	(686,706)	(179,685)
Cash flows from financing activities:
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees	3,985,795	7,464,312
Payment to terminate common stock warrant agreement	(1,650,000)	0
Forfeited common stock shares to satisfy taxes	(56,992)	(24,656)
Proceeds from exercise of warrants to common stock	1,538,348	622,554
Proceeds from exercise of options to common stock	0	2,000
Proceeds from loans	845,000	0
Principal payments on loans	(287,228)	0
Principal payments on financial liabilities	0	(29,715)
Net cash flows from financing activities	4,374,923	8,034,495
Effect of foreign currency translation on cash	(47,775)	(42,678)
Net change in cash and cash equivalents	(2,542,716)	1,928,009
Cash and cash equivalents, beginning of period	3,140,747	1,254,494
Cash and cash equivalents, end of period	598,031	3,182,503
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	2,356	580
Supplemental disclosure of non-cash activities:
Adjustment to investing activities for warrants issued to the Company in lieu of cash	5,000,000	0
Adjustment to operating lease right-of-use assets related to renewed leases	143,594	82,185
Adjustment to operating lease operating lease liabilities related to renewed leases	142,192	83,298
Adjustment to operating lease right-of-use assets related to terminated leases	0	82,095
Adjustment to operating lease liabilities related to terminated leases	0	77,648
Prepaid rent expense reclassified upon termination of leases	$ 0	$ 5,335

Description of Business, Summar

Description of Business, Summary of Significant Accounting Policies, and Going Concern	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Description of Business, Summary of Significant Accounting Policies, and Going Concern
Description of Business, Summary of Significant Accounting Policies, and Going Concern	1. Description of Business, Summary of Significant Accounting Policies, and Going Concern Description of Business Trust Stamp primarily develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning artificial intelligence, including computer vision, cryptography, and data mining, to process and protect data and deliver insightful outputs that identify and defend against fraud, protect sensitive user information, facilitate automated processes, and extend the reach of digital services through global accessibility. We utilize the power and agility of technologies such as GPU processing, edge computing, neural networks, and large language models to process and protect data faster and more effectively than historically possible to deliver results at a disruptively low cost for usage across multiple industries. Our team has substantial expertise in the creation and development of AI-enabled software products. We license our technology and expertise in numerous fields, with an increasing emphasis on addressing diverse markets through established partners who will integrate our technology into field-specific applications. Reverse Split — one Amended and Restated Certificate of Incorporation Going Concern The Company’s ability to continue as a going concern in the next twelve months following the date the unaudited condensed consolidated financial statements were available to be issued is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to generate revenue and raise capital as needed to satisfy the Company’s capital needs. While the negotiation of significant additional revenue is well advanced, it has not reached a stage that allows it to be factored into a going concern evaluation. In addition, although the Company has previously been successful in raising capital as needed and has already made plans to do so as well as restructuring expenses to meet the Company’s cash needs, no assurance can be given that the Company will be successful in its capital raising efforts. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period. Basis of Presentation — Basis of Consolidation — The Company has completed the process of administratively dissolving AIID Payments Limited and the dissolution was effective October 29, 2024. Further, we continue to consolidate Tstamp Incentive Holdings (“TSIH”) which we consider to be a variable interest entity. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments necessary (which adjustments are of a normal and recurring nature) for the fair presentation of the Company’s financial position as of September 30, 2024 and December 31, 2023, and the results of operations for the three and nine months ended September 30, 2024 and 2023. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of results expected for the full year. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to the rules and regulations of the SEC. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The accounting policies employed are substantially the same as those shown in note 1 of the notes to consolidated financial statements included therein. Variable Interest Entity The Company considers this entity to be a variable interest entity (“VIE”) because it is thinly capitalized and holds no cash. Because the Company does not own shares in TSIH, management believes that this gives the Company a variable interest. Further, management of the Company also acts as management of TSIH and is the decision-maker as management grants shares held by TSIH to employees of the Company. As this VIE’s primary purpose is to hold shares in the Company from time to time and holds no other liabilities or assets, the Company is the primary beneficiary of TSIH and will consolidate the VIE. Major Customers and Concentration of Risks — For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures. Three customers represented 86.87% or 65.12%, 17.12%, and 4.63% of the balance of total Accounts receivable as of September 30, 2024 and three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. As of September 30, 2024 and December 31, 2023, the Company had not experienced any significant losses on its Accounts receivable. During the three months ended September 30, 2024, the Company sold to primarily three customers which made up approximately 93.24% of total Net revenue, and consisted of 66.34%, 17.60%, and 9.30% from an S&P 500 Bank, Mastercard, and Triton, respectively. Additionally, during the three months ended September 30, 2023, the Company sold to primarily three customers which made up approximately 95.85% of total Net revenue, and consisted of 81.87%, 7.91%, and 6.07% from IGS, Mastercard, and an S&P 500 Bank, respectively. During the nine months ended September 30, 2024, the Company sold to primarily three customers which made up approximately 94.68% of total Net revenue, and consisted of 63.66%, 21.07%, and 9.95% from an S&P 500 Bank, Mastercard, and Triton, respectively. Additionally, during the nine months ended September 30, 2023, the Company sold to primarily three customers which made up approximately 90.53% of total Net revenue, and consisted of 62.98%, 14.95%, and 12.60% from IGS, an S&P 500 Bank, and Mastercard, respectively. Property and Equipment, Net — Accounting for Impairment of Long-Lived Assets — As of September 30, 2024, the Company determined that $24 thousand of Capitalized internal-use software were impaired . Goodwill — Intangibles—Goodwill and Other financial performance and other relevant entity-specific events in determining whether it is more likely than not that the fair value of the reporting unit is less than the carrying amount. Should the Company conclude that it is more likely than not that the recorded Goodwill amounts have been impaired, the Company would perform the impairment test. Goodwill impairment exists when a reporting unit’s carrying value exceeds its fair value. Significant judgment is applied when Goodwill is assessed for impairment. There were no impairment charges to Goodwill as of September 30, 2024 and December 31, 2023. Remaining Performance Obligations — Disaggregation of Revenue ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Professional services (over time) ​ $ 424,831 ​ $ 2,990,804 ​ $ 1,326,403 ​ $ 3,760,242 License fees (over time) ​ ​ 86,250 ​ ​ 75,000 ​ ​ 258,750 ​ 225,000 Total Revenue ​ $ 511,081 ​ $ 3,065,804 ​ $ 1,585,153 ​ $ 3,985,242 ​ Recent Accounting Pronouncements Not Yet Adopted — , Income Taxes (Topic 740) – Improvements to Income Tax Disclosures In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions . The amendments in this ASU clarify that an entity should measure the fair value of an equity security subject to contractual sale restriction the same way it measures an identical equity security that is not subject to such a restriction. The FASB said the contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, should not affect its fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect this guidance to have a material impact to its unaudited condensed consolidated financial statements or related disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures . ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption of the amendments is permitted. The Company is currently evaluating the impacts of the new standard but does not expect a material impact to its unaudited condensed consolidated financial statements or related disclosures. 1A. Reverse Stock Split Reverse Split — December 30, 2024, the Company filed a Certificate of Amendment to the Company’s Third Amended and Restated Certificate of Incorporation, which was previously approved by the Company’s stockholders at the special meeting held on November 18, 2024 and described in the Company’s definitive proxy statement filed with the SEC on September 30, 2024, to effectuate a reverse stock split at a ratio of one (1) share of Common Stock for every fifteen (15) shares of Common Stock (the “ Reverse Stock Split ”) which became effective as of the opening of business on January 6, 2024 (the “ Effective Time ”). Accordingly, all share and per share amounts for all periods presented in the accompanying financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the reverse stock split.	1. Description of Business and Summary of Significant Accounting Policies And Going Concern Description of Business — Trust Stamp develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning, artificial intelligence, biometric science, cryptography, and data mining, to deliver insightful identity and trust predictions that identify and defend against fraudulent identity attacks, protect sensitive user information, and extend the reach of digital services through global accessibility. We utilize the power and agility of technologies such as GPU processing, edge-computing, neural networks, and large language models to process and protect data faster and more effectively than has ever previously been possible in order to deliver results at a disruptively low cost for usage across multiple industries, including: ● Banking/FinTech ● KYC/AML Compliance ● Humanitarian and Development Services ● Government and Law Enforcement, including Alternative to Detention programs ● Cryptocurrency and Digital Assets ● Biometrically Secured Email and Digital Communications ● P2P Transactions, Social Media, and Sharing Economy ● Real Estate, Travel, and Healthcare Reverse Split — Amended and Restated Certificate of Incorporation Going Concern The Company’s ability to continue as a going concern in the next twelve months following the date the consolidated financial statements were available to be issued is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to generate revenue and raise capital as needed to satisfy the Company’s capital needs. While the negotiation of significant additional revenue is well advanced, it has not reached a stage that allows it to be factored into a going concern evaluation. In addition, although the Company has previously been successful in raising capital as needed and has already made plans to do so as well as restructuring expenses to meet the Company’s cash needs, no assurance can be given that the Company will be successful in its capital raising efforts. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period. Basis of Presentation Basis of Consolidation On February 28, 2023, the Company received the Certificate of Termination from the State of Georgia, which represents the completion of administratively dissolving T Avatar LLC. As there were no operations established under the entity, there is a limited impact to Trust Stamp. The dissolution of T Avatar LLC was effective February 28, 2023. On June 2, 2023, the Company received the termination resolution from the Polish National Court Register, which represents the completion of administratively dissolving Sunflower AI Technologies (“SAIT”). As there were no operations established under the entity, there is a limited impact to Trust Stamp. The dissolution of SAIT was effective May 10, 2023. Further, we continue to consolidate Tstamp Incentive Holdings (“TSIH”) which we consider to be a variable interest entity. Variable Interest Entity The Company does not own any of the shares of Class A Common Stock of the Company held by TSIH. The Company considers this entity to be a variable interest entity (“VIE”) because it is thinly capitalized and holds no cash. Because the Company does not own shares in TSIH, management believes that this gives the Company a variable interest. Further, management of the Company also acts as management of TSIH and is the decision-maker as management grants shares held by TSIH to employees of the Company. As this VIE owns only shares in the Company and no other liabilities or assets, the Company is the primary beneficiary of TSIH and will consolidate the VIE. Use of Estimates Segment Information — Risks and Uncertainties Major Customers and Concentration of Risks For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures. Three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023 and three customers represented 95.37% or 36.90%, 32.69%, and 25.78% of the balance of total Accounts receivable as of December 31, 2022. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. As of December 31, 2023 and 2022, the Company had not experienced any significant losses on its Accounts receivable. During the year ended December 31, 2023, the Company sold to primarily three customers which made up approximately 89.75% of total Net revenue, and consisted of 55.04%, 17.77%, and 16.94% from IGS, an S&P 500 Bank, and Mastercard, respectively. Additionally, during the year ended December 31, 2022, the Company sold to primarily three customers which made up approximately 93.60% of total Net revenue, and consisted of 61.01%, 18.36%, and 14.23% from ICE, an S&P 500 Bank, and Mastercard. Foreign Currencies Cash and Cash Equivalents Accounts Receivable and Allowance for Credit Losses The Company maintains an allowance for credit losses, which represents an estimate of expected losses over the remaining contractual life of its receivables considering current market conditions and estimates for supportable forecasts when appropriate. The Company measures expected credit losses on its trade receivables on a customer basis. The estimate of expected credit losses considers any historical losses, delinquency trends, collection experience, and/or economic risk where appropriate. Additionally, management develops a specific allowance for trade receivables known to have a high risk of expected future credit loss. The Company has historically experienced immaterial write-offs given the nature of the customers and contracts. As of December 31, 2023, the Company had gross receivables (including unbilled receivables) of $694 thousand and an allowance for credit losses of $8 thousand. As of December 31, 2022, the Company had gross receivables of $1.01 million and no allowance for credit losses. As of December 31, 2023 and 2022, Accounts receivable includes unbilled receivables of $143 thousand and $109 thousand, respectively. Property and Equipment, Net Capitalized Internal-Use Software, Net Capitalized Internal-Use Software, Net is a combination of c Accounting for Impairment of Long-Lived Assets As of December 31, 2023, the Company determined that $19 thousand of Capitalized internal-use software and $12 thousand of Intangible assets was impaired. The impaired Capitalized internal-use software was expensed to Research and development during the year ended December 31, 2023.. As of December 31, 2022, the Company determined that no long-lived assets with finite lives were impaired. Goodwill Intangibles—Goodwill and Other Fair Value of Assets and Liabilities — Level 1 Level 2 Level 3 A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The estimated fair values of Cash and cash equivalents, Accounts receivable, Related party receivables, Prepaid expenses and other current assets, Other assets, Accounts payable, Related party payables, Accrued expenses, Deferred revenue, Customer deposit liabilities, and Notes payable approximate their carrying values. The fair values of warrant liabilities issued in connection with equity or debt issuance are determined using the Black-Scholes valuation model, a “Level 3” fair value measurement, based on the estimated fair value of the underlying common stock, volatility based on the historical volatility data of similar companies, considering the industry, products and market capitalization of such other entities, the expected life based on the remaining contractual term of the conversion option and warrant liabilities and the risk free interest rate based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrant liability’s contractual life. The Company accounts for its financial assets and liabilities at fair value regularly. The Company evaluates the fair value of its non-financial assets and liabilities on a nonrecurring basis. Revenue Recognition — ● Identification of the contract, or contracts with a customer; ● Identification of the performance obligations in the contract; ● Determination of the transaction price; ● Allocation of the transaction price to the performance obligations in the contract; and ● Recognition of revenue when or as the Company satisfies the performance obligations. At contract inception, the Company will assess the services agreed upon within each contract and assess whether each service is distinct and determine those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In general, each contract with a customer consists of a single performance obligation to perform services in which revenue is recognized when the service has been delivered. Remaining Performance Obligations considered a remaining performance obligation. As of December 31, 2023 and 2022, the Company did not have any related performance obligations for contracts with terms exceeding twelve months. Disaggregation of Revenue ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Professional services (over time) ​ $ 4,260,275 ​ $ 4,415,512 Termination expense reimbursement (one time) ​ — ​ 719,565 License fees (over time) ​ 300,000 ​ 250,000 Total Revenue ​ $ 4,560,275 ​ $ 5,385,077 ​ Contract Balances — . The payment terms and conditions vary by contract; however, the Company’s terms generally require payment within 30 to 60 days from the invoice date. In instances where the timing of revenue recognition differs from the timing of payment, the Company elected to apply the practical expedient in accordance with ASC 606 to not adjust contract consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when promised goods and services are transferred to the customer and when the customer pays for those goods and services will be one year or less. As such, the Company determined its contracts do not generally contain a significant financing component. Costs to Obtain and Fulfill Contracts — Warrants — Cost of Services Provided — Research and Development — Advertising — Stock- Based Compensation — input of highly subjective assumptions, including the fair value of the underlying common shares, the expected term of the share option, the expected volatility of the price of our common shares, risk-free interest rates, and the expected dividend yield of common shares. The assumptions used to determine the fair value of the option awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment. The calculated fair value is recognized as expense over the requisite service period using the straight-line method. Forfeitures are accounted for in the period in which they occur. Trust Stamp offers the indirect repurchase of shares through a net-settlement feature upon the vesting of RSU awards to satisfy minimum statutory tax-withholding requirements for the recipient. Income Taxes — A valuation allowance is established if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income in assessing the need for a valuation allowance. The Company’s tax positions are subject to income tax audits by multiple tax jurisdictions. The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not the position will be sustainable upon examination by the taxing authority, including resolution of any related appeals or litigation processes. This evaluation is based on all available evidence and assumes that the tax authorities have full knowledge of all relevant information concerning the tax position. The tax benefit recognized is measured as the largest amount of benefit which is more likely than not (greater than 50% likely) to be realized upon ultimate settlement with the taxing authority. The Company recognizes interest accrued and penalties related to unrecognized tax benefits in Income tax benefit (expense). The Company adjusts these reserves in accordance with the income tax guidance when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may affect the provision for income taxes in the period in which such determination is made and could have a material impact on the Company’s financial condition and operating results. The Company computes its tax provision for interim periods by applying the estimated annual effective tax rate to year-to-date pre-tax income from recurring operations and adjusting for discrete tax items arising in that quarter. There were no discrete items that impacted the effective tax rate for the years ended December 31, 2023 and 2022, respectively. The rate remained consistent over the period due to the full valuation allowance recorded in the period. The Company had an effective tax rate of 0% for the years ended December 31, 2023 and 2022, respectively. The Company has incurred U.S. operating losses and has minimal profits in foreign jurisdictions. Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences are deductible. In making this determination, management considers all available positive and negative evidence affecting specific deferred tax assets, including the Company’s past and anticipated future performance, the reversal of deferred tax liabilities, the length of carry-back and carry-forward periods, and the implementation of tax planning strategies. The Company had no unrecognized tax benefits as of December 31, 2023 and 2022. It is the Company’s policy to recognize interest and penalties related to income tax matters in Income tax benefit (expense). The Company has not accrued any penalties related to uncertain tax positions due to offsetting tax attributes as of December 31, 2023 and 2022. The Company files U.S. federal, state, and foreign income tax returns in jurisdictions with varying statutes of limitation. The only material jurisdiction where the Company is subject to potential examination by tax authorities is the U.S. (federal and state) for tax years 2020 through 2022. Leases — Lessors—Certain Leases with Variable Lease Payments Operating lease right-of-use assets represent the Company’s right to use an underlying asset during a lease term and are included in non-current assets on our consolidated balance sheet. Operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease liabilities are divided into two classifications on our consolidated balance sheet as a current liability, Short-term operating lease liabilities, and a non-current liability, Long-term operating lease liabilities. The Company does not have any finance lease right-of-use assets or finance lease liabilities. The Company’s operating lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. The interest rate implicit in the lease is not readily determinable, therefore, the Company uses an estimated incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s Operating lease right-of-use assets are also recognized at the applicable lease commencement date. The Operating lease right-of-use asset equals the carrying amount of the related operating lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable Operating lease right-of-use asset or operating lease liability. The term of our leases equals the non-cancellable period of the lease, including any rent-free periods provided by the lessor, and also include options to renew or extend the lease (including by not terminating the lease) that we are reasonably certain to exercise. We establish the term of each lease at lease commencement and reassess that term in subsequent periods if a triggering event occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term. Some lease contracts include lease and non-lease components. Trust Stamp elected the practical expedient offered by ASC 842 to not separate the lease components from non-lease components. As a result, the Company accounts for leases as a single lease component. In addition, the Company elected not to recognize right-of-use assets and lease liabilities for leases term of twelve months or less. The short-term lease expenses are recognized on a straight-line basis over the lease term. Commitments and Contingencies - Treasury Stock - Net Loss per Share Attributable to Common Stockholders — Recent Accounting Pronouncements Not Yet Adopted — In December 2023, the FASB issued ASU 2023-09 , Income Taxes – Improvements to Income Tax Disclosures . ASU 2023-09 requires enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impacts of the new standard but does not expect a material impact to its consolidated financial statements or related disclosures. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions . The amendments in this ASU clarify that an entity should measure the fair value of an equity security subject to contractual sale restriction the same way it measures an identical equity security that is not subject to such a restriction. The FASB said the contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, should not affect its fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect this guidance to have a material impact to its consolidated financial statements or related disclosures. Recently Adopted Accounting Pronouncement — In June 2016, the FASB issued Accounting Standards Update No. 2016-13, “Financial Instruments - Credit Losses (Topic 326)” (“ASU 2016-13”). ASU 2016-13 revises the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. In November 2019, FASB issued ASU 2019-10, “ Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842 ). ” This ASU defers the effective date of ASU 2016-13 for public companies that are considered smaller reporting companies as defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted this standard as of January 1, 2023, and the guidance did not have a material impact on its consolidated financial statements or related disclosures. 1A. Reverse Stock Split Reverse Split — Reverse Stock Split Effective Time

Borrowings

Borrowings	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Borrowings
Borrowings	2. Borrowings Promissory Notes Payable ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Malta loan receipt 3 – June 3, 2022 ​ $ 511,262 ​ $ 507,035 Malta loan receipt 2 – August 10, 2021 ​ ​ 315,673 ​ ​ 313,063 Malta loan receipt 1 – February 9, 2021 ​ ​ 64,807 ​ ​ 64,271 Interest added to principal ​ ​ 70,088 ​ ​ 29,191 Total principal outstanding ​ ​ 961,830 ​ ​ 913,560 Plus: accrued interest ​ ​ 45,383 ​ ​ 40,317 Total promissory notes payable ​ $ 1,007,213 ​ $ 953,877 ​ In May 2020, the Company formed a subsidiary in the Republic of Malta, Trust Stamp Malta, with the intent to establish a research and development center with the assistance of potential grants and loans from the Maltese government. As part of the creation of this entity, we entered into an agreement with the government of Malta for a potentially repayable advance of up to €800 thousand or $858 thousand to assist in covering the costs of 75% of the first 24 months of payroll costs for any employee who begins 36 months from the execution of the agreement on July 8, 2020. On February 9, 2021 the Company began receiving funds and as of September 30, 2024, the balance received was $892 thousand which includes changes in foreign currency rates. The liability was paid in full on November 15, 2024. The Company will pay an annual interest rate of 2% over the European Central Banks (ECB) base rate as set on the beginning of the year in review. If the ECB rate is below negative 1%, the interest rate shall be fixed at 1%. The Company will repay a minimum of 10% of Trust Stamp Malta’s pre-tax profits per annum capped at 15% of the amount due to the Corporation until the disbursed funds are repaid. At this time, Trust Stamp Malta does not have any revenue-generating contracts and therefore, we do not believe any amounts shall be classified as current. The Malta loan interest rate increased from 4.5% for the nine months ended September 30, 2023 to 6.5% for the nine months ended September 30, 2024 due to the increased interest rate noted by the ECB. The liability was paid in full on November 15, 2024. Subordinated Business Loans ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ ​ 2024 ​ ​ 2023 Agile loan agreement 1 - July 9, 2024 ​ $ 315,000 ​ $ — Agile loan agreement 2 - August 29,2024 ​ 530,000 ​ — Interest added to loan agreement 1 - July 9, 2024 ​ 54,450 ​ — Interest added to loan agreement 2 - August 29, 2024 ​ 33,314 ​ — Total principal and interest outstanding ​ 932,764 ​ — Less: loan repayments ​ 287,228 ​ — Total promissory notes payable ​ $ 645,536 ​ $ — ​ On July 9, 2024, the Company entered into a subordinated secured promissory note with Agile Lending, LLC as lead lender (“Agile”) and Agile Capital Funding, LLC as collateral agent, which provides for a term loan to the Company of $454 thousand with the principal amount of $315 thousand and interest of $139 thousand. Commencing July 18, 2024, the Company is required to make weekly payments of $16 thousand until the due date, January 23, 2025. The loan may be prepaid subject to a prepayment fee. An administrative agent fee of $15 thousand was paid on the loan. In connection with the loan, Agile was issued a subordinated secured promissory note, dated July 9, 2024, in the principal amount of $315 thousand which note is secured by all of the Borrower’s assets, including receivables. On August 29, 2024, the Company entered into another subordinated secured promissory note with Agile Lending, LLC as lead lender (“Agile”) and Agile Capital Funding, LLC as collateral agent, which provides for a term loan to the Company of $763 thousand with the principal amount of $530 thousand and interest of $233 thousand. Commencing September 6, 2024, the Company is required to make weekly payments of $27 thousand until the due date, March 14, 2025. The loan may be prepaid subject to a prepayment fee. An administrative agent fee of $27 thousand was paid on the loan. In connection with the loan, Agile was issued a subordinated secured promissory note, dated August 29, 2024, in the principal amount of $530 thousand which note is secured by all of the Borrower’s assets, including receivables.	2. Borrowings Promissory Notes Payable ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Malta loan receipt 3 – June 3, 2022 ​ $ 507,035 ​ $ 62,365 Malta loan receipt 2 – August 10, 2021 ​ ​ 313,063 ​ ​ 303,778 Malta loan receipt 1 – February 9, 2021 ​ 64,271 ​ 491,996 Interest added to principal ​ ​ 29,191 ​ ​ 11,551 Total principal outstanding ​ 913,560 ​ 869,690 Plus: accrued interest ​ 40,317 ​ 16,775 Total promissory notes payable ​ $ 953,877 ​ $ 886,465 ​ In May 2020, the Company formed a subsidiary in the Republic of Malta, Trust Stamp Malta Limited, with the intent to establish a research and development center with the assistance of potential grants and loans from the Maltese government. As part of the creation of this entity, we entered into an agreement with the government of Malta for a potentially repayable advance of up to €800 thousand or $858 thousand to assist in covering the costs of 75% of the first 24 months of payroll costs for any employee who begins 36 months from the execution of the agreement on July 8, 2020. On February 9, 2021, the Company began receiving funds and as of December 31, 2023 The Company will pay an annual interest rate of 2% over the European Central Banks (ECB) base rate as set on the beginning of the year in review. If the ECB rate is below negative 1%, the interest rate shall be fixed at 1%. The Company will repay a minimum of 10% of Trust Stamp Malta Limited’s pre - tax profits per annum capped at 15% of the amount due to the Corporation until the disbursed funds are repaid. At this time, Trust Stamp Malta Limited does not have any revenue - generating contracts and therefore, we do not believe any amounts shall be classified as current. The Malta loan interest rate increased from 2.5% for the year ended December 31, 2022 to 4.5% for the year ended December 31, 2023.

Warrants

Warrants	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Warrants
Warrants	3. Warrants Liability Classified Warrants The following table presents the change in the liability balance associated with the liability classified warrants, which are classified in Level 3 of the fair value hierarchy from January 1, 2023 to September 30, 2024: ​ ​ ​ ​ ​ ​ Warrants ($) Balance as of January 1, 2023 ​ $ 261,569 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,033) Balance as of December 31, 2023 ​ $ 256,536 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,842) Balance as of September 30, 2024 ​ $ 250,694 ​ As of September 30, 2024, the Company has issued a customer a warrant to purchase up to $1.00 million of capital stock in a future round of financing at a 20% discount of the lowest price paid by another investor. The warrant was issued on November 9, 2016. There is no vesting period, and the warrant expires on November 30, 2026. The Company evaluated the provisions of ASC 480, Distinguishing Liabilities from Equity, noting the warrant should be classified as a liability due to its settlement being for a variable number of shares and potentially for a class of shares not yet authorized. The warrant was determined to have a fair value of $250 thousand which was recorded as a Deferred contract acquisition asset and to a Warrant liability during the year ended December 31, 2016 and was amortized as a revenue discount prior to the current periods presented. The fair value of the warrant was estimated on the date of grant by estimating the warrant’s intrinsic value on issuance using the estimated fair value of the Company as a whole and has a balance of $250 thousand as of September 30, 2024. On December 16, 2016, the Company issued an investor warrant to purchase $50 thousand worth of shares of our Class A Common Stock. The warrants have no vesting period and expires on December 16, 2026. The warrant agreement states that the investor is entitled to the “number of shares of Common Stock with a Fair Market Value as of the Determination Date of The Company used a Black-Scholes-Merton pricing model to determine the fair value of the warrants and uses this model to assess the fair value of the warrant liability. As of September 30, 2024, the warrant liability is recorded at $1 thousand which is a $6 thousand decrease, recorded to Change in fair value of warrant liability, from the balance of $7 thousand as of December 31, 2023. The following assumptions were used to calculate the fair value of the warrant liability during the nine months ended September 30, 2024: ​ ​ ​ ​ ​ ​ Fair Value of Warrants $ 1.65 — $9.60 ​ Exercise price ​ $ 3.90 — $7.35 ​ Risk free interest rate ​ ​ 3.51%— 4.50 % Expected dividend yield ​ ​ — % Expected volatility ​ ​ 79.19% — 79.59 % Expected term ​ ​ 1 year - 3 years ​ Equity Classified Warrants ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, Warrant Issuance Date ​ Strike Price ​ 2024 ​ 2023 November 9, 2016 ​ $ 46.80 5,342 5,342 January 23, 2020 ​ $ 120.00 ​ 12,430 ​ 12,430 January 23, 2020 ​ $ 120.00 ​ 34,974 ​ 34,974 April 18, 2023 ​ $ 20.10 ​ — ​ 51,689 June 5, 2023 ​ $ 4.80 ​ — ​ 85,314 December 21, 2023 ​ $ 4.80 ​ 192,869 ​ 240,000 April 3, 2024 ​ $ 14.55 ​ — ​ — April 3, 2024 ​ $ 15.90 ​ — ​ — September 3, 2024 ​ $ 4.80 ​ 95,494 ​ — September 3, 2024 ​ $ 4.80 ​ 190,987 ​ — September 3, 2024 ​ $ 4.80 ​ 636,404 ​ — September 10, 2024 ​ $ 3.45 ​ 250,930 ​ — Total warrants outstanding ​ ​ ​ ​ 1,419,430 ​ 429,749 ​ November 9, 2016 The Company has issued a customer a warrant to purchase 5,342 shares of Class A Common Stock with an exercise price of $46.80 per share. The warrant was issued on November 9, 2016. There is no vesting period, and the warrant expires on November 30, 2026. January 23, 2020 In January 2020, the Company issued REach®, a related party, a warrant to purchase 12,430 shares of the Company’s Class A Common Stock at a strike price of $120.00 per share in exchange for the cancellation of a $100 thousand SAFE issued on August 18, 2017 by the Company’s affiliate Trusted Mail Inc. with a value of $125 thousand. The warrants were issued on January 23, 2020. There is no vesting period, and the warrants expire on December 20, 2024. January 23, 2020 In January 2020, the Company issued SCV, a related party, a warrant to purchase 62,141 shares of the Company’s Class A Common Stock at a strike price of $120.00 per share in exchange for $300 thousand in cash and “Premium” sponsorship status with a credited value of $100 thousand per year for 3 years totaling $300 thousand. This “premium” sponsorship status provides the Company with certain benefits in marketing and networking, such as the Company being listed on the investor’s website, as well as providing the Company certain other promotional opportunities organized by the investor. The warrants were issued on January 23, 2020. There is no vesting period, and the warrants expire on December 20, 2024. On December 21, 2021, SCV executed a Notice of Exercise for certain of its warrants to purchase 27,168 shares of Class A Common Stock at an exercise price of $120.00 per share for a total purchase price of $3.26 million. The closing occurred on January 10, 2022 and resulted in total cash proceeds of $3,260,000 to the Company for the warrant exercise. The warrants to purchase the remaining 34,974 shares of the Company’s Class A Common Stock remain outstanding as of September 30, 2024. April 18, 2023 On April 14, 2023, the Company entered into a securities purchase agreement (“SPA”) with Armistice Capital Master Fund Ltd. Pursuant to which the Company agreed to issue and sell to the investor (i) in a registered direct offering, 37,559 shares of Class A Common Stock, par value $0.01 per share of the Company at a price of $49.50 per share, and pre-funded warrants to purchase up to 67,330 shares of Class A Common Stock, at a price of $49.485 per prefunded warrant, at an exercise price of $0.015 per share of Class A Common Stock, and (ii) in a concurrent private placement, common stock purchase warrants, exercisable for an aggregate of up to 104,889 shares of Class A Common Stock, at an exercise price of $49.50 per share. On April 18, 2023, the Company sold 37,559 shares of Class A Common Stock to the institutional investor at a price of $49.50 per share for total proceeds $1,859,154. Additionally, on same date, the institutional investor purchased and exercised the 67,330 pre-funded warrants, for total proceeds to the Company of $3,332,835, resulting in an aggregate issuance by the Company of 104,889 shares of Class A Common Stock for net proceeds of $4,778,550 from the registered direct offering after deducting placement fee and legal expense of $363,439 and $50,000, respectively. On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the warrants to purchase the remaining 104,889 shares of Class A Common Stock of the Company was reduced to $20.10 for a total purchase price of $2,108,262. On December 21, 2023, the remaining 104,889 common stock purchase warrants to purchase shares of Class A Common Stock of the Company at a price of $20.10 per warrant were exercised for total proceeds of $2,108,262. As of December 31, 2023, the Company had received Notice to Exercise for 53,200 common stock purchase warrants resulting in an issuance by the Company of 53,200 shares of Class A Common Stock. Due to the beneficial ownership limitation provisions in the Inducement Agreement, as of December 31, 2023 the remaining 51,689 common stock purchase warrants exercised on December 21, 2023 were unissued and held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. On February 7, 2024 and February 27, 2024, the Company issued 21,334 and 30,356 shares, respectively. All warrants related to this investment have been exercised and are no longer outstanding as of September 30, 2024. June 5, 2023 On June 1, 2023, the Company entered into a securities purchase agreement (“SPA”) with an Armistice Capital Master Fund Ltd. Pursuant to which the Company agreed to issue and sell to the investor (i) in a registered direct offering, 49,094 shares of Class A Common Stock, par value $0.01 per share of the Company at a price of $34.50 per share, and pre-funded warrants to purchase up to 36,220 shares of Class A Common Stock, at a price of $34.485 per prefunded warrant, at an exercise price of $0.015 per share of Class A Common Stock, and (ii) in a concurrent private placement, common stock purchase warrants, exercisable for an aggregate of up to 85,314 shares of Class A Common Stock, at an exercise price of $34.50 per share. On June 5, 2023, the Company sold 49,094 shares of Class A Common Stock to the institutional investor at a price of $34.50 per share for total proceeds of $1,693,720. Additionally, on same date, the institutional investor purchased the 36,220 pre-funded warrants at a price of $34.485 per prefunded warrant, for total proceeds to the Company of $1,249,047, resulting in an issuance by the Company of 49,094 shares of Class A Common Stock for net proceeds of $2,686,773 from the registered direct offering after deducting placement fee and legal expense of $205,994 and $50,000, respectively. On June 12, 2023, the institutional investor exercised 21,487 pre-funded warrants at a price of $0.015 per prefunded warrant, resulting in an issuance by the Company of 21,487 shares of Class A Common Stock for total proceeds of $322. Additionally, on June 23, 2023, the institutional investor exercised 14,734 pre-funded warrants at a price of $0.015 per prefunded warrant, resulting in an issuance by the Company of 14,734 shares of Class A Common Stock for total proceeds of $221. On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the common stock purchase warrants to purchase the remaining 85,314 shares of Class A Common Stock of the Company was reduced to $20.10 for a total purchase price of $1,714,798. On December 21, 2023, the institutional investor exercised 7,112 warrants to purchase shares of Class A Common Stock of the Company at a price of $20.10 per warrant for total proceeds of $142,938. As of December 31, 2023, due to the beneficial ownership limitation provisions in the Inducement Agreement, the 7,112 warrants were unissued and held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. These shares were subsequently issued on February 27, 2024. On September 3, 2024, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the common stock purchase warrants to purchase the remaining 78,202 shares of Class A Common Stock of the Company was reduced to $4.8345. All of the 78,202 shares were exercised and issued on September 4, 2024. All warrants related to this investment have been exercised and are no longer outstanding as of September 30, 2024. December 21, 2023 On December 21, 2023, the Company entered into a warrant exercise agreement (the “WEA”) with a certain existing institutional investor, pursuant to which the institutional investor agreed to exercise (the “Exercise”) (i) a portion (7,112) of the warrants issued to the institutional investor on June 5, 2023, which, as of December 21, 2023, were exercisable for 85,314 shares of the Company’s Class A Common Stock, par value $0.01 per share (“Class A Common Stock”) with a current exercise price of $34.50 per share (the “June 2023 Warrants”), (ii) all of the warrants issued to the institutional investor on September 14, 2022, as amended on June 5, 2023, which are exercisable for 8,000 shares of Class A Common Stock, with a current exercise price of $34.50 per share (the “September 2022 Warrants”), and (iii) all of the warrants issued to the institutional investor on April 18, 2023, which are exercisable for 104,889 shares of Class A Common Stock, with a current exercise price of $49.50 per share (the “April 2023 Warrants” and collectively with all of the June 2023 Warrants and the September 2022 Warrants, the “Existing Warrants”). In consideration for the immediate exercise of 120,000 of the Existing Warrants for cash, the Company agreed to reduce the exercise price of all of the Existing Warrants, including any unexercised portion thereof, to $20.10 per share, which was equal to the most recent closing price of the Company’s Class A Common Stock on The Nasdaq Stock Market prior to the execution of the WEA. As of September 30, 2024, the institutional investor had submitted an Exercise Notice for all 120,000 Existing Warrants, in two batches, 61,200 and 58,800, respectively, and the shares of Class A Common Stock were issued to the warrant holders. In addition, in consideration for such Exercise, the Selling Stockholder received new unregistered warrants to purchase up to an aggregate of 240,000 shares of Class A Common Stock, equal to 200% of the shares of Class A Common Stock issued in connection with the Exercise, with an exercise price of $20.10 per share (the “New Warrants”) in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933 (the “Securities Act”). On September 3, 2024, the Company entered into an Inducement Agreement with an institutional investor. Pursuant to the terms of the Inducement Agreement, the exercise price for the common stock purchase warrants to purchase the remaining 240,000 shares of Class A Common Stock of the Company was reduced to $4.835. The 240,000 warrants were subsequently exercised resulting in the Company receiving $1,160,280 in cash proceeds. Due to the beneficial ownership limitation provisions in the Inducement Agreement, 47,132 shares were issued on September 4, 2024. The warrants to purchase the remaining 192,869 shares are held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. These shares were subsequently issued on November 5, 2024. April 3, 2024 On April 3, 2024, the Company closed a Securities Purchase Agreement with a certain institutional investor. Pursuant to the terms of the Securities Purchase Agreement, the investor agreed to purchase from the Company 33,333 shares of Class A Common Stock, par value $0.01 of the Company and pre-funded warrants to purchase 100,001 shares of Class A Common Stock of the Company (“Warrant A”) at a purchase price of $14.52 per share resulting in a total purchase price of $1,936,000. The Company paid offering costs of $245,520 resulting in net proceeds of $1,690,480. Additionally, pursuant to the Securities Purchase Agreement, as additional consideration for the share and Warrant A purchase described above, the Company agreed to issue to the Selling Stockholder a stock purchase warrant for the purchase of 133,334 shares of the Company’s Class A Common Stock at an exercise price of $14.52 per share (“Warrant B”), and a stock purchase warrant for the purchase of 106,667 shares of the Company’s Class A Common Stock at an exercise price of $15.90 per share (“Warrant C”). On May 24, 2024, the institutional investor exercised 36,140 pre-funded warrants from Warrant A to purchase shares of Class A Common Stock of the Company at an exercise price of $0.00 per warrant for total proceeds of $0. On July 26, 2024, the institutional investor exercised a further 53,273 pre-funded warrants from Warrant A to purchase shares of Class A Common Stock of the Company at an exercise price of $0.00 per warrant for total proceeds of $0. On August 20, 2024, the institutional investor exercised the remaining 10,588 pre-funded warrants from Warrant A to purchase shares of Class A Common Stock of the Company at an exercise price of $0.00 per warrant for total proceeds of $0. Subsequent to the August 20, 2024 exercise, there were no remaining securities in Warrant A. On September 3, 2024, the Company entered into a Termination and Release Agreement under which the transaction entered into between the Company and institutional investor that terminated the remaining 133,334 stock purchase warrants in Warrant B and 106,667 stock purchase warrants in Warrant C. In consideration of the termination of the Transaction Documents, the Company made a $1,650,000 payment to the institutional investor. All warrants related to this investment have been exercised or terminated and are no longer outstanding as of September 30, 2024. September 3, 2024 On September 3, 2024, the Company entered into a securities purchase agreement with a single institutional investor to purchase 95,494 shares of Class A Common Stock, par value $0.01 of the Company (or pre-funded warrants in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. The shares were purchased at $4.8195 resulting in proceeds of $460,230. In a concurrent private placement, the Company also agreed to issue and sell unregistered warrants to purchase up to an aggregate of 190,987 shares of Class A Common Stock, par value $0.01 of the Company. The exercise price for each share of common stock (or pre-funded warrant in lieu thereof) and accompanying warrant is $4.8345. The private placement warrants will be exercisable upon receipt of shareholder approval and will expire five years from the initial exercise date and will have an exercise price of $4.8345 per share. As of the date of this Quarterly Report on Form 10-Q, the Company has not received shareholder approval but will hold a vote on November 18, 2024. The warrants to purchase the remaining 95,494 shares of the Company’s Class A Common Stock are held in abeyance as of September 30, 2024 and 190,987 shares of the Company’s Class A Common Stock remain outstanding as of September 30, 2024. On November 6, 2024, the 95,494 shares were issued upon the exercise of the warrants for $0.015 per share resulting in $1,432 in proceeds. September 3, 2024 On September 3, 2024, the Company also entered into a warrant inducement agreement with a single institutional investor to exercise 78,202 outstanding warrants that the Company issued on June 5, 2023 (as amended on December 20, 2023) and 240,000 outstanding warrants that the Company issued on December 20, 2023. These warrant exercises are discussed under the June 5, 2023 and December 20, 2023 sections above. In consideration for the immediate exercise of the warrants, the Company also agreed to issue to the investor unregistered warrants to purchase an aggregate of 636,404 shares of the Company’s common stock. These warrants will have an exercise price of $4.835 per share, will be exercisable upon receipt of shareholder approval and will expire five years from the initial exercise date. As of the date of this Quarterly Report on Form 10-Q, the Company has not received shareholder approval but will hold a vote on November 18, 2024. In accordance with the Inducement Agreement we recognized a deemed dividend of $1.94 million calculated as the fair value of the warrants and reduction in exercise price of the warrants as described above immediately following the Inducement Agreement. The fair values were determined using the Black Sholes Model. This deemed dividend is added to net loss to arrive at net loss attributable to common stockholders on the statements of operations. The warrants to purchase the remaining 636,404 shares of the Company’s Class A Common Stock remain outstanding as of September 30, 2024. September 10, 2024 On September 10, 2024, T Stamp Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement the (“SPA”) with a certain institutional investor. The investor and the Company previously entered into that certain Securities Purchase Agreement dated July 13, 2024, in which the Company issued 306,514 shares of Class A Common Stock, par value $0.01 of the Company (the “Class A Common Stock”) in exchange for the issuance by the investor to the Company of (i) a $500,000 promissory note payable on July 31, 2024; (ii) a $500,000 promissory note payable on August 31, 2024; and (iii) a $1,000,000 promissory note payable within three (3) trading days of an effective resale registration statement. As of the date of this report, all promissory notes have been repaid. Pursuant to the terms of the SPA, the Company agreed, at the closing of the SPA and upon the terms and subject to the conditions set forth in the SPA, to issue certain shares warrants to purchase 250,930 shares of Class A Common Stock, with an exercise price equal to $3.41, subject to adjustment in certain circumstances. The warrants to purchase the remaining 250,930 shares of the Company’s Class A Common Stock remain outstanding as of September 30, 2024.	3. Warrants Liability Classified Warrants The following table presents the change in the liability balance associated with the liability classified warrants, which are classified in Level 3 of the fair value hierarchy from January 1, 2022 to December 31, 2023 ​ ​ ​ ​ ​ ​ Warrants ($) Balance as of January 1, 2022 ​ $ 374,694 Additional warrants issued ​ — Change in fair value ​ ​ (113,125) Balance as of December 31, 2022 ​ $ 261,569 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,033) Balance as of December 31, 2023 ​ $ 256,536 ​ As of December 31, 2023 December 31, 2023 On December 16, 2016, the Company issued an investor warrant to purchase $50 thousand worth of shares of our Class A Common Stock. The warrants have no vesting period and expires on December 16, 2026. The warrant agreement states that the investor is entitled to the “number of shares of Common Stock with a Fair Market Value as of the Determination Date of $50,000”. The determination date is defined as the “date that is the earlier of (A) the conversion of the investor’s Note into the equity interests of the Company or (B) the maturity date of the Note.” The investor converted the referenced Note on June 30, 2020, therefore, defining the determination date. The number of shares to be purchased is settled as 428 shares as of June 30, 2020. The exercise price of the warrants is variable until the exercise date. The Company used a Black-Scholes-Merton pricing model to determine the fair value of the warrants and uses this model to assess the fair value of the warrant liability. As of December 31, 2023 ​ ​ ​ ​ ​ ​ Fair Value of Warrants $ 13.95 – $30.15 ​ Exercise price ​ $ 7.95 – $14.40 ​ Risk free interest rate ​ 4.09% - 4.74 % Expected dividend yield ​ — % Expected volatility ​ 79.08% - 92.90 % Expected term ​ 3 years ​ Equity Classified Warrants ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, Warrant Issuance Date Strike Price 2023 2022 November 9, 2016 ​ $ 46.80 5,342 5,342 January 23, 2020 ​ $ 120.00 ​ 12,430 ​ 12,430 January 23, 2020 ​ $ 120.00 34,974 54,974 August – December 2021 ​ $ 300.00 — 17,917 January – February 2022 ​ $ 300.00 — 1,012 September 14, 2022 ​ $ 20.10 — 26,000 April 18, 2023 ​ $ 20.10 ​ 51,689 (1) — June 5, 2023 ​ $ 20.10 ​ 85,314 (1) — December 21, 2023 ​ $ 20.10 ​ 240,000 ​ — Total warrants outstanding ​ ​ ​ 429,749 97,675 (1) As of December 31, 2023, all 51,689 of the April 18, 2023 warrants and 7,112 of the June 5, 2023 warrants are held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. November 9, 2016 The Company has issued a customer a warrant to purchase 5,342 shares of Class A Common Stock with an exercise price of $46.80 per share. The warrant was issued on November 9, 2016. There is no vesting period, and the warrant expires on November 30, 2026. January 23, 2020 In January 2020, the Company issued REach®, a related party, a warrant to purchase 12,430 shares of the Company’s Class A Common Stock at an exercise of $120.00 per share in exchange for the cancellation of a $100 thousand SAFE issued on August 18, 2017 by the Company’s affiliate Trusted Mail Inc. with a value of $125 thousand. The warrants were issued on January 23, 2020. There is no vesting period, and the warrants expire on December 20, 2024. January 23, 2020 In January 2020, the Company issued SCV, a related party, a warrant to purchase 62,141 shares of the Company’s Class A Common Stock at a strike price of $120.00 per share in exchange for $300 thousand in cash and “Premium” sponsorship status with a credited value of $100 thousand per year for 3 years totaling $300 thousand. This “premium” sponsorship status provides the Company with certain benefits in marketing and networking, such as the Company being listed on the investor’s website, as well as providing the Company certain other promotional opportunities organized by the investor. The warrants were issued on January 23, 2020. There is no vesting period, and the warrants expire on December 20, 2024. On December 21, 2021, SCV executed a Notice of Exercise for certain of its warrants to purchase 27,168 shares of Class A Common Stock at an exercise price of $120.00 per share for a total purchase price of $3.26 million. The closing occurred on January 10, 2022 and resulted in total cash proceeds of $3.26 million to the Company for the warrant exercise. The warrants to purchase the remaining 34,974 shares of the Company’s Class A Common Stock remain outstanding as of December 31, 2023. August – December 2021 and January – February 2022 The Company issued 18,107 warrants from August 2021 to December 2021 and 1,028 warrants from January 2022 to February 2022 related to the Regulation CF, D, and S common stock and warrant offerings. These warrants became exercisable on January 26, 2022 when the Company received SEC qualification of its offering statement on Form 1-A. These warrants expire as of the earlier of: (a) January 26, 2023, (b) the acquisition of the Company by another entity, or (c) immediately prior to the closing of a firm commitment underwritten public offering. On August 25, 2022, we refunded $5,000 in units (comprised of common stock and warrants) sold in the Company’s Regulation CF offering to two investors resulting in the cancellation of 17 warrants. During the quarter ended December 31, 2022, investors exercised 190 warrants at an exercise price of $300.00 per share, resulting in total cash proceeds of $57 thousand to the Company for the warrant exercises. The warrants to purchase the remaining 18,928 shares of the Company’s Class A Common Stock expired on January 26, 2023 and are no longer outstanding as of December 31, 2023 September 14, 2022 On September 11, 2022, the Company entered into a Securities Purchase Agreement (the “SPA”) with Armistice Capital Master Fund Ltd. Pursuant to the terms of the SPA, the Company agreed, at the closing of the SPA, to sell and issue to the Armistice Capital Master Fund Ltd. in a private placement 13,000 shares of Class A Common Stock of the Company and warrants to purchase 26,000 shares of Class A Common Stock of the Company at an exercise price of $132.75 for a total purchase price of $1,511,250. The Company incurred offering costs of $90,675 from this transaction that were recorded as a reduction of the gross proceeds. The 26,000 warrants may be exercised at any time by Armistice Capital Master Fund Ltd. starting on the issuance date, September 14, 2022, until the five year and six-month anniversary thereafter. The warrants also allow for a “cashless exercise” if, at any time after the six (6) month anniversary of the issue date of the warrants there is no effective registration statement registering the resale of the Class A Common Stock issuable pursuant to the warrants. In such a case, then warrants may also be exercised, in whole or in part, by means of a cashless exercise in which Armistice Capital Master Fund Ltd. will be entitled to receive a number of shares of Class A Common Stock as described in the warrants. Trust Stamp filed the registration statement on September 30, 2022 and received the notice of effectiveness on January 26, 2023. On June 5, 2023, the Company entered into an Amendment to Existing Warrants agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Amendment to Existing Warrants, the exercise price for the warrants to purchase 26,000 shares of Class A Common Stock of the Company is reduced to $34.50 for a total purchase price of $897,000. In addition, the expiration date for the 26,000 warrants is amended allowing the exercise of the warrant at any time by Armistice Capital Master Fund Ltd. starting on the closing of the offering, June 5, 2023, until the five year anniversary thereafter. On August 18, 2023, the institutional investor exercised 18,000 warrants to purchase shares of Class A Common Stock of the Company at a price of $34.50 per warrant, resulting in an issuance by the Company of 18,000 shares of Class A Common Stock for total proceeds of $621,000. On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the warrants to purchase the remaining 8,000 shares of Class A Common Stock of the Company was reduced to $20.10 for a total purchase price of $160,800. On December 21, 2023, the remaining 8,000 common stock purchase warrants to purchase shares of Class A Common Stock of the Company at a price of $20.10 per warrant, resulting in an issuance by the Company of 8,000 shares of Class A Common Stock for total proceeds of $160,800. All warrants related to this investment have been exercised and are no longer outstanding as of December 31, 2023. April 18, 2023 On April 14, 2023, the Company entered into a securities purchase agreement (“SPA”) with Armistice Capital Master Fund Ltd. Pursuant to which the Company agreed to issue and sell to the investor (i) in a registered direct offering, 37,559 shares of Class A Common Stock, par value $0.01 per share of the Company at a price of $49.50 per share, and pre-funded warrants to purchase up to 67,330 shares of Class A Common Stock, at a price of $49.485 per prefunded warrant, at an exercise price of $0.015 per share of Class A Common Stock, and (ii) in a concurrent private placement, common stock purchase warrants, exercisable for an aggregate of up to 104,889 shares of Class A Common Stock, at an exercise price of $49.50 per share. On April 18, 2023, the Company sold 37,559 shares of Class A Common Stock to the institutional investor at a price of $49.50 per share for total proceeds $1,859,154. Additionally, on same date, the institutional investor purchased and exercised the 67,330 pre-funded warrants, for total proceeds to the Company of $3,332,835, resulting in an aggregate issuance by the Company of 104,889 shares of Class A Common Stock for net proceeds of $4,778,550 from the registered direct offering after deducting placement fee and legal expense of $363,439 and $50,000, respectively. On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the warrants to purchase the remaining 104,889 shares of Class A Common Stock of the Company was reduced to $20.10 for a total purchase price of $2,108,262. On December 21, 2023, the remaining 104,889 common stock purchase warrants to purchase shares of Class A Common Stock of the Company at a price of $20.10 per warrant were exercised for total proceeds of $2,108,262. As of December 31, 2023, the Company had received Notice to Exercise for 53,200 common stock purchase warrants resulting in an issuance by the Company of 53,200 shares of Class A Common Stock. Due to the beneficial ownership limitation provisions in the Inducement Agreement, as of December 31, 2023 the remaining 51,689 common stock purchase warrants exercised on December 21, 2023 were unissued and held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. On February 7, 2023 and February 27, 2023, the Company issued 21,334 and 30,356 shares, respectively. June 5, 2023 On June 1, 2023, the Company entered into a securities purchase agreement (“SPA”) with an Armistice Capital Master Fund Ltd. Pursuant to which the Company agreed to issue and sell to the investor (i) in a registered direct offering, 49,094 shares of Class A Common Stock, par value $0.01 per share of the Company at a price of $34.50 per share, and pre-funded warrants to purchase up to 36,220 shares of Class A Common Stock, at a price of $34.485 per prefunded warrant, at an exercise price of $0.015 per share of Class A Common Stock, and (ii) in a concurrent private placement, common stock purchase warrants, exercisable for an aggregate of up to 85,314 shares of Class A Common Stock, at an exercise price of $34.50 per share. On June 5, 2023, the Company sold 49,094 shares of Class A Common Stock to the institutional investor at a price of $34.50 per share for total proceeds of $1,693,720. Additionally, on same date, the institutional investor purchased the 36,220 pre-funded warrants at a price of $34.485 per prefunded warrant, for total proceeds to the Company of $1,249,047, resulting in an issuance by the Company of 49,094 shares of Class A Common Stock for net proceeds of $2,686,773 from the registered direct offering after deducting placement fee and legal expense of $205,994 and $50,000, respectively. On June 12, 2023, the institutional investor exercised 21,487 pre-funded warrants at a price of $0.015 per prefunded warrant, resulting in an issuance by the Company of 21,487 shares of Class A Common Stock for total proceeds of $322. Additionally, on June 23, 2023, the institutional investor exercised 14,734 pre-funded warrants at a price of $0.015 per prefunded warrant, resulting in an issuance by the Company of 14,734 shares of Class A Common Stock for total proceeds of $221. On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the common stock purchase warrants to purchase the remaining 85,314 shares of Class A Common Stock of the Company was reduced to $20.10 for a total purchase price of $1,714,798. On December 21, 2023, the institutional investor exercised 7,112 warrants to purchase shares of Class A Common Stock of the Company at a price of $20.10 per warrant for total proceeds of $142,938. As of December 31, 2023, due to the beneficial ownership limitation provisions in the Inducement Agreement, the 7,112 warrants were unissued and held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. These shares were subsequently issued on February 27, 2023. The common stock purchase warrants to purchase 85,314 shares of the Company’s Class A Common Stock remain outstanding as of December 31, 2023. December 21, 2023 On December 21, 2023, the Company entered into a warrant exercise agreement (the “WEA”) with a certain existing institutional investor, pursuant to which the institutional investor agreed to exercise (the “Exercise”) (i) a portion (7,112) of the warrants issued to the institutional investor on June 5, 2023, which are exercisable for 85,314 shares of the Company’s Class A Common Stock, par value $0.01 per share (“Class A Common Stock”) with a current exercise price of $34.50 per share (the “June 2023 Warrants”), (ii) all of the warrants issued to the institutional investor on September 14, 2022, as amended on June 5, 2023, which are exercisable for 8,000 shares of Class A Common Stock, with a current exercise price of $34.50 per share (the “September 2022 Warrants”), and (iii) all of the warrants issued to the institutional investor on April 18, 2023, which are exercisable for 104,889 shares of Class A Common Stock, with a current exercise price of $49.50 per share (the “April 2023 Warrants” and collectively with all of the June 2023 Warrants and the September 2022 Warrants, the “Existing Warrants”). In consideration for the immediate exercise of 120,000 of the Existing Warrants for cash, the Company agreed to reduce the exercise price of all of the Existing Warrants, including any unexercised portion thereof, to $20.10 per share, which is equal to the most recent closing price of the Company’s Class A Common Stock on The Nasdaq Stock Market prior to the execution of the WEA. As of December 31, 2023, Armistice had submitted an Exercise Notice for 61,200 Existing Warrants and the shares of Class A Common Stock were issued to the warrant holders. The remaining 58,800 Existing Warrants from this exercise are held in abeyance until the Company receives notice from the holders that the remaining shares may be issued in compliance with the beneficial ownership limitation. As of the date of this report, the remaining 58,800 Existing Warrants have been issued. In addition, in consideration for such Exercise, the Selling Stockholder received new unregistered warrants to purchase up to an aggregate of 240,000 shares of Class A Common Stock, equal to 200% of the shares of Class A Common Stock issued in connection with the Exercise, with an exercise price of $20.10 per share (the “New Warrants”) in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933 (the “Securities Act”). All 240,000 of the New Warrants remain outstanding as of December 31, 2023.

Investment

Investment	9 Months Ended
	Sep. 30, 2024
Investment
Investment	4. Investment ​ Boumarang License Agreement — Pursuant to the Agreement, the Company agreed to grant a non-exclusive license to Boumarang to exploit certain of the Company’s patents for the purpose of producing, selling, marketing, and distributing drones. As consideration for the grant of the non-exclusive license, Boumarang agreed to pay the Company a non-refundable license fee of $5,000,000 in the form of a prepaid warrant issued by Boumarang to the Company for 5,000,000 shares of common stock of Boumarang at $1.00 per share (the “Prepaid Warrant”). The Prepaid Warrant may be exercised in whole or in part at any time prior to the tenth annual anniversary of the issuance date of the Prepaid Warrant. No additional exercise price must be paid by the Company to exercise any portion of the Prepaid Warrant. The Prepaid Warrant also provides that the Company will receive any dividends declared by Boumarang that it would have been entitled to had the Prepaid Warrant been fully exercised, even if the Prepaid Warrant has not been exercised as of such time the distribution is made. Boumarang agreed to reserve a number a sufficient number of shares at all times to allow the Company to fully exercise the Prepaid Warrant. The Prepaid Warrant has certain anti-dilution protections, whereby the number of shares issuable upon the exercise of the Prepaid Warrant will proportionately adjust in the case of a stock-split or stock dividend of Boumarang’s common stock. The investment in Boumarang was recorded in accordance with ASC 321, Investments – Equity Securities The Company qualitatively assessed the investment for impairment in accordance with ASC 321. As of September 30, 2024, the Company determined that there was no impairment for the investment. Boumarang Subscription Agreement

Balance Sheet Components

Balance Sheet Components	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Balance Sheet Components
Balance Sheet Components	5. Balance Sheet Components Prepaid expenses and other current assets Prepaid expenses and other current assets as of September 30, 2024 and December 31, 2023 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Prepaid operating expenses ​ $ 253,973 ​ $ 216,875 Rent deposit ​ ​ 27,458 ​ ​ 28,400 Value added tax receivable ​ ​ 48,177 ​ ​ 116,095 Tax credit receivable (short-term) ​ ​ 25,045 ​ ​ 102,151 Miscellaneous receivable ​ ​ 859,271 ​ ​ 363,260 Prepaid expenses and other current assets ​ $ 1,213,924 ​ $ 826,781 ​ Capitalized internal-use software, net Capitalized internal-use software, net as of as of September 30, 2024 and December 31, 2023 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Internally developed software ​ 5 Years ​ $ 4,363,338 ​ $ 3,901,801 Less: Accumulated depreciation ​ ​ ​ ​ (2,830,981) ​ ​ (2,429,427) Capitalized internal-use software, net ​ ​ ​ $ 1,532,357 ​ $ 1,472,374 ​ Amortization expense is recognized on a straight-line basis and during the three months ended September 30, 2024 and 2023 totaled $141 thousand and $140 thousand, respectively. Amortization expense during the nine months ended September 30, 2024 and 2023 totaled $419 thousand, respectively. As of September 30, 2024, the Company determined that $24 thousand of Capitalized internal-use software were impaired. The impaired Capitalized internal-use software was expensed to Research and development Property and equipment, net Property and equipment, net as of as of September 30, 2024 and December 31, 2023 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Computer equipment ​ 3-4 Years ​ $ 154,181 ​ $ 152,014 Furniture and fixtures ​ 10 Years ​ ​ 34,675 ​ ​ 28,052 Property and equipment, gross ​ ​ ​ ​ 188,856 ​ ​ 180,066 Less: Accumulated depreciation ​ ​ ​ ​ (149,031) ​ ​ (123,630) Property and equipment, net ​ ​ ​ $ 39,825 ​ $ 56,436 ​ Depreciation expense is recognized on a straight-line basis and during the three months ended September 30, 2024 and 2023 totaled $8 thousand and $10 thousand, respectively. Depreciation expense during the nine months ended September 30, 2024 and 2023 totaled $27 thousand and $62 thousand, respectively. ​ Accrued expenses Accrued expenses as of September 30, 2024 and December 31, 2023 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Compensation payable ​ $ 672,587 ​ $ 377,403 Commission liability ​ ​ 19,885 ​ ​ 26,863 Accrued employee taxes ​ ​ 890,411 ​ ​ 624,525 Other accrued liabilities ​ ​ 87,377 ​ ​ 115,099 Accrued expenses ​ $ 1,670,260 ​ $ 1,143,890 ​	4. Balance Sheet Components Prepaid expenses and other current assets Prepaid expenses and other current assets as of December 31, 2023 and 2022 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ 2023 2022 Prepaid operating expenses ​ $ 216,875 ​ $ 225,756 Rent deposit ​ 28,400 ​ 55,981 Value added tax receivable ​ 116,095 ​ 71,742 Tax credit receivable (short-term) ​ ​ 102,151 ​ ​ 218,239 Miscellaneous receivable ​ 363,260 ​ 8,368 Prepaid expenses and other current assets ​ $ 826,781 ​ $ 580,086 ​ Capitalized internal-use software, net Capitalized internal-use software, net as of December 31, 2023 and 2022 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Internally developed software 5 Years $ 3,901,801 ​ $ 3,314,450 Less: Accumulated depreciation ​ ​ (2,429,427) ​ (1,895,778) Capitalized internal-use software, net ​ ​ ​ $ 1,472,374 ​ $ 1,418,672 ​ Amortization expense is recognized on a straight-line basis and for the years ended December 31, 2023 and 2022 totaled $557 thousand and $517 thousand, respectively. ​ The Company determined that as of December 31, 2023, $19 thousand of Capitalized internal - use software was impaired. The impaired Capitalized internal - use software was expensed to Research and development during the year ended December 31, 2023. ​ Property and equipment, net Property and equipment, net as of December 31, 2023 and 2022 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Computer equipment 3-4 Years ​ $ 152,014 ​ $ 148,832 Furniture and fixtures 10 Years ​ 28,052 ​ 27,220 Mobile hardware ​ 2.5 years ​ ​ — ​ ​ 297,150 Property and equipment, gross ​ ​ ​ 180,066 ​ 473,202 Less: Accumulated depreciation ​ ​ ​ (123,630) ​ (172,538) Property and equipment, net ​ ​ ​ $ 56,436 ​ $ 300,664 ​ Depreciation expense is recognized on a straight-line basis and for the years ended December 31, 2023 and 2022 totaled $72 thousand and $136 thousand, respectively. On April 26, 2023, the Company sold a portion of the mobile hardware for a gross sales price of $180 thousand and a gain of $108 thousand. On May 26, 2023, the Company sold another portion of the mobile hardware for a gross sales price of $197 thousand and a gain of $108 thousand. Accrued expenses ​ Accrued expenses as of December 31, 2023 and 2022 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Compensation payable ​ $ 377,403 ​ $ 171,851 Commission liability ​ ​ 26,863 ​ ​ 58,771 Accrued employee taxes ​ 624,525 ​ 591,992 Accrued mobile expenses ​ ​ — ​ ​ 177,099 Other accrued liabilities ​ 115,099 ​ 100,111 Accrued expenses ​ $ 1,143,890 ​ $ 1,099,824 ​

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Goodwill and Intangible Assets
Goodwill and Intangible Assets	6. Goodwill and Intangible Assets, Net There were no changes in the carrying amount of Goodwill for the nine months ended September 30, 2024. Intangible assets, net as of September 30, 2024 and December 31, 2023 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Patent application costs ​ 3 Years ​ $ 555,918 ​ $ 484,035 Trade name and trademarks ​ 3 Years ​ ​ 71,033 ​ ​ 70,446 Intangible assets, gross ​ ​ ​ ​ 626,951 ​ ​ 554,481 Less: Accumulated amortization ​ ​ ​ ​ (433,647) ​ ​ (330,791) Intangible assets, net ​ ​ ​ $ 193,304 ​ $ 223,690 ​ The Company added 6 new issued patents during the nine months ended September 30, 2024. The patents issued during the nine months ended September 30, 2024 increased our total number of patents to 23 and include: ● On January 2, 2024, the Company received Notice of Issuance for a patent that is a continuation of “Systems and Processes for Lossy Biometric Representation.” This patent is a continuation addresses a long-felt but unresolved need for a system or process that can transform size-variant, personally-identifying biometric templates into fixed-size, privacy-secured representations, while maintaining sufficiently accurate biometric matching capabilities. ● On January 30, 2024, the Company received Notice of Issuance for a patent that is a continuation of “Systems and Processes for Lossy Biometric Representation.” This technology provides a system or process that can transform size-variant, personally-identifying biometric templates into fixed-size, privacy-secured representations, while maintaining sufficiently accurate biometric matching capabilities. ● On March 19, 2024, the Company received Notice of Issuance for a patent entitled “Systems and Methods for Enhanced Hash Transforms.” Conventional cryptographic hashing techniques generally include functions that generate unique signatures given a piece of data, accepting binary strings of characters as an input, and producing a string (e.g., a digital signature) as an output. Our new patent addresses the need for improved techniques for securely handling sensitive data. ● On April 23, 2024, the Company received Notice of Issuance for a patent entitled “Face Cover-compatible Biometrics and Processes for Generating and Using Same.” which allows for enrollment of biometric information from individuals wearing face coverings such that subsequent biometric identification and verification processes may not require the individuals to remove their face coverings. ● On April 30, 2024, the Company received Notice of Issuance for a patent entitled “Systems and Methods for Liveness-verified, Biometric-based Encryption.” This patent fulfills a long-felt but unresolved need for a system or method that permits encryption/decryption based on liveness-verified biometric data that cannot be stolen or spoofed. ● On September 3, 2024 the Company received Notice of Issuance by the US Patent of Trademark Office of Patent No. 17/719,975 entitled, “Personal Identifiable Information Encoder.” This technology provides the means to maintain the essential utility of PII without storing highly sensitive data. Anyone processing or storing PII should embrace this technology to fulfill their data protection obligations and mitigate damage and losses in the event of a data breach.” Intangible asset amortization expense is recognized on a straight-line basis and during the three months ended September 30, 2024 and 2023 totaled $32 thousand and $40 thousand, respectively. Intangible asset amortization expense during the nine months ended September 30, 2024 and 2023 totaled $102 thousand and $115 thousand, respectively. Estimated future amortization expense of Intangible assets, net is as follows: ​ ​ ​ ​ ​ Years Ending December 31, Amount 2024 ​ $ 31,949 2025 ​ ​ 99,005 2026 ​ ​ 52,529 2027 ​ ​ 9,821 Total future amortization ​ $ 193,304 ​	5. Goodwill and Intangible Assets, Net There were no changes in the carrying amount of Goodwill for the years ended December 31, 2023 and 2022. Intangible assets, net as of December 31, 2023 and 2022 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Patent application costs 3 Years ​ $ 484,035 ​ $ 382,285 Trade name and trademarks 3 Years ​ 70,446 ​ 68,356 Intangible assets, gross ​ ​ 554,481 ​ 450,641 Less: Accumulated amortization ​ ​ (330,791) ​ (198,955) Intangible assets, net ​ ​ ​ $ 223,690 ​ $ 251,686 ​ The Company determined that as of December 31, 2023, $12 thousand of Patent application costs were impaired. The impaired Patent application costs were expensed to Selling, general, and administrative expense during the year ended December 31, 2023. The Company added 4 patents and 1 trademark during the year ended December 31, 2023. The patents issued during the year ended December 31, 2023 increased our total number of patents to 17 and include: ● On August 29, 2023, the Company received Notice of Issuance together with a Notice of Allowance on August 17, 2023 both entitled “Systems and Processes for Lossy Biometric Representation.” These patents further expand our intellectual property portfolio related to the tokenization of biometric data and broaden our patent coverage by removing the necessity to use a neural network in our irreversible transformation process. ● On August 15, 2023, the Company received Notice of Issuance for a patent entitled “Systems and Methods for Identity Authentication via Third Party Accounts.” This technology, while leveraging our core privacy-first technologies, provides an optional interlock between different types of user accounts benefiting from the strengths that each can offer in terms of user authentication to produce a more resilient user-centric ecosystem. ● On July 25, 2023, the Company received Notice of Issuance for a patent entitled “Systems and Methods for Privacy-Secured Biometric Identification and Verification.” For the last six years we have invested heavily in research and development which has created a solid foundation for our current and future generations of cutting edge, privacy-first identity products and this patent reflects our systems and methods for matching an encrypted biometric input record with stored encrypted biometric record without data decryption of the input and at least one stored record. ● On June 20, 2023, the Company received Notice of Issuance for a patent entitled “Ownership Validation for Cryptographic Asset Contracts Using Irreversibly Transformed Identity Tokens.” This technology expands the range of use cases for the IT2 into NFT’s and the Metaverse by verifying the ownership of cryptographic asset contracts using embedded IT2 technology. Cryptographic assets are typically associated with a particular digital address (“digital wallet”) which are vulnerable to fraud, pilferage, and user errors. The new patent addresses the long-felt but unresolved need for improved systems and processes for validating ownership of cryptographic assets. Intangible asset amortization expense is recognized on a straight-line basis and for the years ended December 31, 2023 and 2022 totaled $160 thousand and $107 thousand, respectively. Estimated future amortization expense of Intangible assets, net is as follows: ​ ​ ​ ​ ​ Years Ending December 31, Amount 2024 ​ ​ 120,078 2025 ​ 75,043 2026 ​ ​ 28,569 ​ ​ $ 223,690 ​

Net Loss per Share Attributable

Net Loss per Share Attributable to Common Stockholders	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Net Loss per Share Attributable to Common Stockholders
Net Loss per Share Attributable to Common Stockholders	7 . Net Loss per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Numerator: ​ ​ ​ ​ ​ ​ ​ ​ Net loss attributable to common stockholders ​ $ (1,255,915) ​ $ (35,162) ​ $ (6,532,845) ​ $ (4,752,980) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares used in computing net loss per share attributable to common stockholders ​ ​ 1,181,150 ​ ​ 543,708 ​ 891,211 ​ 443,880 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net loss per share attributable to common stockholders ​ $ (1.06) ​ $ (0.06) ​ $ (7.33) ​ $ (10.71) ​ The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been anti-dilutive: ​ ​ ​ ​ ​ ​ ​ ​ As of September 30, ​ 2024 2023 Options, RSUs, and grants ​ 106,434 ​ 52,761 Warrants ​ 1,798,643 ​ 301,880 Total ​ 1,905,077 ​ 354,641 ​	7. Net Loss per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Numerator: ​ ​ ​ ​ ​ ​ Net loss attributable to common stockholders ​ $ (7,637,642) ​ $ (12,091,540) ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ Weighted average shares used in computing net loss per share attributable to common stockholders ​ 475,171 ​ ​ 315,518 ​ ​ ​ ​ ​ ​ ​ Net loss per share attributable to common stockholders ​ $ (16.07) ​ $ (38.32) ​ The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been anti-dilutive: ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Options, RSUs, and grants ​ 60,741 ​ 49,625 Warrants ​ 432,202 ​ 111,742 Total ​ 492,943 ​ 161,367 ​

Stock Awards and Stock-Based Co

Stock Awards and Stock-Based Compensation	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Stock Awards and Stock-Based Compensation
Stock Awards and Stock-Based Compensation	8. Stock Awards and Stock-Based Compensation From time to time, the Company may issue stock awards in the form of Class A Common Stock grants, Restricted Stock Units (RSUs), or Class A Common Stock options with vesting/service terms. Stock awards are valued on the grant date using the Company’s common stock share price quoted on an active market. Stock options are valued using the Black-Scholes-Merton pricing model to determine the fair value of the options. We generally issue our awards in terms of a fixed monthly value, resulting in a variable number of shares being issued, or in terms of a fixed monthly share number. Stock Options The following table summarizes stock option activity for the three and nine months ended September 30, 2024: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ Options Exercise Price Contractual Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2023 25,808 ​ $ 96.00 1.45 ​ $ — Options granted 793 ​ 34.20 — ​ — Options exercised (82) ​ 48.75 — ​ — Options canceled and forfeited ​ (280) ​ ​ 85.95 ​ — ​ ​ — Balance as of December 31, 2023 ​ 26,239 ​ ​ 94.05 ​ 1.95 ​ ​ — Options granted ​ 255 ​ ​ 23.55 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited (95) ​ 63.15 — ​ — Balance as of March 31, 2024 ​ 26,399 ​ ​ 93.60 ​ 1.72 ​ ​ — Options granted ​ 292 ​ ​ 20.55 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited (34) ​ 58.80 — ​ — Balance as of June 30, 2024 26,657 ​ 92.85 1.49 ​ — Options granted ​ 437 ​ ​ 13.80 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited ​ (102) ​ ​ 58.80 ​ — ​ ​ — Options vested and exercisable as of September 30, 2024 26,992 ​ $ 91.65 1.27 ​ ​ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ ​ Options ​ Exercise Price ​ Contractual ​ Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2024 ​ 26,239 ​ $ 94.05 1.95 ​ $ — Options granted ​ 984 ​ ​ 18.30 — ​ ​ — Options exercised ​ — ​ ​ — — ​ ​ — Options canceled and forfeited ​ (231) ​ ​ 60.30 — ​ ​ — Balance as of September 30, 2024 ​ 26,992 ​ ​ 91.65 1.27 ​ ​ — Options vested and exercisable as of September 30, 2024 ​ 26,992 ​ $ 91.65 ​ 1.27 ​ $ — ​ The aggregate intrinsic value of options outstanding, exercisable, and vested is calculated as the difference between the exercise price of the underlying options and the fair value of the Company’s common stock. The aggregate intrinsic value of options exercised during the nine months ended September 30, 2024 and 2023 was $0. The weighted average grant-date fair value of options granted during the nine months ended September 30, 2024 and 2023 was $4.35 and $18.75 per share, respectively. The total grant-date fair value of options that vested during the nine months ended September 30, 2024 and 2023 was $4 thousand and $10 thousand, respectively. The following assumptions were used to calculate the fair value of options granted during the nine months ended September 30, 2024: ​ ​ ​ ​ ​ ​ Fair value of Class A Common Stock $ 0.90 — 10.80 ​ Exercise price ​ $ 12.00 — 24.60 ​ Risk free interest rate ​ ​ 3.51 — 4.71 % Expected dividend yield ​ ​ 0.00 % Expected volatility ​ ​ 77.54 — 79.80 % Expected term ​ ​ 3 Years ​ As of September 30, 2024, the Company had 26,992 stock options outstanding of which all are fully vested options. Stock Grants As of September 30, 2024, the Company has 6,680 common stock grants outstanding of which 5,475 were vested but not issued and 1,205 were not yet vested. All granted and outstanding common stock grants will fully vest by September 30, 2025. The Company had unrecognized stock-based compensation related to common stock grants of $6 thousand as of September 30, 2024. RSU As of September 30, 2024, the Company had 72,762 RSUs outstanding of which 3,428 were vested but not issued and 69,335 were not yet vested. All granted and outstanding RSUs will fully vest by January 2, 2025. The Company had unrecognized stock-based compensation related to RSUs of $343 thousand as of September 30, 2024. During the nine months ended September 30, 2024 the Company issued 3,649 of Class A Common Stock to employees that were designated for employee stock awards and were previously recorded as treasury stock. A summary of outstanding RSU activity as of September 30, 2024 is as follows: ​ ​ ​ ​ ​ RSU Outstanding ​ ​ Number of Shares Balance as of January 1, 2023 19,505 Granted 27,368 Vested (issued) (10,652) Forfeited (6,481) Balance as of December 31, 2023 29,740 Granted 69,335 Vested (issued) (21,255) Forfeited (5,058) Balance as of September 30, 2024 72,762 ​ Stock-based compensation expense Our consolidated statements of operations include stock-based compensation expense as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Cost of services ​ $ 3,144 ​ $ 11,169 ​ $ 3,406 ​ $ 11,825 Research and development ​ ​ 23,878 ​ ​ 48,336 ​ 38,087 ​ 79,956 Selling, general, and administrative ​ ​ 324,571 ​ ​ 88,535 ​ 915,110 ​ 213,569 Total stock-based compensation expense ​ $ 351,593 ​ $ 148,040 ​ $ 956,603 ​ $ 305,350 ​	8. Stock Awards and Stock-Based Compensation From time to time, the Company may issue stock awards in the form of Class A Common Stock grants, Restricted Stock Units (RSUs), or Class A Common Stock options with vesting/service terms. Stock awards are valued on the grant date using the Company’s common stock share price quoted on an active market. Stock options are valued using the Black-Scholes-Merton pricing model to determine the fair value of the options. We generally issue our awards in terms of a fixed monthly value, resulting in a variable number of shares being issued, or in terms of a fixed monthly share number. During the years ended December 31, 2023 and 2022, the Company entered into agreements with advisory board members and other external advisors to issue cash payments and stock awards in exchange for services rendered to the Company monthly. The total granted stock-based awards to advisory board members and other external advisors during the years ended December 31, 2023 and 2022 included grants totaling, $6 thousand and $49 thousand, respectively, options totaling $0, and RSUs totaling $36 thousand and $190 thousand, respectively. In addition to issuing stock awards to advisory board members and other external advisors, during the years ended December 31, 2023 and 2022, the Company granted stock-based awards to multiple employees. The total granted stock-based awards to employees during the years ended December 31, 2023 and 2022 included grants totaling, $82 thousand and $307 thousand, respectively, options totaling $12 thousand and $57 thousand, respectively, and RSUs totaling $627 thousand and $1.80 million, respectively. The following table summarizes stock option activity for the years ended December 31, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ ​ Options ​ Exercise Price ​ Contractual ​ Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2023 ​ ​ 25,808 ​ $ 96.00 1.45 ​ $ — Options granted ​ ​ 793 ​ ​ 34.20 ​ ​ ​ ​ ​ Options exercised ​ ​ (82) ​ ​ 48.75 ​ ​ ​ ​ ​ Options canceled and forfeited ​ ​ (280) ​ ​ 85.95 ​ ​ ​ ​ ​ Balance as of December 31, 2023 ​ ​ 26,239 ​ ​ 94.05 ​ 1.95 ​ ​ — Options vested and exercisable as of December 31, 2023 ​ ​ 26,239 ​ $ 94.05 1.95 ​ ​ — ​ The aggregate intrinsic value of options outstanding, exercisable, and vested is calculated as the difference between the exercise price of the underlying options and the fair value of the Company’s common stock. The aggregate intrinsic value of options exercised during the years ended December 31, 2023 and 2022 was $0. The weighted average grant-date fair value of options granted during the years ended December 31, 2023 and 2022 was $16.20 and $ 114.75 per share, respectively. The total grant-date fair value of options that vested during the years ended December 31, 2023 and 2022 was $12 thousand and $57 thousand, respectively. The following assumptions were used to calculate the fair value of options granted during the year ended December 31, 2023: ​ ​ ​ ​ ​ Fair value of Class A Common Stock $ 5.70 – 25.05 ​ Exercise price ​ $ 26.70 – 46.35 ​ Risk free interest rate ​ 3.76 - 4.89 % Expected dividend yield ​ 0.00 % Expected volatility ​ 79.08– 96.45 % Expected term ​ 3 Years ​ As of December 31, 2023, the Company had 26,239 stock options outstanding of which all are fully vested options. As of December 31, 2023, the Company has 4,761 common stock grants outstanding of which 4,012 were vested but not issued and 750 were not yet vested. All granted and outstanding common stock grants will fully vest by December 31, 2024. The Company had unrecognized stock-based compensation related to common stock grants of $9 thousand as of December 31, 2023. As of December 31, 2023, the Company had 29,740 RSUs outstanding of which 3,187 were vested but not issued and 26,553 were not yet vested. All granted and outstanding RSUs will fully vest by August 1, 2024. The Company had unrecognized stock-based compensation related to RSUs of $25 thousand as of December 31, 2023. A summary of outstanding RSU activity as of December 31, 2023 is as follows: ​ ​ ​ ​ ​ RSU Outstanding ​ ​ Number of Shares Balance as of January 1, 2022 8,460 Granted 14,114 Vested (issued) (3,070) Forfeited — Balance as of December 31, 2022 19,504 Granted 27,368 Vested (issued) (10,652) Forfeited (6,480) Balance as of December 31, 2023 29,740 ​ Stock-based compensation expense Our consolidated statements of operations include stock-based compensation expense as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ ​ 2023 2022 Cost of services ​ $ 21,836 ​ $ 21,721 Research and development ​ 123,109 ​ 292,084 Selling, general, and administrative ​ 618,343 ​ 2,085,258 Total stock-based compensation expense ​ $ 763,288 ​ $ 2,399,063 ​

Related Party Transactions

Related Party Transactions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Related Party Transactions
Related Party Transactions	9. Related Party Transactions Related party payables of $48 thousand and $82 thousand as of September 30, 2024 and December 31, 2023, respectively, primarily relate to amounts owed to 10Clouds, the Company’s contractor for software development and investor in the Company, and smaller amounts payable to members of management as expense reimbursements. Total costs incurred in relation to 10Clouds for the three months ended September 30, 2024 and 2023, totaled approximately $1 thousand and $164 thousand, respectively. Total costs incurred in relation to 10Clouds for the nine months ended September 30, 2024 and 2023, totaled approximately $112 thousand and $699 thousand, respectively. Mutual Channel Agreement On November 15, 2020, the Company entered into a Mutual Channel Agreement with Vital4Data, Inc., a company at which one of our Directors serves as Chief Executive Officer. Pursuant to the agreement, the Company engaged Vita4Data, Inc. as a non-exclusive sales representative for the Company’s products and services. Vital4Data, Inc. is entitled to compensation in the form of commissions, receiving a 20% of commission-eligible on net revenue from sales generated by Vital4Data, Inc. in the first year of the contract term, which is reduced to 10% in the second year, and 5% in the third year. The Company has not earned or expensed any commissions pursuant to the Vital4Data, Inc. agreement to date. As of September 30, 2024 and December 31, 2023, the Vital4Data, Inc. commission due was $0.	10. Related Party Transactions Related party payables of $82 thousand and $273 thousand as of December 31, 2023 and 2022, respectively, primarily relate to amounts owed to 10Clouds, the Company’s contractor for software development and investor in the Company, and smaller amounts payable to members of management as expense reimbursements. Total costs incurred in relation to 10Clouds for the years ended December 31, 2023 and 2022, totaled approximately $816 thousand and $935 thousand, respectively. Legal Services A member of management provides legal services to the Company from a law firm privately owned and separate from the Company. Certain services are provided to the Company through this law firm. Total expenses incurred by the Company in relation to these services totaled $0 and $138 thousand during the years ended December 31, 2023 and 2022, respectively. Amounts payable as of December 31, 2023 and 2022 were $0. Options Agreement The Company has agreed, with effect from November 13, 2020, to grant a three-year loan in the amount of $335 thousand with an abated interest rate of 0.25% per annum to an advisory contractor to purchase 18,777 options. The options provide for the right to acquire shares of Class A Common Stock at a strike price of $ 90.00 per share. The options have no vesting period and will expire in November 2023. The loan was repaid with in-kind services from the contractor at a rate of $9 thousand per month for 36 months with the first payment receipt in April 2020 and the final payment received in February 2023. As of December 31, 2023 and 2022, the shareholder loan balances were $0 and $19 thousand, respectively. Mutual Channel Agreement On November 15, 2020, the Company entered into a Mutual Channel Agreement with Vital4Data, Inc., a company at which one of our Directors serves as Chief Executive Officer. Pursuant to the agreement, the Company engaged Vita4Data, Inc. as a non-exclusive sales representative for the Company’s products and services. Vital4Data, Inc. is entitled to compensation in the form of commissions, receiving a 20% of commission-eligible on net revenue from sales generated by Vital4Data, Inc. in the first year of the contract term, which is reduced to 10% in the second year, and 5% in the third year. The Company has not earned or expensed any commissions pursuant to the Vital4Data, Inc. agreement to date. As of December 31, 2023 and 2022, the Vital4Data, Inc. commission due was $0 .

Malta Grant

Malta Grant	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Malta Grant
Malta Grant	10 . Malta Grant During July 2020 the Company entered into an agreement with the Republic of Malta that would provide for a grant of up to €200 thousand or $251 thousand as reimbursement for operating expenses over the first twelve months following Trust Stamp Malta’s incorporation in the Republic of Malta. The Company must provide an initial capital amount of €50 thousand or $62 thousand, which is matched with a €50 thousand or $62 thousand grant. The remaining €150 thousand or $190 thousand are provided as reimbursement of operating expenses twelve months following incorporation. U.S. GAAP does not provide authoritative guidance regarding the receipt of economic benefits from government entities in return for compliance with certain conditions. Therefore, based on ASC 105-10-05-2, non-authoritative accounting guidance from other sources was considered by analogy in determining the appropriate accounting treatment, the Company elected to apply International Accounting Standards 20 – Accounting for Government Grants and Disclosure of Government Assistance and recognizes the expected reimbursements from the Republic of Malta as deferred income. As reimbursable operating expenses are incurred, a receivable is recognized (reflected within “Prepaid expenses and other current assets” in the consolidated balance sheets) and income is recognized in a similar systematic basis over the same periods in the consolidated statements of operations. During the nine months ended September 30, 2023, the Company incurred $0 in expenses that are reimbursable under the grant. As of September 30, 2024, all amounts provided for under this grant were received. On January 25, 2022, the Company entered into an additional agreement with the government of Malta for a grant of up to €100 thousand or $107 thousand, in terms of the ‘Investment Aid to produce the COVID-19 Relevant Product’ program, to support the proposed investment. The estimated value of the grant is €137 thousand or $146 thousand, at an aid intensity of 75% to cover eligible wage costs incurred after February 1, 2022 in relation to new employees engaged specifically for the implementation of the project. On September 22, 2022, the Company entered into an amendment agreement that enables the Company to submit eligible employee expenses for reimbursement by October 31, 2022. The grant was approved in January 2022, however, the request for payment was not approved and management abandoned the agreement. Hence, during the nine months ended September 30, 2024 and 2023, the Company incurred $0, respectively, in expenses that are reimbursable under the grant. As of September 30, 2024, no amounts provided under this grant were received.	11. Malta Grant During July 2020 the Company entered into an agreement with the Republic of Malta that would provide for a grant of up to €200 thousand or $251 thousand as reimbursement for operating expenses over the first twelve months following Trust Stamp Malta’s incorporation in the Republic of Malta. The Company must provide an initial capital amount of €50 thousand or $62 thousand, which is matched with a €50 thousand or $62 thousand grant. The remaining €150 thousand or $190 thousand are provided as reimbursement of operating expenses twelve months following incorporation. U.S. GAAP does not provide authoritative guidance regarding the receipt of economic benefits from government entities in return for compliance with certain conditions. Therefore, based on ASC 105-10-05-2, non-authoritative accounting guidance from other sources was considered by analogy in determining the appropriate accounting treatment, the Company elected to apply International Accounting Standards 20 – Accounting for Government Grants and Disclosure of Government Assistance and recognizes the expected reimbursements from the Republic of Malta as deferred income. As reimbursable operating expenses are incurred, a receivable is recognized (reflected within “Prepaid expenses and other current assets” in the consolidated balance sheets) and income is recognized in a similar systematic basis over the same periods in the consolidated statements of operations. During the years ended December 31, 2023 and 2022, the Company incurred $0 in expenses that are reimbursable under the grant. As of December 31, 2023, all amounts provided for under this grant were received. On January 25, 2022, the Company entered into an additional agreement with the government of Malta for a grant of up to €100 thousand or $107 thousand, in terms of the ‘Investment Aid to produce the COVID-19 Relevant Product’ program, to support the proposed investment. The estimated value of the grant is €136,568 or $146,493, at an aid intensity of 75% to cover eligible wage costs incurred after February 1, 2022 in relation to new employees engaged specifically for the implementation of the project. On September 22, 2022, the Company entered into an amendment agreement that enables the Company to submit eligible employee expenses for reimbursement by October 31, 2022. The grant was approved in January 2022, however, the request for payment was not approved and management abandoned the agreement. Hence, during the years ended December 31, 2023 and 2022, the Company incurred $0, respectively, in expenses that are reimbursable under the grant. As of December 31, 2023, no amounts provided under this grant were received.

Leases and Commitments

Leases and Commitments	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Leases and Commitments
Leases and Commitments	11. Leases and Commitments Operating Leases — Initial lease terms are determined at commencement date, the date the Company takes possession of the property, and the commencement date is used to calculate straight-line expense for operating leases. Certain leases contain renewal options for varying periods, which are at the Company’s sole discretion. For leases where the Company is reasonably certain to exercise a renewal option, such option periods have been included in the determination of the Company’s Operating lease right-of-use assets and Operating lease liabilities. The Company’s leases have remaining terms of 1 ​ ​ ​ ​ ​ ​ ​ September 30, ​ Lease term and discount rate 2024 ​ Weighted average remaining lease term ​ 1.88 years Weighted average discount rate ​ 5.0 % ​ During the nine months ended September 30, 2024, the Company did terminate one operating lease for office space located in the United States. The lease was terminated upon the conclusion of the agreed upon lease term, therefore, there were no termination fees, Right-of-use assets derecognized, Lease liabilities derecognized, or losses recognized. Balance sheet information related to leases as of as of September 30, 2024 and December 31, 2023 was as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Operating lease right-of-use assets ​ ​ ​ ​ ​ ​ Operating lease right-of-use assets ​ $ 198,634 ​ $ 164,740 ​ ​ ​ ​ ​ ​ ​ Operating lease liabilities ​ ​ ​ ​ ​ ​ Short-term operating lease liabilities ​ $ 95,367 ​ $ 81,236 Long-term operating lease liabilities ​ ​ 70,555 ​ ​ 53,771 Total operating lease liabilities ​ $ 165,922 ​ $ 135,007 ​ Future maturities of ASC 842 lease liabilities as of September 30, 2024 are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Imputed ​ ​ ​ ​ Principal ​ Interest ​ ​ ​ Years Ending December 31, ​ Payments ​ Payments ​ Total Payments 2024 ​ $ 36,976 ​ $ 1,921 ​ $ 38,897 2025 ​ ​ 88,889 ​ ​ 3,696 ​ ​ 92,585 2026 ​ ​ 22,735 ​ ​ 1,170 ​ ​ 23,905 2027 ​ ​ 8,831 ​ ​ 626 ​ ​ 9,457 2028 ​ ​ 8,491 ​ ​ 178 ​ ​ 8,669 Total future maturities ​ $ 165,922 ​ $ 7,591 ​ $ 173,513 ​ Total lease expense, under ASC 842, was included in Selling, general, and administrative expenses in our unaudited condensed consolidated statement of operations for the three and nine months ended September 30, 2024 and 2023 as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Operating lease expense – fixed payments ​ $ 39,368 ​ $ 40,060 ​ $ 117,221 ​ $ 169,496 Short term lease expense ​ ​ 10,710 ​ ​ 10,846 ​ ​ 34,929 ​ ​ 48,399 Total lease expense ​ $ 50,078 ​ $ 50,906 ​ $ 152,150 ​ $ 217,895 ​ Supplemental cash flows information related to leases was as follow: ​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended ​ September 30, ​ 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: ​ ​ ​ ​ ​ ​ Operating cash flows from operating leases ​ $ (111,277) ​ $ (145,483) ​ During the nine months ended September 30, 2024, the Company did not incur variable lease expense. Financial Liability Obligation — Litigation —	12. Leases and Commitments Operating Leases Initial lease terms are determined at commencement date, the date the Company takes possession of the property, and the commencement date is used to calculate straight-line expense for operating leases. Certain leases contain renewal options for varying periods, which are at the Company’s sole discretion. For leases where the Company is reasonably certain to exercise a renewal option, such option periods have been included in the determination of the Company’s Operating lease right-of-use assets and Operating lease liabilities. The Company’s leases have remaining terms of 1 to 5 years. As the Company’s leases do not provide an implicit rate, the present value of future lease payments is determined using the Company’s incremental borrowing rate based on information available at the commencement date. ​ ​ ​ ​ ​ Lease term and discount rate December 31, 2023 Weighted average remaining lease term 2.41 years Weighted average discount rate 5.0 % ​ During the year ended December 31, 2023, the Company terminated four leases including two offices in Malta and two vehicles in Malta. The terminated leases were operating leases. As a result of the terminations, the Company incurred $11 thousand in lease termination fees and recorded a loss of $669 related to this lease termination for the year ended December 31, 2023. ​ ​ ​ ​ ​ ​ December 31, ​ 2023 Leases terminated ​ 4 Lease termination fees ​ $ 10,932 Operating lease right-of-use assets derecognized upon lease termination ​ $ 96,639 Lease liabilities derecognized upon lease termination ​ $ 89,922 Loss recognized upon lease termination ​ $ 669 ​ On April 28, 2023, the Company extended the Malta office lease agreement, which would have ended on July 28, 2023, for a term of one On November 25, 2023, the Company entered into a new motor vehicle lease in Malta, which has term of 60 months. The new lease increased the Operating lease right-of-use asset by $47 thousand and the operating lease liability by $41 thousand. The Company classified the new lease as an operating lease under ASC 842. Balance sheet information related to leases as of December 31, 2023 and 2022 was as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Operating lease right-of-use assets ​ ​ ​ ​ ​ ​ Operating lease right-of-use assets ​ $ 164,740 ​ $ 315,765 ​ ​ ​ ​ ​ ​ ​ Operating lease liabilities ​ ​ ​ ​ Short-term operating lease liabilities ​ $ 81,236 ​ $ 177,795 Long-term operating lease liabilities ​ 53,771 ​ ​ 102,407 Total operating lease liabilities ​ $ 135,007 ​ $ 280,202 ​ Future maturities of ASC 842 lease liabilities as of December 31, 2023 are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Imputed ​ ​ ​ Principal ​ Interest ​ ​ ​ ​ Payments ​ Payments ​ Total Payments 2024 ​ $ 81,236 ​ $ 3,899 ​ $ 85,135 2025 ​ 27,655 ​ 1,802 ​ 29,457 2026 ​ 8,937 ​ 1,047 ​ 9,984 2027 ​ ​ 8,758 ​ ​ 621 ​ ​ 9,379 2028 ​ ​ 8,421 ​ ​ 176 ​ ​ 8,597 Total future maturities ​ $ 135,007 ​ $ 7,545 ​ $ 142,552 ​ Total lease expense, under ASC 842, was included in Selling, general, and administrative expenses in our consolidated statement of operations for the years ended December 31, 2023 and 2022 as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Operating lease expense – fixed payments ​ $ 209,577 ​ $ 276,562 Short term lease expense ​ 59,631 ​ ​ 90,159 Total lease expense ​ $ 269,208 ​ $ 366,721 ​ Supplemental cash flows information related to leases was as follow: ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: ​ ​ ​ ​ Operating cash flows from operating leases ​ $ (179,621) ​ $ (258,892) ​ During the year ended December 31, 2023, the Company did not incur variable lease expense. Financial Liability Obligation — 30-day Litigation —

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2024
Subsequent Events
Subsequent Events	12. Subsequent Events Securities Purchase Agreement On October 28, 2024 (the “Closing Date”), the Closing of the SPA occurred, and the Company received a cash payment of $300,000. The 90,910 shares of Class A Common Stock are held abeyance as of the date of this Quarterly Report on Form 10-Q. The Closing of the SPA was subject to a number of customary closing conditions, including, but not limited to, the Company’s entry into a Registration Rights Agreement, the execution of which were conditions to the Closing of the SPA. Secured Promissory Note —

Description of Business, Summ_2

Description of Business, Summary of Significant Accounting Policies, and Going Concern (Policies)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Description of Business, Summary of Significant Accounting Policies, and Going Concern
Description of Business	Description of Business Trust Stamp primarily develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning artificial intelligence, including computer vision, cryptography, and data mining, to process and protect data and deliver insightful outputs that identify and defend against fraud, protect sensitive user information, facilitate automated processes, and extend the reach of digital services through global accessibility. We utilize the power and agility of technologies such as GPU processing, edge computing, neural networks, and large language models to process and protect data faster and more effectively than historically possible to deliver results at a disruptively low cost for usage across multiple industries. Our team has substantial expertise in the creation and development of AI-enabled software products. We license our technology and expertise in numerous fields, with an increasing emphasis on addressing diverse markets through established partners who will integrate our technology into field-specific applications.	Description of Business — Trust Stamp develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning, artificial intelligence, biometric science, cryptography, and data mining, to deliver insightful identity and trust predictions that identify and defend against fraudulent identity attacks, protect sensitive user information, and extend the reach of digital services through global accessibility. We utilize the power and agility of technologies such as GPU processing, edge-computing, neural networks, and large language models to process and protect data faster and more effectively than has ever previously been possible in order to deliver results at a disruptively low cost for usage across multiple industries, including: ● Banking/FinTech ● KYC/AML Compliance ● Humanitarian and Development Services ● Government and Law Enforcement, including Alternative to Detention programs ● Cryptocurrency and Digital Assets ● Biometrically Secured Email and Digital Communications ● P2P Transactions, Social Media, and Sharing Economy ● Real Estate, Travel, and Healthcare
Reverse Split	Reverse Split — one 1A. Reverse Stock Split Reverse Split — December 30, 2024, the Company filed a Certificate of Amendment to the Company’s Third Amended and Restated Certificate of Incorporation, which was previously approved by the Company’s stockholders at the special meeting held on November 18, 2024 and described in the Company’s definitive proxy statement filed with the SEC on September 30, 2024, to effectuate a reverse stock split at a ratio of one (1) share of Common Stock for every fifteen (15) shares of Common Stock (the “ Reverse Stock Split ”) which became effective as of the opening of business on January 6, 2024 (the “ Effective Time ”). Accordingly, all share and per share amounts for all periods presented in the accompanying financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the reverse stock split.	Reverse Split — Amended and Restated Certificate of Incorporation 1A. Reverse Stock Split Reverse Split — Reverse Stock Split Effective Time
Going Concern	Going Concern The Company’s ability to continue as a going concern in the next twelve months following the date the unaudited condensed consolidated financial statements were available to be issued is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to generate revenue and raise capital as needed to satisfy the Company’s capital needs. While the negotiation of significant additional revenue is well advanced, it has not reached a stage that allows it to be factored into a going concern evaluation. In addition, although the Company has previously been successful in raising capital as needed and has already made plans to do so as well as restructuring expenses to meet the Company’s cash needs, no assurance can be given that the Company will be successful in its capital raising efforts. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period.	Going Concern The Company’s ability to continue as a going concern in the next twelve months following the date the consolidated financial statements were available to be issued is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to generate revenue and raise capital as needed to satisfy the Company’s capital needs. While the negotiation of significant additional revenue is well advanced, it has not reached a stage that allows it to be factored into a going concern evaluation. In addition, although the Company has previously been successful in raising capital as needed and has already made plans to do so as well as restructuring expenses to meet the Company’s cash needs, no assurance can be given that the Company will be successful in its capital raising efforts. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period.
Basis of Presentation	Basis of Presentation —	Basis of Presentation
Basis of Consolidation	Basis of Consolidation — The Company has completed the process of administratively dissolving AIID Payments Limited and the dissolution was effective October 29, 2024. Further, we continue to consolidate Tstamp Incentive Holdings (“TSIH”) which we consider to be a variable interest entity. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments necessary (which adjustments are of a normal and recurring nature) for the fair presentation of the Company’s financial position as of September 30, 2024 and December 31, 2023, and the results of operations for the three and nine months ended September 30, 2024 and 2023. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of results expected for the full year. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to the rules and regulations of the SEC. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The accounting policies employed are substantially the same as those shown in note 1 of the notes to consolidated financial statements included therein.	Basis of Consolidation On February 28, 2023, the Company received the Certificate of Termination from the State of Georgia, which represents the completion of administratively dissolving T Avatar LLC. As there were no operations established under the entity, there is a limited impact to Trust Stamp. The dissolution of T Avatar LLC was effective February 28, 2023. On June 2, 2023, the Company received the termination resolution from the Polish National Court Register, which represents the completion of administratively dissolving Sunflower AI Technologies (“SAIT”). As there were no operations established under the entity, there is a limited impact to Trust Stamp. The dissolution of SAIT was effective May 10, 2023. Further, we continue to consolidate Tstamp Incentive Holdings (“TSIH”) which we consider to be a variable interest entity.
Variable Interest Entity	Variable Interest Entity The Company considers this entity to be a variable interest entity (“VIE”) because it is thinly capitalized and holds no cash. Because the Company does not own shares in TSIH, management believes that this gives the Company a variable interest. Further, management of the Company also acts as management of TSIH and is the decision-maker as management grants shares held by TSIH to employees of the Company. As this VIE’s primary purpose is to hold shares in the Company from time to time and holds no other liabilities or assets, the Company is the primary beneficiary of TSIH and will consolidate the VIE.	Variable Interest Entity The Company does not own any of the shares of Class A Common Stock of the Company held by TSIH. The Company considers this entity to be a variable interest entity (“VIE”) because it is thinly capitalized and holds no cash. Because the Company does not own shares in TSIH, management believes that this gives the Company a variable interest. Further, management of the Company also acts as management of TSIH and is the decision-maker as management grants shares held by TSIH to employees of the Company. As this VIE owns only shares in the Company and no other liabilities or assets, the Company is the primary beneficiary of TSIH and will consolidate the VIE.
Use of Estimates		Use of Estimates
Segment Information		Segment Information —
Risks and Uncertainties		Risks and Uncertainties
Major Customers and Concentration of Risks	Major Customers and Concentration of Risks — For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures. Three customers represented 86.87% or 65.12%, 17.12%, and 4.63% of the balance of total Accounts receivable as of September 30, 2024 and three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. As of September 30, 2024 and December 31, 2023, the Company had not experienced any significant losses on its Accounts receivable. During the three months ended September 30, 2024, the Company sold to primarily three customers which made up approximately 93.24% of total Net revenue, and consisted of 66.34%, 17.60%, and 9.30% from an S&P 500 Bank, Mastercard, and Triton, respectively. Additionally, during the three months ended September 30, 2023, the Company sold to primarily three customers which made up approximately 95.85% of total Net revenue, and consisted of 81.87%, 7.91%, and 6.07% from IGS, Mastercard, and an S&P 500 Bank, respectively. During the nine months ended September 30, 2024, the Company sold to primarily three customers which made up approximately 94.68% of total Net revenue, and consisted of 63.66%, 21.07%, and 9.95% from an S&P 500 Bank, Mastercard, and Triton, respectively. Additionally, during the nine months ended September 30, 2023, the Company sold to primarily three customers which made up approximately 90.53% of total Net revenue, and consisted of 62.98%, 14.95%, and 12.60% from IGS, an S&P 500 Bank, and Mastercard, respectively.	Major Customers and Concentration of Risks For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures. Three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023 and three customers represented 95.37% or 36.90%, 32.69%, and 25.78% of the balance of total Accounts receivable as of December 31, 2022. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. As of December 31, 2023 and 2022, the Company had not experienced any significant losses on its Accounts receivable. During the year ended December 31, 2023, the Company sold to primarily three customers which made up approximately 89.75% of total Net revenue, and consisted of 55.04%, 17.77%, and 16.94% from IGS, an S&P 500 Bank, and Mastercard, respectively. Additionally, during the year ended December 31, 2022, the Company sold to primarily three customers which made up approximately 93.60% of total Net revenue, and consisted of 61.01%, 18.36%, and 14.23% from ICE, an S&P 500 Bank, and Mastercard.
Foreign Currencies		Foreign Currencies
Cash and Cash Equivalents		Cash and Cash Equivalents
Property and Equipment, Net	Property and Equipment, Net —	Property and Equipment, Net
Capitalized Internal-Use Software, Net		Capitalized Internal-Use Software, Net Capitalized Internal-Use Software, Net is a combination of c
Accounting for Impairment of Long-Lived Assets	Accounting for Impairment of Long-Lived Assets — As of September 30, 2024, the Company determined that $24 thousand of Capitalized internal-use software were impaired .	Accounting for Impairment of Long-Lived Assets As of December 31, 2023, the Company determined that $19 thousand of Capitalized internal-use software and $12 thousand of Intangible assets was impaired. The impaired Capitalized internal-use software was expensed to Research and development during the year ended December 31, 2023.. As of December 31, 2022, the Company determined that no long-lived assets with finite lives were impaired.
Goodwill	Goodwill — Intangibles—Goodwill and Other financial performance and other relevant entity-specific events in determining whether it is more likely than not that the fair value of the reporting unit is less than the carrying amount. Should the Company conclude that it is more likely than not that the recorded Goodwill amounts have been impaired, the Company would perform the impairment test. Goodwill impairment exists when a reporting unit’s carrying value exceeds its fair value. Significant judgment is applied when Goodwill is assessed for impairment. There were no impairment charges to Goodwill as of September 30, 2024 and December 31, 2023.	Goodwill Intangibles—Goodwill and Other
Fair Value of Assets and Liabilities		Fair Value of Assets and Liabilities — Level 1 Level 2 Level 3 A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The estimated fair values of Cash and cash equivalents, Accounts receivable, Related party receivables, Prepaid expenses and other current assets, Other assets, Accounts payable, Related party payables, Accrued expenses, Deferred revenue, Customer deposit liabilities, and Notes payable approximate their carrying values. The fair values of warrant liabilities issued in connection with equity or debt issuance are determined using the Black-Scholes valuation model, a “Level 3” fair value measurement, based on the estimated fair value of the underlying common stock, volatility based on the historical volatility data of similar companies, considering the industry, products and market capitalization of such other entities, the expected life based on the remaining contractual term of the conversion option and warrant liabilities and the risk free interest rate based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrant liability’s contractual life. The Company accounts for its financial assets and liabilities at fair value regularly. The Company evaluates the fair value of its non-financial assets and liabilities on a nonrecurring basis.
Remaining Performance Obligations	Remaining Performance Obligations — Disaggregation of Revenue ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Professional services (over time) ​ $ 424,831 ​ $ 2,990,804 ​ $ 1,326,403 ​ $ 3,760,242 License fees (over time) ​ ​ 86,250 ​ ​ 75,000 ​ ​ 258,750 ​ 225,000 Total Revenue ​ $ 511,081 ​ $ 3,065,804 ​ $ 1,585,153 ​ $ 3,985,242	Revenue Recognition — ● Identification of the contract, or contracts with a customer; ● Identification of the performance obligations in the contract; ● Determination of the transaction price; ● Allocation of the transaction price to the performance obligations in the contract; and ● Recognition of revenue when or as the Company satisfies the performance obligations. At contract inception, the Company will assess the services agreed upon within each contract and assess whether each service is distinct and determine those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In general, each contract with a customer consists of a single performance obligation to perform services in which revenue is recognized when the service has been delivered. Remaining Performance Obligations considered a remaining performance obligation. As of December 31, 2023 and 2022, the Company did not have any related performance obligations for contracts with terms exceeding twelve months. Disaggregation of Revenue ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Professional services (over time) ​ $ 4,260,275 ​ $ 4,415,512 Termination expense reimbursement (one time) ​ — ​ 719,565 License fees (over time) ​ 300,000 ​ 250,000 Total Revenue ​ $ 4,560,275 ​ $ 5,385,077 ​ Contract Balances — . The payment terms and conditions vary by contract; however, the Company’s terms generally require payment within 30 to 60 days from the invoice date. In instances where the timing of revenue recognition differs from the timing of payment, the Company elected to apply the practical expedient in accordance with ASC 606 to not adjust contract consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when promised goods and services are transferred to the customer and when the customer pays for those goods and services will be one year or less. As such, the Company determined its contracts do not generally contain a significant financing component. Costs to Obtain and Fulfill Contracts —
Warrants		Warrants —
Cost of Services Provided		Cost of Services Provided —
Research and Development		Research and Development —
Advertising		Advertising —
Stock- Based Compensation		Stock- Based Compensation — input of highly subjective assumptions, including the fair value of the underlying common shares, the expected term of the share option, the expected volatility of the price of our common shares, risk-free interest rates, and the expected dividend yield of common shares. The assumptions used to determine the fair value of the option awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment. The calculated fair value is recognized as expense over the requisite service period using the straight-line method. Forfeitures are accounted for in the period in which they occur. Trust Stamp offers the indirect repurchase of shares through a net-settlement feature upon the vesting of RSU awards to satisfy minimum statutory tax-withholding requirements for the recipient.
Income Taxes		Income Taxes — A valuation allowance is established if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income in assessing the need for a valuation allowance. The Company’s tax positions are subject to income tax audits by multiple tax jurisdictions. The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not the position will be sustainable upon examination by the taxing authority, including resolution of any related appeals or litigation processes. This evaluation is based on all available evidence and assumes that the tax authorities have full knowledge of all relevant information concerning the tax position. The tax benefit recognized is measured as the largest amount of benefit which is more likely than not (greater than 50% likely) to be realized upon ultimate settlement with the taxing authority. The Company recognizes interest accrued and penalties related to unrecognized tax benefits in Income tax benefit (expense). The Company adjusts these reserves in accordance with the income tax guidance when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may affect the provision for income taxes in the period in which such determination is made and could have a material impact on the Company’s financial condition and operating results. The Company computes its tax provision for interim periods by applying the estimated annual effective tax rate to year-to-date pre-tax income from recurring operations and adjusting for discrete tax items arising in that quarter. There were no discrete items that impacted the effective tax rate for the years ended December 31, 2023 and 2022, respectively. The rate remained consistent over the period due to the full valuation allowance recorded in the period. The Company had an effective tax rate of 0% for the years ended December 31, 2023 and 2022, respectively. The Company has incurred U.S. operating losses and has minimal profits in foreign jurisdictions. Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences are deductible. In making this determination, management considers all available positive and negative evidence affecting specific deferred tax assets, including the Company’s past and anticipated future performance, the reversal of deferred tax liabilities, the length of carry-back and carry-forward periods, and the implementation of tax planning strategies. The Company had no unrecognized tax benefits as of December 31, 2023 and 2022. It is the Company’s policy to recognize interest and penalties related to income tax matters in Income tax benefit (expense). The Company has not accrued any penalties related to uncertain tax positions due to offsetting tax attributes as of December 31, 2023 and 2022. The Company files U.S. federal, state, and foreign income tax returns in jurisdictions with varying statutes of limitation. The only material jurisdiction where the Company is subject to potential examination by tax authorities is the U.S. (federal and state) for tax years 2020 through 2022.
Leases		Leases — Lessors—Certain Leases with Variable Lease Payments Operating lease right-of-use assets represent the Company’s right to use an underlying asset during a lease term and are included in non-current assets on our consolidated balance sheet. Operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease liabilities are divided into two classifications on our consolidated balance sheet as a current liability, Short-term operating lease liabilities, and a non-current liability, Long-term operating lease liabilities. The Company does not have any finance lease right-of-use assets or finance lease liabilities. The Company’s operating lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. The interest rate implicit in the lease is not readily determinable, therefore, the Company uses an estimated incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s Operating lease right-of-use assets are also recognized at the applicable lease commencement date. The Operating lease right-of-use asset equals the carrying amount of the related operating lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable Operating lease right-of-use asset or operating lease liability. The term of our leases equals the non-cancellable period of the lease, including any rent-free periods provided by the lessor, and also include options to renew or extend the lease (including by not terminating the lease) that we are reasonably certain to exercise. We establish the term of each lease at lease commencement and reassess that term in subsequent periods if a triggering event occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term. Some lease contracts include lease and non-lease components. Trust Stamp elected the practical expedient offered by ASC 842 to not separate the lease components from non-lease components. As a result, the Company accounts for leases as a single lease component. In addition, the Company elected not to recognize right-of-use assets and lease liabilities for leases term of twelve months or less. The short-term lease expenses are recognized on a straight-line basis over the lease term.
Commitments and Contingencies		Commitments and Contingencies -
Treasury Stock		Treasury Stock -
Net Loss per Share Attributable to Common Stockholders		Net Loss per Share Attributable to Common Stockholders —
Recent Accounting Pronouncements Not Yet Adopted	Recent Accounting Pronouncements Not Yet Adopted — , Income Taxes (Topic 740) – Improvements to Income Tax Disclosures In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions . The amendments in this ASU clarify that an entity should measure the fair value of an equity security subject to contractual sale restriction the same way it measures an identical equity security that is not subject to such a restriction. The FASB said the contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, should not affect its fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect this guidance to have a material impact to its unaudited condensed consolidated financial statements or related disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures . ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption of the amendments is permitted. The Company is currently evaluating the impacts of the new standard but does not expect a material impact to its unaudited condensed consolidated financial statements or related disclosures.	Recent Accounting Pronouncements Not Yet Adopted — In December 2023, the FASB issued ASU 2023-09 , Income Taxes – Improvements to Income Tax Disclosures . ASU 2023-09 requires enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impacts of the new standard but does not expect a material impact to its consolidated financial statements or related disclosures. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions . The amendments in this ASU clarify that an entity should measure the fair value of an equity security subject to contractual sale restriction the same way it measures an identical equity security that is not subject to such a restriction. The FASB said the contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, should not affect its fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect this guidance to have a material impact to its consolidated financial statements or related disclosures.
Recently Adopted Accounting Pronouncement		Recently Adopted Accounting Pronouncement — In June 2016, the FASB issued Accounting Standards Update No. 2016-13, “Financial Instruments - Credit Losses (Topic 326)” (“ASU 2016-13”). ASU 2016-13 revises the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. In November 2019, FASB issued ASU 2019-10, “ Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842 ). ” This ASU defers the effective date of ASU 2016-13 for public companies that are considered smaller reporting companies as defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted this standard as of January 1, 2023, and the guidance did not have a material impact on its consolidated financial statements or related disclosures.

Description of Business, Summ_3

Description of Business, Summary of Significant Accounting Policies, and Going Concern (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Description of Business, Summary of Significant Accounting Policies, and Going Concern
Schedule of Disaggregation of Revenue	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Professional services (over time) ​ $ 424,831 ​ $ 2,990,804 ​ $ 1,326,403 ​ $ 3,760,242 License fees (over time) ​ ​ 86,250 ​ ​ 75,000 ​ ​ 258,750 ​ 225,000 Total Revenue ​ $ 511,081 ​ $ 3,065,804 ​ $ 1,585,153 ​ $ 3,985,242	​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Professional services (over time) ​ $ 4,260,275 ​ $ 4,415,512 Termination expense reimbursement (one time) ​ — ​ 719,565 License fees (over time) ​ 300,000 ​ 250,000 Total Revenue ​ $ 4,560,275 ​ $ 5,385,077

Borrowings (Tables)

Borrowings (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Borrowings
Summary of Non-Convertible Promissory Notes Payable	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Malta loan receipt 3 – June 3, 2022 ​ $ 511,262 ​ $ 507,035 Malta loan receipt 2 – August 10, 2021 ​ ​ 315,673 ​ ​ 313,063 Malta loan receipt 1 – February 9, 2021 ​ ​ 64,807 ​ ​ 64,271 Interest added to principal ​ ​ 70,088 ​ ​ 29,191 Total principal outstanding ​ ​ 961,830 ​ ​ 913,560 Plus: accrued interest ​ ​ 45,383 ​ ​ 40,317 Total promissory notes payable ​ $ 1,007,213 ​ $ 953,877	​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Malta loan receipt 3 – June 3, 2022 ​ $ 507,035 ​ $ 62,365 Malta loan receipt 2 – August 10, 2021 ​ ​ 313,063 ​ ​ 303,778 Malta loan receipt 1 – February 9, 2021 ​ 64,271 ​ 491,996 Interest added to principal ​ ​ 29,191 ​ ​ 11,551 Total principal outstanding ​ 913,560 ​ 869,690 Plus: accrued interest ​ 40,317 ​ 16,775 Total promissory notes payable ​ $ 953,877 ​ $ 886,465
Schedule of Short-Term Debt	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ ​ 2024 ​ ​ 2023 Agile loan agreement 1 - July 9, 2024 ​ $ 315,000 ​ $ — Agile loan agreement 2 - August 29,2024 ​ 530,000 ​ — Interest added to loan agreement 1 - July 9, 2024 ​ 54,450 ​ — Interest added to loan agreement 2 - August 29, 2024 ​ 33,314 ​ — Total principal and interest outstanding ​ 932,764 ​ — Less: loan repayments ​ 287,228 ​ — Total promissory notes payable ​ $ 645,536 ​ $ —

Warrants (Tables)

Warrants (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Warrants
Schedule of Changes in Warrant Liability	​ ​ ​ ​ ​ ​ Warrants ($) Balance as of January 1, 2023 ​ $ 261,569 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,033) Balance as of December 31, 2023 ​ $ 256,536 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,842) Balance as of September 30, 2024 ​ $ 250,694	​ ​ ​ ​ ​ ​ Warrants ($) Balance as of January 1, 2022 ​ $ 374,694 Additional warrants issued ​ — Change in fair value ​ ​ (113,125) Balance as of December 31, 2022 ​ $ 261,569 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,033) Balance as of December 31, 2023 ​ $ 256,536
Schedule of Fair Value of Warrants Liabilities	​ ​ ​ ​ ​ ​ Fair Value of Warrants $ 1.65 — $9.60 ​ Exercise price ​ $ 3.90 — $7.35 ​ Risk free interest rate ​ ​ 3.51%— 4.50 % Expected dividend yield ​ ​ — % Expected volatility ​ ​ 79.19% — 79.59 % Expected term ​ ​ 1 year - 3 years	​ ​ ​ ​ ​ ​ Fair Value of Warrants $ 13.95 – $30.15 ​ Exercise price ​ $ 7.95 – $14.40 ​ Risk free interest rate ​ 4.09% - 4.74 % Expected dividend yield ​ — % Expected volatility ​ 79.08% - 92.90 % Expected term ​ 3 years
Schedule of Warrant Issuance Date	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, Warrant Issuance Date ​ Strike Price ​ 2024 ​ 2023 November 9, 2016 ​ $ 46.80 5,342 5,342 January 23, 2020 ​ $ 120.00 ​ 12,430 ​ 12,430 January 23, 2020 ​ $ 120.00 ​ 34,974 ​ 34,974 April 18, 2023 ​ $ 20.10 ​ — ​ 51,689 June 5, 2023 ​ $ 4.80 ​ — ​ 85,314 December 21, 2023 ​ $ 4.80 ​ 192,869 ​ 240,000 April 3, 2024 ​ $ 14.55 ​ — ​ — April 3, 2024 ​ $ 15.90 ​ — ​ — September 3, 2024 ​ $ 4.80 ​ 95,494 ​ — September 3, 2024 ​ $ 4.80 ​ 190,987 ​ — September 3, 2024 ​ $ 4.80 ​ 636,404 ​ — September 10, 2024 ​ $ 3.45 ​ 250,930 ​ — Total warrants outstanding ​ ​ ​ ​ 1,419,430 ​ 429,749	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, Warrant Issuance Date Strike Price 2023 2022 November 9, 2016 ​ $ 46.80 5,342 5,342 January 23, 2020 ​ $ 120.00 ​ 12,430 ​ 12,430 January 23, 2020 ​ $ 120.00 34,974 54,974 August – December 2021 ​ $ 300.00 — 17,917 January – February 2022 ​ $ 300.00 — 1,012 September 14, 2022 ​ $ 20.10 — 26,000 April 18, 2023 ​ $ 20.10 ​ 51,689 (1) — June 5, 2023 ​ $ 20.10 ​ 85,314 (1) — December 21, 2023 ​ $ 20.10 ​ 240,000 ​ — Total warrants outstanding ​ ​ ​ 429,749 97,675 (1) As of December 31, 2023, all 51,689 of the April 18, 2023 warrants and 7,112 of the June 5, 2023 warrants are held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation.

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Balance Sheet Components
Schedule of prepaid expenses and other current assets	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Prepaid operating expenses ​ $ 253,973 ​ $ 216,875 Rent deposit ​ ​ 27,458 ​ ​ 28,400 Value added tax receivable ​ ​ 48,177 ​ ​ 116,095 Tax credit receivable (short-term) ​ ​ 25,045 ​ ​ 102,151 Miscellaneous receivable ​ ​ 859,271 ​ ​ 363,260 Prepaid expenses and other current assets ​ $ 1,213,924 ​ $ 826,781	​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ 2023 2022 Prepaid operating expenses ​ $ 216,875 ​ $ 225,756 Rent deposit ​ 28,400 ​ 55,981 Value added tax receivable ​ 116,095 ​ 71,742 Tax credit receivable (short-term) ​ ​ 102,151 ​ ​ 218,239 Miscellaneous receivable ​ 363,260 ​ 8,368 Prepaid expenses and other current assets ​ $ 826,781 ​ $ 580,086
Schedule of capitalized internal-use software, net	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Internally developed software ​ 5 Years ​ $ 4,363,338 ​ $ 3,901,801 Less: Accumulated depreciation ​ ​ ​ ​ (2,830,981) ​ ​ (2,429,427) Capitalized internal-use software, net ​ ​ ​ $ 1,532,357 ​ $ 1,472,374	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Internally developed software 5 Years $ 3,901,801 ​ $ 3,314,450 Less: Accumulated depreciation ​ ​ (2,429,427) ​ (1,895,778) Capitalized internal-use software, net ​ ​ ​ $ 1,472,374 ​ $ 1,418,672
Schedule of property and equipment, net	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Computer equipment ​ 3-4 Years ​ $ 154,181 ​ $ 152,014 Furniture and fixtures ​ 10 Years ​ ​ 34,675 ​ ​ 28,052 Property and equipment, gross ​ ​ ​ ​ 188,856 ​ ​ 180,066 Less: Accumulated depreciation ​ ​ ​ ​ (149,031) ​ ​ (123,630) Property and equipment, net ​ ​ ​ $ 39,825 ​ $ 56,436	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Computer equipment 3-4 Years ​ $ 152,014 ​ $ 148,832 Furniture and fixtures 10 Years ​ 28,052 ​ 27,220 Mobile hardware ​ 2.5 years ​ ​ — ​ ​ 297,150 Property and equipment, gross ​ ​ ​ 180,066 ​ 473,202 Less: Accumulated depreciation ​ ​ ​ (123,630) ​ (172,538) Property and equipment, net ​ ​ ​ $ 56,436 ​ $ 300,664
Schedule of accrued expenses	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Compensation payable ​ $ 672,587 ​ $ 377,403 Commission liability ​ ​ 19,885 ​ ​ 26,863 Accrued employee taxes ​ ​ 890,411 ​ ​ 624,525 Other accrued liabilities ​ ​ 87,377 ​ ​ 115,099 Accrued expenses ​ $ 1,670,260 ​ $ 1,143,890 ​	​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Compensation payable ​ $ 377,403 ​ $ 171,851 Commission liability ​ ​ 26,863 ​ ​ 58,771 Accrued employee taxes ​ 624,525 ​ 591,992 Accrued mobile expenses ​ ​ — ​ ​ 177,099 Other accrued liabilities ​ 115,099 ​ 100,111 Accrued expenses ​ $ 1,143,890 ​ $ 1,099,824 ​

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Goodwill and Intangible Assets
Schedule of Intangible Assets	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Patent application costs ​ 3 Years ​ $ 555,918 ​ $ 484,035 Trade name and trademarks ​ 3 Years ​ ​ 71,033 ​ ​ 70,446 Intangible assets, gross ​ ​ ​ ​ 626,951 ​ ​ 554,481 Less: Accumulated amortization ​ ​ ​ ​ (433,647) ​ ​ (330,791) Intangible assets, net ​ ​ ​ $ 193,304 ​ $ 223,690	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Patent application costs 3 Years ​ $ 484,035 ​ $ 382,285 Trade name and trademarks 3 Years ​ 70,446 ​ 68,356 Intangible assets, gross ​ ​ 554,481 ​ 450,641 Less: Accumulated amortization ​ ​ (330,791) ​ (198,955) Intangible assets, net ​ ​ ​ $ 223,690 ​ $ 251,686
Schedule of Estimated Future Amortization Expense of Intangible Assets	​ ​ ​ ​ ​ Years Ending December 31, Amount 2024 ​ $ 31,949 2025 ​ ​ 99,005 2026 ​ ​ 52,529 2027 ​ ​ 9,821 Total future amortization ​ $ 193,304 ​	​ ​ ​ ​ ​ Years Ending December 31, Amount 2024 ​ ​ 120,078 2025 ​ 75,043 2026 ​ ​ 28,569 ​ ​ $ 223,690 ​

Net Loss per Share Attributab_2

Net Loss per Share Attributable to Common Stockholders (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Net Loss per Share Attributable to Common Stockholders
Schedule of Basic and Diluted Loss Per Share Attributable to Common Stockholders	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Numerator: ​ ​ ​ ​ ​ ​ ​ ​ Net loss attributable to common stockholders ​ $ (1,255,915) ​ $ (35,162) ​ $ (6,532,845) ​ $ (4,752,980) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares used in computing net loss per share attributable to common stockholders ​ ​ 1,181,150 ​ ​ 543,708 ​ 891,211 ​ 443,880 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net loss per share attributable to common stockholders ​ $ (1.06) ​ $ (0.06) ​ $ (7.33) ​ $ (10.71)	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Numerator: ​ ​ ​ ​ ​ ​ Net loss attributable to common stockholders ​ $ (7,637,642) ​ $ (12,091,540) ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ Weighted average shares used in computing net loss per share attributable to common stockholders ​ 475,171 ​ ​ 315,518 ​ ​ ​ ​ ​ ​ ​ Net loss per share attributable to common stockholders ​ $ (16.07) ​ $ (38.32) ​
Schedule of Anti-Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share	​ ​ ​ ​ ​ ​ ​ ​ As of September 30, ​ 2024 2023 Options, RSUs, and grants ​ 106,434 ​ 52,761 Warrants ​ 1,798,643 ​ 301,880 Total ​ 1,905,077 ​ 354,641 ​	​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Options, RSUs, and grants ​ 60,741 ​ 49,625 Warrants ​ 432,202 ​ 111,742 Total ​ 492,943 ​ 161,367 ​

Stock Awards and Stock-Based _2

Stock Awards and Stock-Based Compensation (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Stock Awards and Stock-Based Compensation
Schedule of stock options activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ Options Exercise Price Contractual Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2023 25,808 ​ $ 96.00 1.45 ​ $ — Options granted 793 ​ 34.20 — ​ — Options exercised (82) ​ 48.75 — ​ — Options canceled and forfeited ​ (280) ​ ​ 85.95 ​ — ​ ​ — Balance as of December 31, 2023 ​ 26,239 ​ ​ 94.05 ​ 1.95 ​ ​ — Options granted ​ 255 ​ ​ 23.55 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited (95) ​ 63.15 — ​ — Balance as of March 31, 2024 ​ 26,399 ​ ​ 93.60 ​ 1.72 ​ ​ — Options granted ​ 292 ​ ​ 20.55 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited (34) ​ 58.80 — ​ — Balance as of June 30, 2024 26,657 ​ 92.85 1.49 ​ — Options granted ​ 437 ​ ​ 13.80 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited ​ (102) ​ ​ 58.80 ​ — ​ ​ — Options vested and exercisable as of September 30, 2024 26,992 ​ $ 91.65 1.27 ​ ​ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ ​ Options ​ Exercise Price ​ Contractual ​ Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2024 ​ 26,239 ​ $ 94.05 1.95 ​ $ — Options granted ​ 984 ​ ​ 18.30 — ​ ​ — Options exercised ​ — ​ ​ — — ​ ​ — Options canceled and forfeited ​ (231) ​ ​ 60.30 — ​ ​ — Balance as of September 30, 2024 ​ 26,992 ​ ​ 91.65 1.27 ​ ​ — Options vested and exercisable as of September 30, 2024 ​ 26,992 ​ $ 91.65 ​ 1.27 ​ $ — ​	The following table summarizes stock option activity for the years ended December 31, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ ​ Options ​ Exercise Price ​ Contractual ​ Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2023 ​ ​ 25,808 ​ $ 96.00 1.45 ​ $ — Options granted ​ ​ 793 ​ ​ 34.20 ​ ​ ​ ​ ​ Options exercised ​ ​ (82) ​ ​ 48.75 ​ ​ ​ ​ ​ Options canceled and forfeited ​ ​ (280) ​ ​ 85.95 ​ ​ ​ ​ ​ Balance as of December 31, 2023 ​ ​ 26,239 ​ ​ 94.05 ​ 1.95 ​ ​ — Options vested and exercisable as of December 31, 2023 ​ ​ 26,239 ​ $ 94.05 1.95 ​ ​ — ​
Schedule of stock options valuation assumptions	​ ​ ​ ​ ​ ​ Fair value of Class A Common Stock $ 0.90 — 10.80 ​ Exercise price ​ $ 12.00 — 24.60 ​ Risk free interest rate ​ ​ 3.51 — 4.71 % Expected dividend yield ​ ​ 0.00 % Expected volatility ​ ​ 77.54 — 79.80 % Expected term ​ ​ 3 Years	The following assumptions were used to calculate the fair value of options granted during the year ended December 31, 2023: ​ ​ ​ ​ ​ Fair value of Class A Common Stock $ 5.70 – 25.05 ​ Exercise price ​ $ 26.70 – 46.35 ​ Risk free interest rate ​ 3.76 - 4.89 % Expected dividend yield ​ 0.00 % Expected volatility ​ 79.08– 96.45 % Expected term ​ 3 Years
Schedule of outstanding RSU activity	​ ​ ​ ​ ​ RSU Outstanding ​ ​ Number of Shares Balance as of January 1, 2023 19,505 Granted 27,368 Vested (issued) (10,652) Forfeited (6,481) Balance as of December 31, 2023 29,740 Granted 69,335 Vested (issued) (21,255) Forfeited (5,058) Balance as of September 30, 2024 72,762	A summary of outstanding RSU activity as of December 31, 2023 is as follows: ​ ​ ​ ​ ​ RSU Outstanding ​ ​ Number of Shares Balance as of January 1, 2022 8,460 Granted 14,114 Vested (issued) (3,070) Forfeited — Balance as of December 31, 2022 19,504 Granted 27,368 Vested (issued) (10,652) Forfeited (6,480) Balance as of December 31, 2023 29,740
Schedule of stock-based compensation expense	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Cost of services ​ $ 3,144 ​ $ 11,169 ​ $ 3,406 ​ $ 11,825 Research and development ​ ​ 23,878 ​ ​ 48,336 ​ 38,087 ​ 79,956 Selling, general, and administrative ​ ​ 324,571 ​ ​ 88,535 ​ 915,110 ​ 213,569 Total stock-based compensation expense ​ $ 351,593 ​ $ 148,040 ​ $ 956,603 ​ $ 305,350 ​	​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ ​ 2023 2022 Cost of services ​ $ 21,836 ​ $ 21,721 Research and development ​ 123,109 ​ 292,084 Selling, general, and administrative ​ 618,343 ​ 2,085,258 Total stock-based compensation expense ​ $ 763,288 ​ $ 2,399,063 ​

Leases and Commitments (Tables)

Leases and Commitments (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Leases and Commitments
Summary of lease term and discount rate	​ ​ ​ ​ ​ ​ ​ September 30, ​ Lease term and discount rate 2024 ​ Weighted average remaining lease term ​ 1.88 years Weighted average discount rate ​ 5.0 %	​ ​ ​ ​ ​ Lease term and discount rate December 31, 2023 Weighted average remaining lease term 2.41 years Weighted average discount rate 5.0 %
Summary of lease termination		​ ​ ​ ​ ​ ​ December 31, ​ 2023 Leases terminated ​ 4 Lease termination fees ​ $ 10,932 Operating lease right-of-use assets derecognized upon lease termination ​ $ 96,639 Lease liabilities derecognized upon lease termination ​ $ 89,922 Loss recognized upon lease termination ​ $ 669
Summary of balance sheet information related to leases	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Operating lease right-of-use assets ​ ​ ​ ​ ​ ​ Operating lease right-of-use assets ​ $ 198,634 ​ $ 164,740 ​ ​ ​ ​ ​ ​ ​ Operating lease liabilities ​ ​ ​ ​ ​ ​ Short-term operating lease liabilities ​ $ 95,367 ​ $ 81,236 Long-term operating lease liabilities ​ ​ 70,555 ​ ​ 53,771 Total operating lease liabilities ​ $ 165,922 ​ $ 135,007	​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Operating lease right-of-use assets ​ ​ ​ ​ ​ ​ Operating lease right-of-use assets ​ $ 164,740 ​ $ 315,765 ​ ​ ​ ​ ​ ​ ​ Operating lease liabilities ​ ​ ​ ​ Short-term operating lease liabilities ​ $ 81,236 ​ $ 177,795 Long-term operating lease liabilities ​ 53,771 ​ ​ 102,407 Total operating lease liabilities ​ $ 135,007 ​ $ 280,202
Summary of future maturities of ASC 842 lease liabilities	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Imputed ​ ​ ​ ​ Principal ​ Interest ​ ​ ​ Years Ending December 31, ​ Payments ​ Payments ​ Total Payments 2024 ​ $ 36,976 ​ $ 1,921 ​ $ 38,897 2025 ​ ​ 88,889 ​ ​ 3,696 ​ ​ 92,585 2026 ​ ​ 22,735 ​ ​ 1,170 ​ ​ 23,905 2027 ​ ​ 8,831 ​ ​ 626 ​ ​ 9,457 2028 ​ ​ 8,491 ​ ​ 178 ​ ​ 8,669 Total future maturities ​ $ 165,922 ​ $ 7,591 ​ $ 173,513	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Imputed ​ ​ ​ Principal ​ Interest ​ ​ ​ ​ Payments ​ Payments ​ Total Payments 2024 ​ $ 81,236 ​ $ 3,899 ​ $ 85,135 2025 ​ 27,655 ​ 1,802 ​ 29,457 2026 ​ 8,937 ​ 1,047 ​ 9,984 2027 ​ ​ 8,758 ​ ​ 621 ​ ​ 9,379 2028 ​ ​ 8,421 ​ ​ 176 ​ ​ 8,597 Total future maturities ​ $ 135,007 ​ $ 7,545 ​ $ 142,552
Summary of total lease expense, under ASC 842, was included in selling, general, and administrative expenses in consolidated statement of operations	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Operating lease expense – fixed payments ​ $ 39,368 ​ $ 40,060 ​ $ 117,221 ​ $ 169,496 Short term lease expense ​ ​ 10,710 ​ ​ 10,846 ​ ​ 34,929 ​ ​ 48,399 Total lease expense ​ $ 50,078 ​ $ 50,906 ​ $ 152,150 ​ $ 217,895	​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Operating lease expense – fixed payments ​ $ 209,577 ​ $ 276,562 Short term lease expense ​ 59,631 ​ ​ 90,159 Total lease expense ​ $ 269,208 ​ $ 366,721
Summary of supplemental cash flows information related to leases	​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended ​ September 30, ​ 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: ​ ​ ​ ​ ​ ​ Operating cash flows from operating leases ​ $ (111,277) ​ $ (145,483)	​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: ​ ​ ​ ​ Operating cash flows from operating leases ​ $ (179,621) ​ $ (258,892)

Description of Business, Summ_4

Description of Business, Summary of Significant Accounting Policies, and Going Concern - Narrative (Details)											3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 06, 2025	Dec. 30, 2024	Dec. 21, 2023 shares	Jun. 23, 2023 USD ($) shares	Jun. 12, 2023 USD ($) shares	Jun. 05, 2023 USD ($) shares	Jun. 01, 2023 shares	Apr. 18, 2023 USD ($) shares	Jan. 08, 2021 shares	Apr. 25, 2019 shares	Sep. 30, 2024 USD ($) customer shares	Sep. 30, 2023 USD ($) customer	Sep. 30, 2024 USD ($) customer shares	Sep. 30, 2023 USD ($) customer	Dec. 31, 2023 USD ($) customer shares	Dec. 31, 2022 USD ($) shares	Jul. 06, 2023 shares	Feb. 15, 2023 shares	Sep. 11, 2022 shares	Dec. 31, 2021 USD ($)	Jun. 30, 2020 shares	Jan. 31, 2020 shares	Nov. 09, 2016 shares
Description of Business and Summary of Significant Accounting Policies And Going Concern
Common stock, shares authorized (in shares) | shares											50,000,000		50,000,000		50,000,000	50,000,000	50,000,000
Stock split													0.20
Reverse stock split		0.06
Net loss attributable to T Stamp Inc.											$ 1,255,915	$ 35,162	$ 6,532,845	$ 4,752,980	$ 7,637,642	$ 12,091,540
Operating cash outflows													6,183,158	5,884,123	7,852,546	6,337,386
Working capital											(1,450,000)		(1,450,000)		(1,980,000)
Accumulated deficit											$ 55,446,691		55,446,691		50,853,285	39,299,726
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees													$ 3,985,795	7,464,312	$ 7,464,312	$ 983,195
Number of warrants exercised for issuance of shares (in shares) | shares											1,419,430		1,419,430		429,749	97,675					428
Shares issued upon exercise of warrants (in shares) | shares			104,889	47,132			85,314
Shares issued (in shares) | shares											0		0		3,649	3,768
Common stock, shares issued (in shares) | shares											1,254,650		1,254,650		613,206	327,389
Cash and cash equivalents											$ 598,031	$ 3,182,503	$ 598,031	$ 3,182,503	$ 3,140,747	$ 1,254,494				$ 3,475,695
Impairment of intangible assets finite lived													24,000		12,000	0
Goodwill impairment loss													0		0	0
Gross receivables															694,000	1,010,000
Allowance for credit losses															8,000	0
Unbilled receivables											$ 4,463		4,463		143,219	109,475
Advertising and marketing expense															224,000	217,000
Impaired capitalized internal-use software													$ 24,000		$ 19,000
Effective tax rate															0%
Unrecognized tax benefits															$ 0	$ 0
Third Restated Certificate
Description of Business and Summary of Significant Accounting Policies And Going Concern
Common stock, shares authorized (in shares) | shares																	50,000,000
Securities purchase agreement
Description of Business and Summary of Significant Accounting Policies And Going Concern
Number of shares agreed to issue and sell (in shares) | shares					21,487	49,094		37,559
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees				$ 14,734	$ 322	$ 1,693,720		$ 1,859,154
Number of warrants exercised for issuance of shares (in shares) | shares				14,734	21,487	36,220		67,330
Proceeds from warrant exercises				$ 221		$ 1,249,047		$ 3,332,835
Shares issued upon exercise of warrants (in shares) | shares						49,094		104,889
Proceeds from offering after deducting placement fee and legal expense						$ 2,686,773		$ 4,778,550
Placement fee						205,994		363,439
Legal expense						$ 50,000		$ 50,000
Subsequent Events
Description of Business and Summary of Significant Accounting Policies And Going Concern
Stock split	15
Sales revenue net | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Number of customers | customer											3	3	3	3
Top Three Customers | Accounts receivable | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Concentration risk (as a percent)													86.87%		91.11%	95.37%
Number of customers | customer													3		3
Top Three Customers | Sales revenue net | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Concentration risk (as a percent)											93.24%	95.85%	94.68%	90.53%
Customer One | Accounts receivable | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Concentration risk (as a percent)													65.12%		53.55%	36.90%
Customer Two | Accounts receivable | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Concentration risk (as a percent)													17.12%		30.43%	32.69%
Customer Three | Accounts receivable | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Concentration risk (as a percent)													4.63%		7.13%	25.78%
Customer | Sales revenue net | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Concentration risk (as a percent)															89.75%	93.60%
S And P 500 Bank | Sales revenue net | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Concentration risk (as a percent)											66.34%	81.87%	63.66%	14.95%	17.77%	18.36%
Mastercard | Sales revenue net | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Concentration risk (as a percent)											17.60%	6.07%	21.07%		16.94%	14.23%
Triton | Sales revenue net | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Concentration risk (as a percent)											9.30%		9.95%
FIS | Sales revenue net | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Concentration risk (as a percent)														12.60%
ICE | Sales revenue net | Customer Concentration Risk
Description of Business and Summary of Significant Accounting Policies And Going Concern
Concentration risk (as a percent)												7.91%		62.98%		61.01%
Bank Time Deposits
Description of Business and Summary of Significant Accounting Policies And Going Concern
Cash and cash equivalents											$ 30,342		$ 30,342		$ 2,620,765	$ 71,000
Common Class A
Description of Business and Summary of Significant Accounting Policies And Going Concern
Number of warrants exercised for issuance of shares (in shares) | shares															18,928				26,000			62,141	5,342
Shares issued (in shares) | shares										21,368					13,736
Common stock, shares issued (in shares) | shares																		13,736
Common stock, shares held (in shares) | shares													0
Common Class A | Various employees
Description of Business and Summary of Significant Accounting Policies And Going Concern
Number of shares transferred (in shares) | shares									17,600	17,600
Pre Funded Warrants
Description of Business and Summary of Significant Accounting Policies And Going Concern
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees				$ 221	$ 322
Shares issued upon exercise of warrants (in shares) | shares				14,734	21,487

Description of Business, Summ_5

Description of Business, Summary of Significant Accounting Policies, and Going Concern - Schedule of Disaggregation of Revenue (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Description of Business and Summary of Significant Accounting Policies And Going Concern
Total Revenue	$ 511,081	$ 3,065,804	$ 1,585,153	$ 3,985,242	$ 4,560,275	$ 5,385,077
Professional services (over time)
Description of Business and Summary of Significant Accounting Policies And Going Concern
Total Revenue	424,831	2,990,804	1,326,403	3,760,242
License fees (over time)
Description of Business and Summary of Significant Accounting Policies And Going Concern
Total Revenue	$ 86,250	$ 75,000	$ 258,750	$ 225,000

Borrowings - Non Convertible Pr

Borrowings - Non Convertible Promissory Notes Payable (Details) - Non-Convertible Promissory Notes Payable - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Borrowings
Total principal outstanding	$ 961,830	$ 913,560	$ 869,690
Interest added to principal	70,088	29,191	11,551
Plus: accrued interest	45,383	40,317	16,775
Total promissory notes payable	1,007,213	953,877	886,465
Malta loan receipt 3
Borrowings
Total principal outstanding	511,262	507,035	62,365
Malta loan receipt 2
Borrowings
Total principal outstanding	315,673	313,063	303,778
Malta loan receipt 1
Borrowings
Total principal outstanding	$ 64,807	$ 64,271	$ 491,996

Borrowings - Subordinated Busin

Borrowings - Subordinated Business Loans (Details) - Secured Debt - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Borrowings
Total principal and interest outstanding	$ 932,764	$ 0
Less: loan repayments	287,228	0
Total promissory notes payable	645,536	0
Agile Loan Agreement 1
Borrowings
Short-term debt	315,000	0
Interest added	54,450	0
Agile Loan Agreement 2
Borrowings
Short-term debt	530,000	0
Interest added	$ 33,314	$ 0

Borrowings - Narrative (Details

Borrowings - Narrative (Details) € in Thousands

1 Months Ended

9 Months Ended

12 Months Ended

Sep. 06, 2024 USD ($)

Jul. 18, 2023 USD ($)

Jul. 08, 2020 EUR (€)

May 01, 2020

May 31, 2020 EUR (€)

Sep. 30, 2024 USD ($)

Sep. 30, 2023

Dec. 31, 2023 USD ($)

Dec. 31, 2022 USD ($)

Aug. 29, 2024 USD ($)

Jul. 18, 2024 USD ($)

Jul. 09, 2024 USD ($)

Jul. 08, 2020 USD ($)

May 31, 2020 USD ($)

Borrowings

Interest

$ 233,000

Weekly payments

27,000

Proceeds from non-convertible notes

$ 0

$ 61,361

Minimum base rate for interest

1%

Fixed interest rate percentage

1%

1%

Promissory Note Payable January 23 2025

Borrowings

Potential repayable advance

$ 454,000

Principal amount

$ 315,000

Interest

139,000

Weekly payments

16,000

Administrative agent fee

$ 15,000

Promissory Note Payable March 14 2025

Borrowings

Potential repayable advance

763,000

Principal amount

530,000

Administrative agent fee

$ 27,000

Base Rate

Borrowings

Minimum base rate for interest

1%

Fixed interest rate percentage

1%

1%

Agile Lending LLC | Secured Debt

Borrowings

Potential repayable advance

$ 530,000

$ 315,000

Loans from Maltese government | Trust Stamp Malta Limited

Borrowings

Potential repayable advance

€ 800

€ 800

$ 858,000

$ 858,000

Percentage of payroll cost covered by advance

75%

75%

Term of payroll costs covered by advance

24 months

24 months

Employment term for receiving advances

36 months

36 months

Proceeds from non-convertible notes

$ 892,000

$ 884,000

Spread on variable rate

2%

Loan interest rate

6.50%

4.50%

4.50%

2.50%

Loans from Maltese government | Trust Stamp Malta Limited | Minimum

Borrowings

Percentage of pre-tax profits per annum to be repaid

10%

Loans from Maltese government | Trust Stamp Malta Limited | Maximum

Borrowings

Percentage of pre-tax profits per annum to be repaid

15%

Loans from Maltese government | Trust Stamp Malta Limited | Base Rate

Borrowings

Spread on variable rate

2%

Loans from Maltese government | Trust Stamp Malta Limited | Base Rate | Minimum

Borrowings

Percentage of pre-tax profits per annum to be repaid

10%

Loans from Maltese government | Trust Stamp Malta Limited | Base Rate | Maximum

Borrowings

Percentage of pre-tax profits per annum to be repaid

15%

Warrants - Schedule of Changes

Warrants - Schedule of Changes in Warrant Liability (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Change In Financial Instruments [Roll Forward]
Balance, beginning of period	$ 256,536	$ 261,569
Balance, end of period	250,694	256,536	$ 261,569
Fair Value, Inputs, Level 3
Change In Financial Instruments [Roll Forward]
Balance, beginning of period	256,536	261,569	374,694
Additional warrants issued	0	0
Change in fair value	(5,842)	(5,033)	(113,125)
Balance, end of period	$ 250,694	$ 256,536	$ 261,569

Warrants - Narrative (Details)

Warrants - Narrative (Details)																						1 Months Ended	3 Months Ended			9 Months Ended		12 Months Ended
	Nov. 06, 2024 USD ($) $ / shares shares	Oct. 28, 2024 $ / shares shares	Sep. 04, 2024 shares	Sep. 03, 2024 USD ($) $ / shares shares	Aug. 20, 2024 USD ($) $ / shares shares	Jul. 26, 2024 USD ($) $ / shares shares	Jul. 13, 2024 USD ($) $ / shares shares	May 24, 2024 USD ($) $ / shares shares	Apr. 03, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 21, 2023 USD ($) $ / shares shares	Aug. 18, 2023 USD ($) $ / shares shares	Jun. 23, 2023 USD ($) $ / shares shares	Jun. 12, 2023 USD ($) $ / shares shares	Jun. 05, 2023 USD ($) $ / shares shares	Jun. 01, 2023 $ / shares shares	Apr. 18, 2023 USD ($) $ / shares shares	Apr. 14, 2023 $ / shares shares	Sep. 11, 2022 USD ($) $ / shares shares	Dec. 21, 2021 USD ($) $ / shares shares	Dec. 16, 2016 USD ($)	Jan. 31, 2020 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Sep. 10, 2024 $ / shares shares	Aug. 06, 2024 $ / shares	Feb. 27, 2024 shares	Feb. 07, 2024 shares	Feb. 27, 2023 shares	Feb. 15, 2023 shares	Feb. 07, 2023 shares	Aug. 25, 2022 USD ($) item shares	Feb. 28, 2022 shares	Dec. 31, 2021 shares	Jun. 30, 2020 shares	Nov. 09, 2016 $ / shares shares
Warrants
Maximum number of warrants issued to purchase common stock in future | $										$ 1,000,000													$ 1,000,000			$ 1,000,000		$ 1,000,000
Percentage of discount of future issuance of preferred stock																										20%		20%
Fair value of warrants | $										$ 250,000											$ 50,000		$ 250,000			$ 250,000		$ 250,000
Proceeds from issuance of Common Stock warrants | $																												$ 0	$ 667,290
Number of warrants exercised for issuance of shares (in shares)										429,749													1,419,430		97,675	1,419,430		429,749	97,675											428
Warrant liabilities | $										$ 256,536													$ 250,694		$ 261,569	$ 250,694		$ 256,536	$ 261,569
Change in fair value of warrant liability | $																							(974)	$ 2,142		(5,842)	$ (3,473)	$ (5,033)	$ (113,125)
Exercise price of warrants (in dollars per share) | $ / shares																			$ 132.75												$ 1
Deemed dividend | $																							$ 1,939,439	$ 0		$ 1,939,439	0
Number of warrants cancelled (in shares)																			26,000
Common stock, shares issued (in shares)										613,206													1,254,650		327,389	1,254,650		613,206	327,389
Common stock, par value (in dollars per share) | $ / shares										$ 0.01													$ 0.01		$ 0.01	$ 0.01		$ 0.01	$ 0.01
Shares issued upon exercise of warrants (in shares)											104,889		47,132			85,314
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees | $																										$ 3,985,795	$ 7,464,312	$ 7,464,312	$ 983,195
Investors exercised
Warrants
Proceeds from issuance of Common Stock warrants | $																									$ 57,000
Number of warrants exercised for issuance of shares (in shares)																									190				190
Exercise price of warrants (in dollars per share) | $ / shares																									$ 300				$ 300
Institutional Investor
Warrants
Proceeds from issuance of Common Stock warrants | $												$ 621,000,000
Number of warrants exercised for issuance of shares (in shares)												18,000
Exercise price of warrants (in dollars per share) | $ / shares												$ 34.50
Warrants exercised (in shares)										7,112																		7,112
September 14, 2022
Warrants
Number of warrants exercised for issuance of shares (in shares)										0															26,000			0	26,000
Exercise price of warrants (in dollars per share) | $ / shares										$ 20.10																		$ 20.10
April 18, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)										51,689													0		0	0		51,689	0
Exercise price of warrants (in dollars per share) | $ / shares										$ 20.10													$ 20.10			$ 20.10		$ 20.10
Warrants, held in abeyance (in shares)										51,689																		51,689
Pre Funded Warrants
Warrants
Proceeds from issuance of Common Stock warrants | $					$ 0	$ 0		$ 0
Exercise price of warrants (in dollars per share) | $ / shares					$ 0	$ 0		$ 0					$ 0.015	$ 0.015
Shares issued upon exercise of warrants (in shares)													14,734	21,487
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees | $													$ 221	$ 322
Warrants exercised (in shares)					10,588	53,273		36,140					14,734	21,487
December 21, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)										240,000													192,869		0	192,869		240,000	0
Exercise price of warrants (in dollars per share) | $ / shares										$ 20.10													$ 4.80			$ 4.80		$ 20.10
Warrants exercised (in shares)											(7,112)
June 5, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)										85,314													0		0	0		85,314	0
Exercise price of warrants (in dollars per share) | $ / shares										$ 20.10													$ 4.80			$ 4.80		$ 20.10
Warrants, held in abeyance (in shares)										7,112																		7,112
April 3, 2024
Warrants
Number of warrants exercised for issuance of shares (in shares)										0													0			0		0
Exercise price of warrants (in dollars per share) | $ / shares																							$ 14.55			$ 14.55
April 3, 2024
Warrants
Number of warrants exercised for issuance of shares (in shares)										0													0			0		0
Exercise price of warrants (in dollars per share) | $ / shares																							$ 15.90			$ 15.90
September 3, 2024
Warrants
Number of warrants exercised for issuance of shares (in shares)										0													95,494			95,494		0
Exercise price of warrants (in dollars per share) | $ / shares																							$ 4.80			$ 4.80
September 3, 2024
Warrants
Number of warrants exercised for issuance of shares (in shares)										0													636,404			636,404		0
Exercise price of warrants (in dollars per share) | $ / shares																							$ 4.80			$ 4.80
September 3, 2024
Warrants
Number of warrants exercised for issuance of shares (in shares)										0													190,987			190,987		0
Exercise price of warrants (in dollars per share) | $ / shares																							$ 4.80			$ 4.80
September 10, 2024
Warrants
Number of warrants exercised for issuance of shares (in shares)										0													250,930			250,930		0
Exercise price of warrants (in dollars per share) | $ / shares																							$ 3.45			$ 3.45				$ 3.41
Warrants to purchase shares of common stock agreed to issue and sell (in shares)																														250,930
Regulation CF, D, and S Common Stock And Warrant Offering
Warrants
Number of warrants exercised for issuance of shares (in shares)																																						1,028	18,107
Private Placement | Promissory Note Payable Within Three Trading Days of Effective Resale Registration Statement
Warrants
Sale of Stock, Consideration Received on Transaction | $							$ 1,000,000
Private Placement | Promissory Note Payable August 31 2024
Warrants
Sale of Stock, Consideration Received on Transaction | $							500,000
Private Placement | Promissory Note Payable July 31, 2024
Warrants
Sale of Stock, Consideration Received on Transaction | $							$ 500,000
Notice to Exercise | April 18, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)										53,200																		53,200
Securities Purchase Agreement With Armistice Capital Master Fund Ltd. | Private Placement
Warrants
Number of warrants exercised for issuance of shares (in shares)																			13,000
Securities purchase agreement
Warrants
Number of warrants exercised for issuance of shares (in shares)													14,734	21,487	36,220		67,330
Exercise price of warrants (in dollars per share) | $ / shares													$ 0.015	$ 0.015
Number of shares agreed to issue and sell (in shares)														21,487	49,094		37,559
Common stock, par value (in dollars per share) | $ / shares															$ 34.50		$ 49.50
Share issue price (in dollars per share) | $ / shares															34.50		$ 49.50
Price per warrant (in dollars per share) | $ / shares															$ 34.485
Shares issued upon exercise of warrants (in shares)															49,094		104,889
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees | $													$ 14,734	$ 322	$ 1,693,720		$ 1,859,154
Proceeds from warrant exercises | $													$ 221		1,249,047		3,332,835
Proceeds from offering after deducting placement fee and legal expense | $															2,686,773		4,778,550
Placement fee | $															205,994		363,439
Legal expense | $															$ 50,000		$ 50,000
Securities purchase agreement | Private Placement
Warrants
Payments of Stock Issuance Costs | $									$ 245,520
Exercise price of warrants (in dollars per share) | $ / shares											$ 34.50					$ 34.50		$ 49.50
Sale of stock, number of shares issued in transaction (in shares)									33,333
Sale of Stock, Consideration Received on Transaction | $									$ 1,936,000
Shares issued upon exercise of warrants (in shares)																85,314		104,889
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees | $									$ 1,690,480
Class Of Warrant Or Right, Payment For Number Of Securities Terminated | $				$ 1,650,000
Securities purchase agreement | Private Placement | Warrant A
Warrants
Number of warrants exercised for issuance of shares (in shares)									100,001
Sale of stock, price per share (in dollars per share) | $ / shares									$ 14.52
Securities purchase agreement | Private Placement | Warrant B
Warrants
Number of warrants exercised for issuance of shares (in shares)				133,334					133,334
Sale of stock, price per share (in dollars per share) | $ / shares									$ 14.52
Securities purchase agreement | Private Placement | Warrant C
Warrants
Number of warrants exercised for issuance of shares (in shares)				106,667					106,667
Sale of stock, price per share (in dollars per share) | $ / shares									$ 15.90
Securities purchase agreement | Private Placement | April 18, 2023
Warrants
Proceeds from issuance of Common Stock warrants | $											$ 2,108,262
Common stock, par value (in dollars per share) | $ / shares											$ 20.10
Shares issued upon exercise of warrants (in shares)											104,889
Securities purchase agreement | Private Placement | December 21, 2023
Warrants
Shares issued upon exercise of warrants (in shares)											85,314
Securities purchase agreement | Private Placement | June 5, 2023
Warrants
Proceeds from issuance of Common Stock warrants | $											$ 142,938
Common stock, par value (in dollars per share) | $ / shares											$ 20.10
Securities purchase agreement | Private Placement | September 3, 2024
Warrants
Exercise price of warrants (in dollars per share) | $ / shares				$ 4.8345
Warrant expiration period				5 years
Common stock, par value (in dollars per share) | $ / shares				$ 0.01
Warrants to purchase shares of common stock agreed to issue and sell (in shares)				190,987																			190,987			190,987
Securities purchase agreement | Registered direct offering
Warrants
Exercise price of warrants (in dollars per share) | $ / shares																$ 0.015		$ 0.015
Number of shares agreed to issue and sell (in shares)																49,094		37,559
Common stock, par value (in dollars per share) | $ / shares											0.01					$ 0.01		$ 0.01
Share issue price (in dollars per share) | $ / shares											34.50					$ 34.50		$ 49.50
Warrants to purchase shares of common stock agreed to issue and sell (in shares)																36,220		67,330
Price per warrant (in dollars per share) | $ / shares											$ 49.50				$ 34.485	$ 34.485		$ 49.485
Securities purchase agreement | Registered direct offering | September 3, 2024
Warrants
Sale of stock, price per share (in dollars per share) | $ / shares				$ 4.8195
Sale of stock, number of shares issued in transaction (in shares)				95,494
Sale of Stock, Consideration Received on Transaction | $				$ 460,230
Common stock, par value (in dollars per share) | $ / shares				$ 0.01
Securities purchase agreement | Registered direct offering | September 3, 2024 | Subsequent Events
Warrants
Proceeds from issuance of Common Stock warrants | $	$ 1,432
Exercise price of warrants (in dollars per share) | $ / shares	$ 0.015
Sale of stock, number of shares issued in transaction (in shares)	95,494
Warrant inducement agreement | December 21, 2023
Warrants
Shares expected to be exercised (in shares)				240,000
Warrant inducement agreement | June 5, 2023
Warrants
Shares expected to be exercised (in shares)				78,202
Shares issued upon exercise of warrants (in shares)			78,202
Warrant inducement agreement | September 3, 2024
Warrants
Number of warrants exercised for issuance of shares (in shares)				636,404
Exercise price of warrants (in dollars per share) | $ / shares				$ 4.835
Deemed dividend | $				$ 1,940,000
Warrant expiration period				5 years
Warrants to purchase shares of common stock agreed to issue and sell (in shares)				636,404
Second Century Ventures, LLC | January 2020 Warrant Purchase Agreement
Warrants
Proceeds from issuance of Common Stock warrants | $											$ 160,800									$ 3,260,000
Number of warrants exercised for issuance of shares (in shares)											8,000
Exercise price of warrants (in dollars per share) | $ / shares											$ 20.10
Armistice Capital Master Fund Ltd.
Warrants
Exercise price of warrants (in dollars per share) | $ / shares															$ 34.50
Armistice Capital Master Fund Ltd. | September 14, 2022
Warrants
Exercise price of warrants (in dollars per share) | $ / shares											20.10
Armistice Capital Master Fund Ltd. | April 18, 2023
Warrants
Exercise price of warrants (in dollars per share) | $ / shares											20.10
Armistice Capital Master Fund Ltd. | December 21, 2023
Warrants
Exercise price of warrants (in dollars per share) | $ / shares				$ 4.835							$ 20.10
Warrants exercised (in shares)											120,000
Armistice Capital Master Fund Ltd. | June 5, 2023
Warrants
Exercise price of warrants (in dollars per share) | $ / shares				$ 4.8345							$ 20.10
Trusted Mail
Warrants
Cancellation of shares | $																						$ 100,000
Exchange of SAFEs for warrants | $																						$ 125,000
Trusted Mail | Second Century Ventures, LLC | January 2020 Warrant Purchase Agreement
Warrants
Proceeds from issuance of Common Stock warrants | $																				$ 3,260,000
Common Class A
Warrants
Maximum number of warrants issued to purchase common stock in future | $																			$ 1,511,250
Proceeds from issuance of Common Stock warrants | $																			$ 90,675		$ 50,000
Number of warrants exercised for issuance of shares (in shares)										18,928									26,000			62,141						18,928													5,342
Exercise price of warrants (in dollars per share) | $ / shares																						$ 120																			$ 46.80
Fair value of consideration received from warrants | $																						$ 300,000
Credited value over three years | $																						$ 100,000
Threshold period after which cashless exercise of warrants																												6 months
Common stock, shares issued (in shares)																																			13,736
Common Class A | Institutional Investor
Warrants
Number of warrants exercised for issuance of shares (in shares)																							192,869			192,869
Common stock, shares issued (in shares)												18,000
Common Class A | September 14, 2022
Warrants
Number of warrants exercised for issuance of shares (in shares)											8,000
Common stock, shares issued (in shares)											8,000
Common Class A | April 18, 2023
Warrants
Common stock, shares issued (in shares)										53,200																		53,200				30,356	21,334	30,356		21,334
Common Class A | Securities purchase agreement | Subsequent Events
Warrants
Sale of stock, price per share (in dollars per share) | $ / shares		$ 3.30
Sale of stock, number of shares issued in transaction (in shares)		90,910
Common stock, par value (in dollars per share) | $ / shares		$ 0.01
Common Class A | Securities purchase agreement | Private Placement
Warrants
Sale of stock, number of shares issued in transaction (in shares)							306,514
Common stock, par value (in dollars per share) | $ / shares							$ 0.01
Common Class A | Securities purchase agreement | Private Placement | December 21, 2023
Warrants
Shares issued upon exercise of warrants (in shares)											240,000
Percentage of shares issued											200%
Common Class A | Securities purchase agreement | Registered direct offering
Warrants
Common stock, par value (in dollars per share) | $ / shares									$ 0.01
Common Class A | Second Century Ventures, LLC
Warrants
Number of warrants exercised for issuance of shares (in shares)										34,974													34,974			34,974		34,974
Common Class A | Second Century Ventures, LLC | January 2020 Warrant Purchase Agreement
Warrants
Number of warrants exercised for issuance of shares (in shares)																				27,168
Exercise price of warrants (in dollars per share) | $ / shares																				$ 120
Common Class A | Armistice Capital Master Fund Ltd.
Warrants
Maximum number of warrants issued to purchase common stock in future | $															$ 897,000
Number of warrants exercised for issuance of shares (in shares)															26,000
Expiration period															5 years
Common Class A | Armistice Capital Master Fund Ltd. | September 14, 2022
Warrants
Maximum number of warrants issued to purchase common stock in future | $											$ 160,800
Common Class A | Armistice Capital Master Fund Ltd. | April 18, 2023
Warrants
Maximum number of warrants issued to purchase common stock in future | $											$ 2,108,262
Number of warrants exercised for issuance of shares (in shares)											2,108,262
Common Class A | Armistice Capital Master Fund Ltd. | December 21, 2023
Warrants
Maximum number of warrants issued to purchase common stock in future | $				$ 1,160,280
Number of warrants exercised for issuance of shares (in shares)											8,000
Common Class A | Armistice Capital Master Fund Ltd. | June 5, 2023
Warrants
Maximum number of warrants issued to purchase common stock in future | $											$ 1,714,798
Common Class A | Armistice Capital Master Fund Ltd. | Notice to Exercise | December 21, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)											61,200
Common Class A | Trusted Mail
Warrants
Number of warrants exercised for issuance of shares (in shares)																						12,430
Fair Value of Warrant Liability
Warrants
Warrant liabilities | $										$ 7,000													$ 1,000			$ 1,000		$ 7,000
Change in fair value of warrant liability | $																										$ 6,000		$ 5,000	$ 12,000
CF Common stock
Warrants
Units refunded | $																																					$ 5,000,000
Number of investors refunded | item																																					2
Number of warrants cancelled (in shares)																																					17
Existing Warrants | Armistice Capital Master Fund Ltd. | December 21, 2023
Warrants
Warrants exercised (in shares)											58,800

Warrants - Schedule of Fair Val

Warrants - Schedule of Fair Value of Warrants Liabilities (Details)	Sep. 30, 2024 $ / shares Y	Dec. 31, 2023 $ / shares Y
Fair Value of Warrants | Minimum
Warrants
Warrants measurement input	1.65	13.95
Fair Value of Warrants | Maximum
Warrants
Warrants measurement input	9.60	30.15
Exercise price | Minimum
Warrants
Warrants measurement input	3.90	7.95
Exercise price | Maximum
Warrants
Warrants measurement input	7.35	14.40
Risk free interest rate | Minimum
Warrants
Warrants measurement input	0.0351	0.0409
Risk free interest rate | Maximum
Warrants
Warrants measurement input	0.0450	0.0474
Expected dividend yield
Warrants
Warrants measurement input	0	0
Expected volatility | Minimum
Warrants
Warrants measurement input	0.7919	0.7908
Expected volatility | Maximum
Warrants
Warrants measurement input	0.7959	0.9290
Expected term
Warrants
Warrants measurement input | Y		3
Expected term | Minimum
Warrants
Warrants measurement input | Y	1
Expected term | Maximum
Warrants
Warrants measurement input | Y	3

Warrants - Schedule of Warrant

Warrants - Schedule of Warrant Issuance Date (Details) - $ / shares	Sep. 30, 2024	Sep. 10, 2024	Aug. 06, 2024	Dec. 31, 2023	Dec. 31, 2022	Sep. 11, 2022	Jun. 30, 2020
Warrants
Exercise price of warrants (in dollars per share)			$ 1			$ 132.75
Number of warrants exercised for issuance of shares (in shares)	1,419,430			429,749	97,675		428
November 9, 2016
Warrants
Exercise price of warrants (in dollars per share)	$ 46.80			$ 46.80
Number of warrants exercised for issuance of shares (in shares)	5,342			5,342	5,342
January 23, 2020
Warrants
Exercise price of warrants (in dollars per share)	$ 120			$ 120
Number of warrants exercised for issuance of shares (in shares)	12,430			12,430	12,430
January 23, 2020
Warrants
Exercise price of warrants (in dollars per share)	$ 120			$ 120
Number of warrants exercised for issuance of shares (in shares)	34,974			34,974	54,974
August - December 2021
Warrants
Exercise price of warrants (in dollars per share)				$ 300
Number of warrants exercised for issuance of shares (in shares)				0	17,917
January - February 2022
Warrants
Exercise price of warrants (in dollars per share)				$ 300
Number of warrants exercised for issuance of shares (in shares)				0	1,012
September 14, 2022
Warrants
Exercise price of warrants (in dollars per share)				$ 20.10
Number of warrants exercised for issuance of shares (in shares)				0	26,000
April 18, 2023
Warrants
Exercise price of warrants (in dollars per share)	$ 20.10			$ 20.10
Number of warrants exercised for issuance of shares (in shares)	0			51,689	0
Warrants, held in abeyance (in shares)				51,689
June 5, 2023
Warrants
Exercise price of warrants (in dollars per share)	$ 4.80			$ 20.10
Number of warrants exercised for issuance of shares (in shares)	0			85,314	0
Warrants, held in abeyance (in shares)				7,112
December 21, 2023
Warrants
Exercise price of warrants (in dollars per share)	$ 4.80			$ 20.10
Number of warrants exercised for issuance of shares (in shares)	192,869			240,000	0
April 3, 2024
Warrants
Exercise price of warrants (in dollars per share)	$ 14.55
Number of warrants exercised for issuance of shares (in shares)	0			0
April 3, 2024
Warrants
Exercise price of warrants (in dollars per share)	$ 15.90
Number of warrants exercised for issuance of shares (in shares)	0			0
September 3, 2024
Warrants
Exercise price of warrants (in dollars per share)	$ 4.80
Number of warrants exercised for issuance of shares (in shares)	95,494			0
September 3, 2024
Warrants
Exercise price of warrants (in dollars per share)	$ 4.80
Number of warrants exercised for issuance of shares (in shares)	190,987			0
September 3, 2024
Warrants
Exercise price of warrants (in dollars per share)	$ 4.80
Number of warrants exercised for issuance of shares (in shares)	636,404			0
September 10, 2024
Warrants
Exercise price of warrants (in dollars per share)	$ 3.45	$ 3.41
Number of warrants exercised for issuance of shares (in shares)	250,930			0

Investment (Details)

Investment (Details) - USD ($)	Aug. 06, 2024	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022	Sep. 11, 2022	Jun. 30, 2020	Dec. 16, 2016
Investment
Fair value of warrants		$ 250,000	$ 250,000				$ 50,000
Number of warrants exercised for issuance of shares (in shares)		1,419,430	429,749	97,675		428
Exercise price of warrants (in dollars per share)	$ 1				$ 132.75
Boumarang
Investment
Sale of stock, number of shares issued in transaction (in shares)	100,000
Subscription payment	$ 100,000
Sale of stock, price per share (in dollars per share)	$ 1
Prepaid warrant | Boumarang
Investment
Fair value of warrants	$ 5,000,000
Number of warrants exercised for issuance of shares (in shares)	5,000,000

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Balance Sheet Components
Prepaid operating expenses	$ 253,973	$ 216,875	$ 225,756
Rent deposit	27,458	28,400	55,981
VAT receivable associated with SAIT	48,177	116,095	71,742
Tax credit receivable (short-term)	25,045	102,151	218,239
Miscellaneous receivable	859,271	363,260	8,368
Prepaid expenses and other current assets	$ 1,213,924	$ 826,781	$ 580,086

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Capitalized Internal-Use Software, Net (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Balance Sheet Components
Internally developed software	$ 4,363,338	$ 3,901,801	$ 3,314,450
Less accumulated depreciation	(2,830,981)	(2,429,427)	(1,895,778)
Capitalized internal-use software, net	$ 1,532,357	$ 1,472,374	$ 1,418,672
Useful Lives	5 years	5 years

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Balance Sheet Components
Amortization expense is recognized on a straight-line basis	$ 141	$ 140	$ 419	$ 419	$ 557	$ 517
Impairment of intangible assets finite lived			$ 24		12	0
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]			Research and Development Expense
Depreciation	$ 8	$ 10	$ 27	$ 62	$ 72	$ 136

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Property and Equipment, Net
Property and equipment, gross	$ 188,856		$ 188,856		$ 180,066	$ 473,202
Less accumulated depreciation	(149,031)		(149,031)		(123,630)	(172,538)
Property and equipment, net	39,825		39,825		56,436	300,664
Depreciation	8,000	$ 10,000	27,000	$ 62,000	72,000	136,000
Computer equipment
Property and Equipment, Net
Property and equipment, gross	$ 154,181		$ 154,181		$ 152,014	148,832
Computer equipment | Minimum
Property and Equipment, Net
Useful Lives	3 years		3 years		3 years
Computer equipment | Maximum
Property and Equipment, Net
Useful Lives	4 years		4 years		4 years
Furniture and fixtures
Property and Equipment, Net
Property and equipment, gross	$ 34,675		$ 34,675		$ 28,052	27,220
Useful Lives	10 years		10 years		10 years
Mobile hardware
Property and Equipment, Net
Property and equipment, gross					$ 0	$ 297,150
Useful Lives					2 years 6 months

Balance Sheet Components - Held

Balance Sheet Components - Held for Sale Equipment, Net (Details) - USD ($)	May 26, 2023	Apr. 26, 2023	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Equipment assets held for sale
Phone equipment			$ 188,856	$ 180,066	$ 473,202
Accumulated depreciation			$ (149,031)	$ (123,630)	$ (172,538)
Property and equipment gross sale price	$ 108,000	$ 108,000

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Balance Sheet Components
Compensation payable	$ 672,587	$ 377,403	$ 171,851
Commission liability	19,885	26,863	58,771
Accrued employee taxes	890,411	624,525	591,992
Accrued mobile expenses		0	177,099
Other accrued liabilities	87,377	115,099	100,111
Accrued expenses	$ 1,670,260	$ 1,143,890	$ 1,099,824

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets, Net
Intangible assets, gross	$ 626,951	$ 554,481	$ 450,641
Less: Accumulated amortization	(433,647)	(330,791)	(198,955)
Intangible assets, net	$ 193,304	$ 223,690	251,686
Patent application costs
Goodwill and Intangible Assets, Net
Useful Lives	3 years	3 years
Intangible assets, gross	$ 555,918	$ 484,035	382,285
Trade name and trademarks
Goodwill and Intangible Assets, Net
Useful Lives	3 years	3 years
Intangible assets, gross	$ 71,033	$ 70,446	$ 68,356

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) patent	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) patent	Dec. 31, 2022 USD ($)
Goodwill and Intangible Assets, Net
Number of intangible assets added			23		17
Amortization expense | $	$ 32	$ 40	$ 102	$ 115	$ 160	$ 107
Patents
Goodwill and Intangible Assets, Net
Number of intangible assets added			6		4

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Schedule of Estimated Future Amortization Expense of Intangible Assets (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Estimated future amortization expense of intangible assets
2023	$ 31,949
2024	99,005	$ 120,078
2025	52,529	75,043
2026	9,821	28,569
Total	$ 193,304	$ 223,690	$ 251,686

Net Loss per Share Attributab_3

Net Loss per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Loss Per Share Attributable to Common Stockholders (Details) - USD ($)		3 Months Ended		9 Months Ended		12 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Numerator:
Net income (loss) attributable to T Stamp Inc.		$ (1,255,915)	$ (35,162)	$ (6,532,845)	$ (4,752,980)	$ (7,637,642)	$ (12,091,540)
Denominator:
Weighted average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	[1]	1,181,150	543,708	891,211	443,880	475,171	315,518
Weighted average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	[1]	1,181,150	543,708	891,211	443,880	475,171	315,518
Net loss per share attributable to common stockholders, basic (in dollars per share)	[1]	$ (1.06)	$ (0.06)	$ (7.33)	$ (10.71)	$ (16.07)	$ (38.32)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	[1]	$ (1.06)	$ (0.06)	$ (7.33)	$ (10.71)	$ (16.07)	$ (38.32)
[1] After giving effect to the 15 for 1 reverse stock split effected on January 6, 2025.

Net Loss per Share Attributab_4

Net Loss per Share Attributable to Common Stockholders - Schedule of Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share (Details) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Net Loss per Share Attributable to Common Stockholders
Total	$ 1,905,077	$ 354,641	$ 492,943	$ 161,367
Options, RSUs, and grants
Net Loss per Share Attributable to Common Stockholders
Total	106,434	52,761	60,741	49,625
Warrants
Net Loss per Share Attributable to Common Stockholders
Total	$ 1,798,643	$ 301,880	$ 432,202	$ 111,742

Stock Awards and Stock-Based _3

Stock Awards and Stock-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended	9 Months Ended		12 Months Ended
		Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2024	Mar. 31, 2023	Dec. 31, 2021
Stock Awards and Stock-Based Compensation
Aggregate intrinsic value of options exercised			$ 0		$ 0	$ 0
Weighted average grant-date fair value of options granted per share			$ 4.35	$ 18.75	$ 16.20	$ 114.75
Weighted average grant-date fair value of options granted amount		$ 10	$ 4	$ 10	$ 12	$ 57
Stock options outstanding			26,992		26,239	25,808	26,657	26,399	25,808
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)			3,649
Share-Based Payment Arrangement, Option
Stock Awards and Stock-Based Compensation
Stock options outstanding			26,992		26,239
Restricted stock units, outstanding			6,680		4,761
Stock not yet issued			5,475		4,012
Stock granted not yet vested			1,205		750
Unrecognized stock-based compensation related to common stock grants			$ 6		$ 9
Restricted Stock Units (RSUs)
Stock Awards and Stock-Based Compensation
Restricted stock units, outstanding			72,762		29,740
Stock not yet issued			3,428		3,187
Restricted stock units ("RSUs") granted but not yet vested			69,335		26,553
Unrecognized stock compensation related to the RSUs			$ 343		$ 25
Treasury Stock
Stock Awards and Stock-Based Compensation
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)	[1]	(150)		(2,796)	(118)
Management | Grants
Stock Awards and Stock-Based Compensation
Stock based awards granted					$ 6	$ 49
Management | Share-Based Payment Arrangement, Option
Stock Awards and Stock-Based Compensation
Stock based awards granted					0
Management | Restricted Stock Units (RSUs)
Stock Awards and Stock-Based Compensation
Stock based awards granted					36	190
Various employees | Grants
Stock Awards and Stock-Based Compensation
Stock based awards granted					82	307
Various employees | Share-Based Payment Arrangement, Option
Stock Awards and Stock-Based Compensation
Stock based awards granted					12	57
Various employees | Restricted Stock Units (RSUs)
Stock Awards and Stock-Based Compensation
Stock based awards granted					$ 627	$ 1,800
[1] After giving effect to the 15 for 1 reverse stock split effected on January 6, 2025.

Stock Awards and Stock-Based _4

Stock Awards and Stock-Based Compensation - Schedule of Stock Options Activity (Details) - $ / shares	3 Months Ended				9 Months Ended	12 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Options Outstanding
Beginning balance (in shares)	26,657		26,399	25,808	26,239	25,808	25,808
Options granted (in shares)	437	292		255	984	793
Options exercised (in shares)	0			0	0	(82)
Options canceled and forfeited (in shares)	(102)		(34)	(95)	(231)	(280)
Ending balance (in shares)	26,992	26,657		26,399	26,992	26,239	25,808	25,808
Options vested and exercisable (in shares)	26,992				26,992	26,239
Weighted Average Exercise Price Per Share
Beginning balance (in dollars per share)	$ 92.85		$ 93.60	$ 96	$ 94.05	$ 96	$ 96
Options granted (in dollars per share)	13.80	$ 20.55		23.55	18.30	34.20
Options exercised (in dollars per share)	0			0	0	48.75
Options canceled and forfeited (in dollars per share)	58.80		$ 58.80	63.15	60.30	85.95
Ending balance (in dollars per share)	91.65	$ 92.85		$ 93.60	91.65	94.05	$ 96	$ 96
Options vested and exercisable (in dollars per share)	$ 91.65				$ 91.65	$ 94.05
Weighted Average Remaining Contractual Life (years)
Outstanding		1 year 5 months 26 days		1 year 8 months 19 days	1 year 3 months 7 days	1 year 11 months 12 days	1 year 5 months 12 days	1 year 5 months 12 days
Options vested and exercisable	1 year 3 months 7 days				1 year 3 months 7 days	1 year 11 months 12 days

Stock Awards and Stock-Based _5

Stock Awards and Stock-Based Compensation - Schedule of Outstanding RSU Activity (Details) - Restricted Stock Units (RSUs) - shares	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Balance at the beginning (in shares)	29,740	19,505	8,460
Granted (in shares)	69,335	27,368	14,114
Vested (issued) (in shares)	(21,255)	(10,652)	(3,070)
Forfeited (in shares)	(5,058)	(6,481)	0
Balance at the end (in shares)	72,762	29,740	19,505

Stock Awards and Stock-Based _6

Stock Awards and Stock-Based Compensation - Schedule of Stock Options Valuation Assumptions (Details) - Share-Based Payment Arrangement, Option - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Stock Awards and Stock-Based Compensation
Expected dividend yield	0%	0%
Expected term	3 years	3 years
Minimum
Stock Awards and Stock-Based Compensation
Fair value of Class A Shares of Common Stock (in dollars per share)	$ 0.90	$ 5.70
Exercise Price (in dollars per share)	$ 12	$ 26.70
Risk free interest rate	3.51%	3.76%
Expected volatility	77.54%	79.08%
Maximum
Stock Awards and Stock-Based Compensation
Fair value of Class A Shares of Common Stock (in dollars per share)	$ 10.80	$ 25.05
Exercise Price (in dollars per share)	$ 24.60	$ 46.35
Risk free interest rate	4.71%	4.89%
Expected volatility	79.80%	96.45%

Stock Awards and Stock-Based _7

Stock Awards and Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	$ 351,593	$ 148,040	$ 956,603	$ 305,350	$ 763,288	$ 2,399,063
Cost of services
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	3,144	11,169	3,406	11,825	21,836	21,721
Research and development
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	23,878	48,336	38,087	79,956	123,109	292,084
Selling, general, and administrative
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	$ 324,571	$ 88,535	$ 915,110	$ 213,569	$ 618,343	$ 2,085,258

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)			3 Months Ended				9 Months Ended		12 Months Ended
	Nov. 15, 2020	Nov. 13, 2020	Sep. 30, 2024	Jun. 30, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Related Party Transactions
Related party receivables			$ 23,781				$ 23,781		$ 44,087	$ 31,446
Number of stock options purchased (in shares)			437	292		255	984		793
Stock options expiration period		36 months
Related party
Related Party Transactions
Related party receivables			$ 48,000				$ 48,000		$ 82,000	273,000
Related party cost			$ 1,000		$ 164,000		112,000	$ 699,000	816,000	935,000
Expenses incurred in relation to legal services									0	138,000
Amounts payable										$ 0	$ 0
Percentage of commission received, first year	20%
Percentage of commission received, second year	10%
Percentage of commission received, third year	5%
Payment of commission							$ 0		$ 0

Malta Grant (Details)

Malta Grant (Details) - Malta Grant Agreement		9 Months Ended		12 Months Ended
	Jan. 25, 2022 EUR (€)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jan. 25, 2022 USD ($)	Jul. 31, 2020 EUR (€)	Jul. 31, 2020 USD ($)
Malta Grant
Maximum amount grant	€ 100,000					$ 107,000	€ 200,000	$ 251,000
Requirement of initial capital amount							50,000	62,000
Reimbursement of grant for initial capital amount							50,000	62,000
Remaining reimbursement amount of grant for operating expenses incurred up to 12 Months from incorporation							€ 150,000	$ 190,000
Expenses incurred for grant		$ 0	$ 0	$ 0	$ 0
Estimated amount of grant	€ 136,568					$ 146,493
Percentage of aid intensity to cover eligible wage cost	75%
Amounts received from grants		$ 0		$ 0

Leases and Commitments - Narrat

Leases and Commitments - Narrative (Details)		9 Months Ended	12 Months Ended
	Mar. 03, 2023	Sep. 30, 2024 USD ($) lease	Dec. 31, 2023 USD ($) lease	Dec. 31, 2022 USD ($)
Leases and Commitments
Minimum lease commitments related to month-to-month lease arrangements		$ 0	$ 0
Remaining lease term			1 year
Number of leases terminated		1	4
Number of office lease terminated | lease			2
Number of vehicle lease terminated | lease			2
Lease termination fees			$ 10,932
Loss related to lease termination			669
Termination notice term	30 days
Operating lease right of use assets		$ 198,634	164,740	$ 315,765
Operating lease liabilities		165,922	135,007	$ 280,202
Purchase obligation		$ 0	$ 162,000
Minimum
Leases and Commitments
Remaining lease term		1 year	1 year
Maximum
Leases and Commitments
Remaining lease term		4 years	5 years

Leases and Commitments - Summar

Leases and Commitments - Summary of Lease Term and Discount Rate (Details)	Sep. 30, 2024	Dec. 31, 2023
Leases and Commitments
Weighted average remaining lease term	1 year 10 months 17 days	2 years 4 months 28 days
Weighted average discount rate	5%	5%

Leases and Commitments - Summ_2

Leases and Commitments - Summary of Balance Sheet Information Related to Leases (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Balance sheet information related to leases
Operating lease right-of-use assets	$ 198,634	$ 164,740	$ 315,765
Operating lease liabilities
Short-term operating lease liabilities	95,367	81,236	177,795
Long-term operating lease liabilities	70,555	53,771	102,407
Total operating lease liabilities	$ 165,922	$ 135,007	$ 280,202

Leases and Commitments - Summ_3

Leases and Commitments - Summary of Future Maturities of ASC 842 Lease Liabilities (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Proncipal Payments
2024	$ 36,976	$ 81,236
2025	88,889	27,655
2026	22,735	8,937
2027	8,831	8,758
2028	8,491	8,421
Total future maturities	165,922
Imputed Interest Payments
2024	1,921	3,899
2025	3,696	1,802
2026	1,170	1,047
2027	626	621
2028	178	176
Total future maturities	7,591	7,545
Total Payments
2024	38,897	85,135
2025	92,585	29,457
2026	23,905	9,984
2027	9,457	9,379
2028	8,669	8,597
Total future maturities	$ 173,513	$ 142,552

Leases and Commitments - Summ_4

Leases and Commitments - Summary of Total Lease Expense, Under ASC 842, was Included in Selling, General, and Administrative Expenses in Consolidated Statement of Operations (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Total lease expense
Operating lease expense - fixed payments	$ 39,368	$ 40,060	$ 117,221	$ 169,496	$ 209,577	$ 276,562
Short term lease expense	10,710	10,846	34,929	48,399	59,631	90,159
Total lease expense	$ 50,078	$ 50,906	152,150	217,895	269,208	366,721
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases			$ (111,277)	$ (145,483)	$ (179,621)	$ (258,892)

Subsequent Events - Narrative (

Subsequent Events - Narrative (Details) - USD ($)	Nov. 13, 2024	Oct. 28, 2024	Sep. 30, 2024	Dec. 31, 2023	Jun. 05, 2023	Apr. 18, 2023	Dec. 31, 2022
Subsequent Events
Common stock, par value (in dollars per share)			$ 0.01	$ 0.01			$ 0.01
Securities purchase agreement
Subsequent Events
Common stock, par value (in dollars per share)					$ 34.50	$ 49.50
Subsequent Events | Securities purchase agreement
Subsequent Events
Sale of stock, consideration received per transaction		$ 300,000
Subsequent Events | Secured Promissory Note
Subsequent Events
Principal amount	$ 3,000,000
Interest rate (in percent)	14%
Subsequent Events | Common Class A | Securities purchase agreement
Subsequent Events
Sale of stock, number of shares issued in transaction (in shares)		90,910
Common stock, par value (in dollars per share)		$ 0.01
Sale of stock, price per share (in dollars per share)		$ 3.30

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)		Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents		$ 3,140,747	$ 1,254,494
Accounts receivable, net (includes unbilled receivables of $143,219 and $109,475 as of December 31, 2023 and 2022, respectively)		686,327	1,008,375
Related party receivables		44,087	31,446
Prepaid expenses and other current assets		826,781	580,086
Total Current Assets		4,697,942	2,874,401
Noncurrent Assets:
Capitalized internal-use software, net		1,472,374	1,418,672
Goodwill		1,248,664	1,248,664
Intangible assets, net		223,690	251,686
Property and equipment, net		56,436	300,664
Operating lease right of use assets		164,740	315,765
Other assets		29,468	2,066
Total Assets		7,893,314	6,411,918
Current Liabilities:
Accounts payable		1,232,118	945,162
Related party payables		82,101	273,176
Accrued expenses		1,143,890	1,099,824
Deferred revenue		10,800	1,811,680
Income tax payable		1,975	21,076
Short-term operating lease liabilities		81,236	177,795
Short-term financial liabilities		162,130	118,860
Total Current Liabilities		2,714,250	4,447,573
Noncurrent Liabilities:
Warrant liabilities		256,536	261,569
Notes payable, plus accrued interest of $40,317 and $16,458, as of December 31, 2023 and 2022, respectively		953,877	886,465
Long-term operating lease liabilities		53,771	102,407
Long-term financial liabilities		0	88,760
Total Liabilities		3,978,434	5,786,774
Commitments, Note 11
Stockholders' Equity:
Common stock $0.01 par value, 50,000,000 shares authorized, 9,198,089 and 4,910,815 shares issued, and 9,143,355 and 4,854,302 outstanding at December 31, 2023 and 2022, respectively	[1]	6,096	3,237
Treasury stock, at cost: 54,734 and 56,513 shares held as of December 31, 2023 and 2022, respectively	[1]	0	0
Additional paid-in capital	[1]	54,460,960	39,541,489
Stockholders' notes receivable		0	(18,547)
Accumulated other comprehensive income		139,670	237,252
Accumulated deficit		(50,853,285)	(39,299,726)
Total T Stamp Inc. Stockholders' Equity		3,753,441	463,705
Non-controlling interest		161,439	161,439
Total Stockholders' Equity		3,914,880	625,144
Total Liabilities and Stockholders' Equity		$ 7,893,314	$ 6,411,918
[1] After giving effect to the 15 for 1 reverse stock split effected on January 6, 2025.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical)		9 Months Ended
	Jan. 06, 2025	Sep. 30, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Jul. 06, 2023 shares	Dec. 31, 2022 USD ($) $ / shares shares
Unbilled receivables | $		$ 4,463	$ 143,219		$ 109,475
Non-convertible notes payable, current accrued interest | $		$ 45,383	$ 40,317		$ 16,458
Common stock, par value (in dollars per share) | $ / shares		$ 0.01	$ 0.01		$ 0.01
Common stock, shares authorized (in shares)		50,000,000	50,000,000	50,000,000	50,000,000
Common stock, shares issued (in shares)		1,254,650	613,206		327,389
Common stock, shares outstanding (in shares)		1,254,650	609,557		323,621
Treasury stock, at cost, shares held (in shares)		0	3,649		3,768
Stock split		0.20
Subsequent Event
Stock split	15

CONSOLIDATED STATEMENTS OF OP_2

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Net revenue		$ 4,560,275	$ 5,385,077
Operating Expenses:
Cost of services (exclusive of depreciation and amortization shown separately below)		914,176	1,785,167
Research and development		2,350,677	2,474,327
Selling, general, and administrative		8,395,638	12,444,009
Depreciation and amortization		789,586	760,497
Total Operating Expenses		12,450,077	17,464,000
Operating Loss		(7,889,802)	(12,078,923)
Non-Operating Income (Expense):
Interest expense, net		(73,273)	(8,890)
Change in fair value of warrant liability		5,033	113,125
Impairment of digital assets		0	(27,934)
Other income		309,896	50,354
Other expense		(2,981)	(118,196)
Total Other Expense (Income), Net		238,675	8,459
Net Loss before Taxes		(7,651,127)	(12,070,464)
Income tax benefit (expense)		13,485	(21,076)
Net loss before non-controlling interest		(7,637,642)	(12,091,540)
Net loss attributable to non-controlling interest		0	0
Net loss attributable to T Stamp Inc.		$ (7,637,642)	$ (12,091,540)
Basic net loss per share attributable to T Stamp Inc. (in dollars per share)	[1]	$ (16.07)	$ (38.32)
Diluted net loss per share attributable to T Stamp Inc. (in dollars per share)	[1]	$ (16.07)	$ (38.32)
Weighted-average shares used to compute basic net loss per share (in shares)	[1]	475,171	315,518
Weighted-average shares used to compute diluted net loss per share (in shares)	[1]	475,171	315,518
[1] After giving effect to the 15 for 1 reverse stock split effected on January 6, 2025.

CONSOLIDATED STATEMENTS OF OP_3

CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)		9 Months Ended
	Jan. 06, 2025	Sep. 30, 2024
Stock split		0.20
Subsequent Event
Stock split	15

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Net loss including non-controlling interest	$ (1,255,915)	$ (35,162)	$ (6,532,845)	$ (4,752,980)	$ (7,637,642)	$ (12,091,540)
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(88,623)	18,204	(53,234)	(30,842)	(97,582)	53,352
Total Other Comprehensive Income (Loss)	(88,623)	18,204	(53,234)	(30,842)	(97,582)	53,352
Comprehensive loss	(1,344,538)	(16,958)	(6,586,079)	(4,783,822)	(7,735,224)	(12,038,188)
Comprehensive loss attributable to non-controlling interest	0	0	0	0	0	0
Comprehensive loss attributable to T Stamp Inc.	$ (1,344,538)	$ (16,958)	$ (6,586,079)	$ (4,783,822)	$ (7,735,224)	$ (12,038,188)

CONSOLIDATED STATEMENTS OF ST_2

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)		Common Stock		Additional Paid-In Capital		Treasury Stock		Stockholders' Notes Receivable	Accumulated Other Comprehensive Income	Accumulated Deficit	Non-controlling Interest	Total
Beginning balance (in shares) at Dec. 31, 2021	[1]	273,002
Beginning balance at Dec. 31, 2021		$ 2,730	[1]	$ 32,024,100	[1]			$ (130,267)	$ 183,900	$ (27,208,186)	$ 161,439	$ 5,033,716
Beginning balance (in shares) at Dec. 31, 2021	[1]					3,768
Beginning balance at Dec. 31, 2021	[1]					$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of warrants to common stock (in shares)	[1]	32,700
Exercise of warrants to common stock		$ 327	[1]	3,383,435	[1]							3,383,762
Exercise of options to common stock (in shares)	[1]	931
Exercise of options to common stock		$ 9	[1]	95,107	[1]							95,116
Issuance of common stock (in shares)	[1]	14,056
Issuance of common stock		$ 141	[1]	1,023,504	[1]							1,023,645
Issuance of common stock warrants				667,290	[1]							667,290
Issuance of common stock in relation to vested restricted stock units (in shares)	[1]	2,932
Issuance of common stock in relation to vested restricted stock units		$ 30	[1]	(51,010)	[1]							(50,980)
Repayment of shareholders loan through in-kind services								111,720				111,720
Stock-based compensation				2,399,063	[1]							2,399,063
Currency translation adjustment									53,352			53,352
Net loss attributable to T Stamp Inc.										(12,091,540)		(12,091,540)
Ending balance (in shares) at Dec. 31, 2022	[1]	323,621
Ending balance at Dec. 31, 2022		$ 3,237	[1]	39,541,489	[1]	$ 0	[1]	(18,547)	237,252	(39,299,726)	161,439	$ 625,144
Ending balance (in shares) at Dec. 31, 2022						3,768	[1]					3,768
Ending balance at Dec. 31, 2022	[1]					$ 0						$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of warrants to common stock (in shares)	[1]	121,550
Exercise of warrants to common stock		$ 1,216	[1]	621,338	[1]							622,554
Exercise of options to common stock (in shares)	[1]	116
Exercise of options to common stock		$ 1	[1]	1,999	[1]							2,000
Issuance of common stock (in shares)	[1]	87,498
Issuance of common stock		$ 875	[1]	7,463,437	[1]							7,464,312
Issuance of common stock in relation to vested restricted stock units (in shares)	[1]	16,532				(2,796)
Issuance of common stock in relation to vested restricted stock units		$ 165	[1]	(24,821)	[1]							(24,656)
Reverse stock split rounding (in shares)	[1]	318
Reverse stock split rounding	[1]	$ 3		(3)
Repayment of shareholders loan through in-kind services								18,547				18,547
Stock-based compensation				305,350	[1]							305,350
Currency translation adjustment									(30,842)			(30,842)
Net loss attributable to T Stamp Inc.												(4,752,980)
Ending balance (in shares) at Sep. 30, 2023	[1]	549,635
Ending balance at Sep. 30, 2023		$ 5,497	[1]	47,908,789	[1]	$ 0	[1]	0	206,410	(44,052,706)	161,439	4,229,429
Ending balance (in shares) at Sep. 30, 2023	[1]					972
Ending balance at Sep. 30, 2023	[1]					$ 0
Beginning balance (in shares) at Dec. 31, 2022	[1]	323,621
Beginning balance at Dec. 31, 2022		$ 3,237	[1]	39,541,489	[1]	$ 0	[1]	(18,547)	237,252	(39,299,726)	161,439	$ 625,144
Beginning balance (in shares) at Dec. 31, 2022						3,768	[1]					3,768
Beginning balance at Dec. 31, 2022	[1]					$ 0						$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of warrants to common stock (in shares)	[1]	182,750
Exercise of warrants to common stock		$ 1,828	[1]	2,853,886	[1]							$ 2,855,714
Exercise of options to common stock (in shares)		116	[1]									82
Exercise of options to common stock		$ 1	[1]	1,999	[1]							$ 2,000
Issuance of common stock (in shares)	[1]	1,403				(1)
Issuance of common stock		$ 14	[1]	(14)	[1]							0
Issuance of common stock warrants				3,915,917	[1]					(3,915,917)		0
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees (in shares)	[1]	87,498
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees		$ 874	[1]	7,463,438	[1]							7,464,312
Issuance of common stock in relation to vested restricted stock units (in shares)	[1]	13,853				(118)
Issuance of common stock in relation to vested restricted stock units		$ 139	[1]	(79,040)	[1]							(78,901)
Reverse stock split rounding (in shares)	[1]	316
Reverse stock split rounding		$ 3	[1]	(3)	[1]							0
Repayment of shareholders loan through in-kind services								18,547				18,547
Stock-based compensation				763,288	[1]							763,288
Currency translation adjustment									(97,582)			(97,582)
Net loss attributable to T Stamp Inc.										(7,637,642)		(7,637,642)
Ending balance (in shares) at Dec. 31, 2023	[1]	609,557
Ending balance at Dec. 31, 2023		$ 6,096	[1]	54,460,960	[1]	$ 0	[1]	0	139,670	(50,853,285)	161,439	$ 3,914,880
Ending balance (in shares) at Dec. 31, 2023						3,649	[1]					3,649
Ending balance at Dec. 31, 2023	[1]					$ 0						$ 0
Beginning balance (in shares) at Jun. 30, 2023	[1]	531,485
Beginning balance at Jun. 30, 2023		$ 5,315	[1]	47,141,784	[1]				188,206	(44,017,544)	161,439	3,479,200
Beginning balance (in shares) at Jun. 30, 2023	[1]					1,122
Beginning balance at Jun. 30, 2023	[1]					$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of warrants to common stock (in shares)	[1]	18,000
Exercise of warrants to common stock		$ 180	[1]	620,820	[1]							621,000
Issuance of common stock in relation to vested restricted stock units (in shares)	[1]	150				(150)
Issuance of common stock in relation to vested restricted stock units		$ 2	[1]	(1,855)	[1]							(1,853)
Stock-based compensation				148,040	[1]							148,040
Currency translation adjustment									18,204			18,204
Net loss attributable to T Stamp Inc.												(35,162)
Ending balance (in shares) at Sep. 30, 2023	[1]	549,635
Ending balance at Sep. 30, 2023		$ 5,497	[1]	47,908,789	[1]	$ 0	[1]	0	206,410	(44,052,706)	161,439	4,229,429
Ending balance (in shares) at Sep. 30, 2023	[1]					972
Ending balance at Sep. 30, 2023	[1]					$ 0
Beginning balance (in shares) at Dec. 31, 2023	[1]	609,557
Beginning balance at Dec. 31, 2023		$ 6,096	[1]	54,460,960	[1]	$ 0	[1]	$ 0	139,670	(50,853,285)	161,439	$ 3,914,880
Beginning balance (in shares) at Dec. 31, 2023						3,649	[1]					3,649
Beginning balance at Dec. 31, 2023	[1]					$ 0						$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of warrants to common stock (in shares)	[1]	158,800
Exercise of warrants to common stock		$ 1,588	[1]	(1,588)	[1]							$ 0
Exercise of options to common stock (in shares)		125,333	[1]									0
Exercise of options to common stock		$ 1,253	[1]	3,476,534	[1]							$ 3,477,787
Issuance of common stock in relation to vested restricted stock units (in shares)												3,649
Stock-based compensation				956,603	[1]							$ 956,603
Currency translation adjustment									(53,234)			(53,234)
Net loss attributable to T Stamp Inc.												(6,532,845)
Ending balance (in shares) at Sep. 30, 2024	[1]	1,254,650
Ending balance at Sep. 30, 2024		$ 12,547	[1]	60,755,010	[1]	$ 0	[1]		86,436	(55,446,691)	161,439	$ 5,568,741
Ending balance (in shares) at Sep. 30, 2024						0	[1]					0
Ending balance at Sep. 30, 2024	[1]											$ 0
Beginning balance (in shares) at Jun. 30, 2024	[1]	758,943
Beginning balance at Jun. 30, 2024		$ 7,590	[1]	56,697,964	[1]	$ 0	[1]		175,059	(56,130,215)	161,439	911,837
Increase (Decrease) in Stockholders' Equity
Exercise of warrants to common stock (in shares)	[1]	125,333
Exercise of warrants to common stock		$ 1,253	[1]	3,476,534	[1]							$ 3,477,787
Exercise of options to common stock (in shares)												0
Issuance of common stock (in shares)	[1]	306,514
Issuance of common stock		$ 3,065	[1]	2,652,557	[1]							$ 2,655,622
Stock-based compensation				351,593	[1]							351,593
Currency translation adjustment									(88,623)			(88,623)
Net loss attributable to T Stamp Inc.												(1,255,915)
Ending balance (in shares) at Sep. 30, 2024	[1]	1,254,650
Ending balance at Sep. 30, 2024		$ 12,547	[1]	$ 60,755,010	[1]	$ 0	[1]		$ 86,436	$ (55,446,691)	$ 161,439	$ 5,568,741
Ending balance (in shares) at Sep. 30, 2024						0	[1]					0
Ending balance at Sep. 30, 2024	[1]											$ 0
[1] After giving effect to the 15 for 1 reverse stock split effected on January 6, 2025.

CONSOLIDATED STATEMENTS OF ST_3

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)		9 Months Ended
	Jan. 06, 2025	Sep. 30, 2024
Stock split		0.20
Subsequent Event
Stock split	15

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss attributable to T Stamp Inc.	$ (7,637,642)	$ (12,091,540)
Net loss attributable to non-controlling interest	0	0
Adjustments to reconcile net loss to cash flows used in operating activities:
Depreciation and amortization	789,586	760,497
Stock-based compensation	763,288	2,399,063
Change in fair value of warrant liability	(5,033)	(113,125)
Repayment of shareholder loan through in-kind services	18,547	111,720
Impairment of assets	31,474	27,934
Gain on sale of property and equipment	(216,189)	0
Non-cash interest	90,250	16,458
Non-cash lease expense	183,084	266,086
Non-cash write off of mobile hardware	(15,775)	0
Loss on retirement of equipment	17,930	0
Changes in assets and liabilities:
Accounts receivable	322,048	269,911
Related party receivables	(12,641)	(17,798)
Prepaid expenses and other current assets	(244,483)	373,760
Other assets	(27,402)	178,140
Accounts payable	260,523	630,492
Accrued expense	20,566	40,290
Related party payables	(191,075)	20,403
Deferred revenue	(1,800,880)	1,308,247
Income tax payable	(19,101)	21,076
Operating lease liabilities	(179,621)	(258,892)
Customer deposit liabilities	0	(280,108)
Net cash flows from operating activities	(7,852,546)	(6,337,386)
Cash flows from investing activities:
Proceeds from sale of property and equipment	377,360	0
Capitalized internally developed software costs	(630,111)	(776,055)
Patent application costs	(144,219)	(174,655)
Acquisition of Pixelpin intangible asset	0	13,362
Purchases of property and equipment	(4,710)	(30,842)
Purchase of digital assets	0	(30,000)
Net cash flows from investing activities	(401,680)	(998,190)
Cash flows from financing activities:
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees	7,464,312	983,195
Proceeds from exercise of warrants to common stock	2,855,714	3,383,762
Proceeds from exercise of options to common stock	2,000	95,116
Forfeited common stock shares to satisfy taxes	(78,901)	0
Proceeds from issuance of common stock warrants	0	667,290
Proceeds from loan from Maltese government	0	61,361
Principal payments on financial liabilities	(29,715)	(89,530)
Net cash flows from financing activities	10,213,410	5,101,194
Effect of foreign currency translation on cash	(72,931)	13,181
Net change in cash and cash equivalents	1,886,253	(2,221,201)
Cash and cash equivalents, beginning of period	1,254,494	3,475,695
Cash and cash equivalents, end of period	3,140,747	1,254,494
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	580	8
Supplemental disclosure of non-cash activities:
Adjustment to operating lease right-of-use assets related to renewed leases	82,185	259,292
Adjustment to operating lease operating lease liabilities related to renewed leases	83,298	236,521
Adjustment to operating lease right-of-use assets related to terminated leases	96,639	0
Adjustment to operating lease liabilities related to terminated leases	89,922	0
Prepaid rent expense reclassified upon termination of leases	7,674	0
Adjustment to operating lease liabilities related to new lease commencement	41,051	0
Adjustment to operating lease right-of-use assets for new lease commencement	46,512	0
Adjustment to prepaid rent upon commencement of new lease	5,462	0
Property and equipment acquired under financial liability	0	297,150
Operating lease right-of-use assets established upon adoption of ASC 842	0	322,559
Operating lease liabilities established upon adoption of ASC 842	0	302,573
Prepaid rent expense reclassified upon adoption of ASC 842	$ 0	$ 42,756

Description of Business and Sum

Description of Business and Summary of Significant Accounting Policies And Going Concern	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Description of Business, Summary of Significant Accounting Policies, and Going Concern
Description of Business and Summary of Significant Accounting Policies And Going Concern	1. Description of Business, Summary of Significant Accounting Policies, and Going Concern Description of Business Trust Stamp primarily develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning artificial intelligence, including computer vision, cryptography, and data mining, to process and protect data and deliver insightful outputs that identify and defend against fraud, protect sensitive user information, facilitate automated processes, and extend the reach of digital services through global accessibility. We utilize the power and agility of technologies such as GPU processing, edge computing, neural networks, and large language models to process and protect data faster and more effectively than historically possible to deliver results at a disruptively low cost for usage across multiple industries. Our team has substantial expertise in the creation and development of AI-enabled software products. We license our technology and expertise in numerous fields, with an increasing emphasis on addressing diverse markets through established partners who will integrate our technology into field-specific applications. Reverse Split — one Amended and Restated Certificate of Incorporation Going Concern The Company’s ability to continue as a going concern in the next twelve months following the date the unaudited condensed consolidated financial statements were available to be issued is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to generate revenue and raise capital as needed to satisfy the Company’s capital needs. While the negotiation of significant additional revenue is well advanced, it has not reached a stage that allows it to be factored into a going concern evaluation. In addition, although the Company has previously been successful in raising capital as needed and has already made plans to do so as well as restructuring expenses to meet the Company’s cash needs, no assurance can be given that the Company will be successful in its capital raising efforts. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period. Basis of Presentation — Basis of Consolidation — The Company has completed the process of administratively dissolving AIID Payments Limited and the dissolution was effective October 29, 2024. Further, we continue to consolidate Tstamp Incentive Holdings (“TSIH”) which we consider to be a variable interest entity. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments necessary (which adjustments are of a normal and recurring nature) for the fair presentation of the Company’s financial position as of September 30, 2024 and December 31, 2023, and the results of operations for the three and nine months ended September 30, 2024 and 2023. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of results expected for the full year. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to the rules and regulations of the SEC. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The accounting policies employed are substantially the same as those shown in note 1 of the notes to consolidated financial statements included therein. Variable Interest Entity The Company considers this entity to be a variable interest entity (“VIE”) because it is thinly capitalized and holds no cash. Because the Company does not own shares in TSIH, management believes that this gives the Company a variable interest. Further, management of the Company also acts as management of TSIH and is the decision-maker as management grants shares held by TSIH to employees of the Company. As this VIE’s primary purpose is to hold shares in the Company from time to time and holds no other liabilities or assets, the Company is the primary beneficiary of TSIH and will consolidate the VIE. Major Customers and Concentration of Risks — For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures. Three customers represented 86.87% or 65.12%, 17.12%, and 4.63% of the balance of total Accounts receivable as of September 30, 2024 and three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. As of September 30, 2024 and December 31, 2023, the Company had not experienced any significant losses on its Accounts receivable. During the three months ended September 30, 2024, the Company sold to primarily three customers which made up approximately 93.24% of total Net revenue, and consisted of 66.34%, 17.60%, and 9.30% from an S&P 500 Bank, Mastercard, and Triton, respectively. Additionally, during the three months ended September 30, 2023, the Company sold to primarily three customers which made up approximately 95.85% of total Net revenue, and consisted of 81.87%, 7.91%, and 6.07% from IGS, Mastercard, and an S&P 500 Bank, respectively. During the nine months ended September 30, 2024, the Company sold to primarily three customers which made up approximately 94.68% of total Net revenue, and consisted of 63.66%, 21.07%, and 9.95% from an S&P 500 Bank, Mastercard, and Triton, respectively. Additionally, during the nine months ended September 30, 2023, the Company sold to primarily three customers which made up approximately 90.53% of total Net revenue, and consisted of 62.98%, 14.95%, and 12.60% from IGS, an S&P 500 Bank, and Mastercard, respectively. Property and Equipment, Net — Accounting for Impairment of Long-Lived Assets — As of September 30, 2024, the Company determined that $24 thousand of Capitalized internal-use software were impaired . Goodwill — Intangibles—Goodwill and Other financial performance and other relevant entity-specific events in determining whether it is more likely than not that the fair value of the reporting unit is less than the carrying amount. Should the Company conclude that it is more likely than not that the recorded Goodwill amounts have been impaired, the Company would perform the impairment test. Goodwill impairment exists when a reporting unit’s carrying value exceeds its fair value. Significant judgment is applied when Goodwill is assessed for impairment. There were no impairment charges to Goodwill as of September 30, 2024 and December 31, 2023. Remaining Performance Obligations — Disaggregation of Revenue ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Professional services (over time) ​ $ 424,831 ​ $ 2,990,804 ​ $ 1,326,403 ​ $ 3,760,242 License fees (over time) ​ ​ 86,250 ​ ​ 75,000 ​ ​ 258,750 ​ 225,000 Total Revenue ​ $ 511,081 ​ $ 3,065,804 ​ $ 1,585,153 ​ $ 3,985,242 ​ Recent Accounting Pronouncements Not Yet Adopted — , Income Taxes (Topic 740) – Improvements to Income Tax Disclosures In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions . The amendments in this ASU clarify that an entity should measure the fair value of an equity security subject to contractual sale restriction the same way it measures an identical equity security that is not subject to such a restriction. The FASB said the contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, should not affect its fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect this guidance to have a material impact to its unaudited condensed consolidated financial statements or related disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures . ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption of the amendments is permitted. The Company is currently evaluating the impacts of the new standard but does not expect a material impact to its unaudited condensed consolidated financial statements or related disclosures. 1A. Reverse Stock Split Reverse Split — December 30, 2024, the Company filed a Certificate of Amendment to the Company’s Third Amended and Restated Certificate of Incorporation, which was previously approved by the Company’s stockholders at the special meeting held on November 18, 2024 and described in the Company’s definitive proxy statement filed with the SEC on September 30, 2024, to effectuate a reverse stock split at a ratio of one (1) share of Common Stock for every fifteen (15) shares of Common Stock (the “ Reverse Stock Split ”) which became effective as of the opening of business on January 6, 2024 (the “ Effective Time ”). Accordingly, all share and per share amounts for all periods presented in the accompanying financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the reverse stock split.	1. Description of Business and Summary of Significant Accounting Policies And Going Concern Description of Business — Trust Stamp develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning, artificial intelligence, biometric science, cryptography, and data mining, to deliver insightful identity and trust predictions that identify and defend against fraudulent identity attacks, protect sensitive user information, and extend the reach of digital services through global accessibility. We utilize the power and agility of technologies such as GPU processing, edge-computing, neural networks, and large language models to process and protect data faster and more effectively than has ever previously been possible in order to deliver results at a disruptively low cost for usage across multiple industries, including: ● Banking/FinTech ● KYC/AML Compliance ● Humanitarian and Development Services ● Government and Law Enforcement, including Alternative to Detention programs ● Cryptocurrency and Digital Assets ● Biometrically Secured Email and Digital Communications ● P2P Transactions, Social Media, and Sharing Economy ● Real Estate, Travel, and Healthcare Reverse Split — Amended and Restated Certificate of Incorporation Going Concern The Company’s ability to continue as a going concern in the next twelve months following the date the consolidated financial statements were available to be issued is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to generate revenue and raise capital as needed to satisfy the Company’s capital needs. While the negotiation of significant additional revenue is well advanced, it has not reached a stage that allows it to be factored into a going concern evaluation. In addition, although the Company has previously been successful in raising capital as needed and has already made plans to do so as well as restructuring expenses to meet the Company’s cash needs, no assurance can be given that the Company will be successful in its capital raising efforts. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period. Basis of Presentation Basis of Consolidation On February 28, 2023, the Company received the Certificate of Termination from the State of Georgia, which represents the completion of administratively dissolving T Avatar LLC. As there were no operations established under the entity, there is a limited impact to Trust Stamp. The dissolution of T Avatar LLC was effective February 28, 2023. On June 2, 2023, the Company received the termination resolution from the Polish National Court Register, which represents the completion of administratively dissolving Sunflower AI Technologies (“SAIT”). As there were no operations established under the entity, there is a limited impact to Trust Stamp. The dissolution of SAIT was effective May 10, 2023. Further, we continue to consolidate Tstamp Incentive Holdings (“TSIH”) which we consider to be a variable interest entity. Variable Interest Entity The Company does not own any of the shares of Class A Common Stock of the Company held by TSIH. The Company considers this entity to be a variable interest entity (“VIE”) because it is thinly capitalized and holds no cash. Because the Company does not own shares in TSIH, management believes that this gives the Company a variable interest. Further, management of the Company also acts as management of TSIH and is the decision-maker as management grants shares held by TSIH to employees of the Company. As this VIE owns only shares in the Company and no other liabilities or assets, the Company is the primary beneficiary of TSIH and will consolidate the VIE. Use of Estimates Segment Information — Risks and Uncertainties Major Customers and Concentration of Risks For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures. Three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023 and three customers represented 95.37% or 36.90%, 32.69%, and 25.78% of the balance of total Accounts receivable as of December 31, 2022. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. As of December 31, 2023 and 2022, the Company had not experienced any significant losses on its Accounts receivable. During the year ended December 31, 2023, the Company sold to primarily three customers which made up approximately 89.75% of total Net revenue, and consisted of 55.04%, 17.77%, and 16.94% from IGS, an S&P 500 Bank, and Mastercard, respectively. Additionally, during the year ended December 31, 2022, the Company sold to primarily three customers which made up approximately 93.60% of total Net revenue, and consisted of 61.01%, 18.36%, and 14.23% from ICE, an S&P 500 Bank, and Mastercard. Foreign Currencies Cash and Cash Equivalents Accounts Receivable and Allowance for Credit Losses The Company maintains an allowance for credit losses, which represents an estimate of expected losses over the remaining contractual life of its receivables considering current market conditions and estimates for supportable forecasts when appropriate. The Company measures expected credit losses on its trade receivables on a customer basis. The estimate of expected credit losses considers any historical losses, delinquency trends, collection experience, and/or economic risk where appropriate. Additionally, management develops a specific allowance for trade receivables known to have a high risk of expected future credit loss. The Company has historically experienced immaterial write-offs given the nature of the customers and contracts. As of December 31, 2023, the Company had gross receivables (including unbilled receivables) of $694 thousand and an allowance for credit losses of $8 thousand. As of December 31, 2022, the Company had gross receivables of $1.01 million and no allowance for credit losses. As of December 31, 2023 and 2022, Accounts receivable includes unbilled receivables of $143 thousand and $109 thousand, respectively. Property and Equipment, Net Capitalized Internal-Use Software, Net Capitalized Internal-Use Software, Net is a combination of c Accounting for Impairment of Long-Lived Assets As of December 31, 2023, the Company determined that $19 thousand of Capitalized internal-use software and $12 thousand of Intangible assets was impaired. The impaired Capitalized internal-use software was expensed to Research and development during the year ended December 31, 2023.. As of December 31, 2022, the Company determined that no long-lived assets with finite lives were impaired. Goodwill Intangibles—Goodwill and Other Fair Value of Assets and Liabilities — Level 1 Level 2 Level 3 A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The estimated fair values of Cash and cash equivalents, Accounts receivable, Related party receivables, Prepaid expenses and other current assets, Other assets, Accounts payable, Related party payables, Accrued expenses, Deferred revenue, Customer deposit liabilities, and Notes payable approximate their carrying values. The fair values of warrant liabilities issued in connection with equity or debt issuance are determined using the Black-Scholes valuation model, a “Level 3” fair value measurement, based on the estimated fair value of the underlying common stock, volatility based on the historical volatility data of similar companies, considering the industry, products and market capitalization of such other entities, the expected life based on the remaining contractual term of the conversion option and warrant liabilities and the risk free interest rate based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrant liability’s contractual life. The Company accounts for its financial assets and liabilities at fair value regularly. The Company evaluates the fair value of its non-financial assets and liabilities on a nonrecurring basis. Revenue Recognition — ● Identification of the contract, or contracts with a customer; ● Identification of the performance obligations in the contract; ● Determination of the transaction price; ● Allocation of the transaction price to the performance obligations in the contract; and ● Recognition of revenue when or as the Company satisfies the performance obligations. At contract inception, the Company will assess the services agreed upon within each contract and assess whether each service is distinct and determine those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In general, each contract with a customer consists of a single performance obligation to perform services in which revenue is recognized when the service has been delivered. Remaining Performance Obligations considered a remaining performance obligation. As of December 31, 2023 and 2022, the Company did not have any related performance obligations for contracts with terms exceeding twelve months. Disaggregation of Revenue ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Professional services (over time) ​ $ 4,260,275 ​ $ 4,415,512 Termination expense reimbursement (one time) ​ — ​ 719,565 License fees (over time) ​ 300,000 ​ 250,000 Total Revenue ​ $ 4,560,275 ​ $ 5,385,077 ​ Contract Balances — . The payment terms and conditions vary by contract; however, the Company’s terms generally require payment within 30 to 60 days from the invoice date. In instances where the timing of revenue recognition differs from the timing of payment, the Company elected to apply the practical expedient in accordance with ASC 606 to not adjust contract consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when promised goods and services are transferred to the customer and when the customer pays for those goods and services will be one year or less. As such, the Company determined its contracts do not generally contain a significant financing component. Costs to Obtain and Fulfill Contracts — Warrants — Cost of Services Provided — Research and Development — Advertising — Stock- Based Compensation — input of highly subjective assumptions, including the fair value of the underlying common shares, the expected term of the share option, the expected volatility of the price of our common shares, risk-free interest rates, and the expected dividend yield of common shares. The assumptions used to determine the fair value of the option awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment. The calculated fair value is recognized as expense over the requisite service period using the straight-line method. Forfeitures are accounted for in the period in which they occur. Trust Stamp offers the indirect repurchase of shares through a net-settlement feature upon the vesting of RSU awards to satisfy minimum statutory tax-withholding requirements for the recipient. Income Taxes — A valuation allowance is established if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income in assessing the need for a valuation allowance. The Company’s tax positions are subject to income tax audits by multiple tax jurisdictions. The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not the position will be sustainable upon examination by the taxing authority, including resolution of any related appeals or litigation processes. This evaluation is based on all available evidence and assumes that the tax authorities have full knowledge of all relevant information concerning the tax position. The tax benefit recognized is measured as the largest amount of benefit which is more likely than not (greater than 50% likely) to be realized upon ultimate settlement with the taxing authority. The Company recognizes interest accrued and penalties related to unrecognized tax benefits in Income tax benefit (expense). The Company adjusts these reserves in accordance with the income tax guidance when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may affect the provision for income taxes in the period in which such determination is made and could have a material impact on the Company’s financial condition and operating results. The Company computes its tax provision for interim periods by applying the estimated annual effective tax rate to year-to-date pre-tax income from recurring operations and adjusting for discrete tax items arising in that quarter. There were no discrete items that impacted the effective tax rate for the years ended December 31, 2023 and 2022, respectively. The rate remained consistent over the period due to the full valuation allowance recorded in the period. The Company had an effective tax rate of 0% for the years ended December 31, 2023 and 2022, respectively. The Company has incurred U.S. operating losses and has minimal profits in foreign jurisdictions. Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences are deductible. In making this determination, management considers all available positive and negative evidence affecting specific deferred tax assets, including the Company’s past and anticipated future performance, the reversal of deferred tax liabilities, the length of carry-back and carry-forward periods, and the implementation of tax planning strategies. The Company had no unrecognized tax benefits as of December 31, 2023 and 2022. It is the Company’s policy to recognize interest and penalties related to income tax matters in Income tax benefit (expense). The Company has not accrued any penalties related to uncertain tax positions due to offsetting tax attributes as of December 31, 2023 and 2022. The Company files U.S. federal, state, and foreign income tax returns in jurisdictions with varying statutes of limitation. The only material jurisdiction where the Company is subject to potential examination by tax authorities is the U.S. (federal and state) for tax years 2020 through 2022. Leases — Lessors—Certain Leases with Variable Lease Payments Operating lease right-of-use assets represent the Company’s right to use an underlying asset during a lease term and are included in non-current assets on our consolidated balance sheet. Operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease liabilities are divided into two classifications on our consolidated balance sheet as a current liability, Short-term operating lease liabilities, and a non-current liability, Long-term operating lease liabilities. The Company does not have any finance lease right-of-use assets or finance lease liabilities. The Company’s operating lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. The interest rate implicit in the lease is not readily determinable, therefore, the Company uses an estimated incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s Operating lease right-of-use assets are also recognized at the applicable lease commencement date. The Operating lease right-of-use asset equals the carrying amount of the related operating lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable Operating lease right-of-use asset or operating lease liability. The term of our leases equals the non-cancellable period of the lease, including any rent-free periods provided by the lessor, and also include options to renew or extend the lease (including by not terminating the lease) that we are reasonably certain to exercise. We establish the term of each lease at lease commencement and reassess that term in subsequent periods if a triggering event occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term. Some lease contracts include lease and non-lease components. Trust Stamp elected the practical expedient offered by ASC 842 to not separate the lease components from non-lease components. As a result, the Company accounts for leases as a single lease component. In addition, the Company elected not to recognize right-of-use assets and lease liabilities for leases term of twelve months or less. The short-term lease expenses are recognized on a straight-line basis over the lease term. Commitments and Contingencies - Treasury Stock - Net Loss per Share Attributable to Common Stockholders — Recent Accounting Pronouncements Not Yet Adopted — In December 2023, the FASB issued ASU 2023-09 , Income Taxes – Improvements to Income Tax Disclosures . ASU 2023-09 requires enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impacts of the new standard but does not expect a material impact to its consolidated financial statements or related disclosures. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions . The amendments in this ASU clarify that an entity should measure the fair value of an equity security subject to contractual sale restriction the same way it measures an identical equity security that is not subject to such a restriction. The FASB said the contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, should not affect its fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect this guidance to have a material impact to its consolidated financial statements or related disclosures. Recently Adopted Accounting Pronouncement — In June 2016, the FASB issued Accounting Standards Update No. 2016-13, “Financial Instruments - Credit Losses (Topic 326)” (“ASU 2016-13”). ASU 2016-13 revises the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. In November 2019, FASB issued ASU 2019-10, “ Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842 ). ” This ASU defers the effective date of ASU 2016-13 for public companies that are considered smaller reporting companies as defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted this standard as of January 1, 2023, and the guidance did not have a material impact on its consolidated financial statements or related disclosures. 1A. Reverse Stock Split Reverse Split — Reverse Stock Split Effective Time

Borrowings_2

Borrowings	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Borrowings
Borrowings	2. Borrowings Promissory Notes Payable ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Malta loan receipt 3 – June 3, 2022 ​ $ 511,262 ​ $ 507,035 Malta loan receipt 2 – August 10, 2021 ​ ​ 315,673 ​ ​ 313,063 Malta loan receipt 1 – February 9, 2021 ​ ​ 64,807 ​ ​ 64,271 Interest added to principal ​ ​ 70,088 ​ ​ 29,191 Total principal outstanding ​ ​ 961,830 ​ ​ 913,560 Plus: accrued interest ​ ​ 45,383 ​ ​ 40,317 Total promissory notes payable ​ $ 1,007,213 ​ $ 953,877 ​ In May 2020, the Company formed a subsidiary in the Republic of Malta, Trust Stamp Malta, with the intent to establish a research and development center with the assistance of potential grants and loans from the Maltese government. As part of the creation of this entity, we entered into an agreement with the government of Malta for a potentially repayable advance of up to €800 thousand or $858 thousand to assist in covering the costs of 75% of the first 24 months of payroll costs for any employee who begins 36 months from the execution of the agreement on July 8, 2020. On February 9, 2021 the Company began receiving funds and as of September 30, 2024, the balance received was $892 thousand which includes changes in foreign currency rates. The liability was paid in full on November 15, 2024. The Company will pay an annual interest rate of 2% over the European Central Banks (ECB) base rate as set on the beginning of the year in review. If the ECB rate is below negative 1%, the interest rate shall be fixed at 1%. The Company will repay a minimum of 10% of Trust Stamp Malta’s pre-tax profits per annum capped at 15% of the amount due to the Corporation until the disbursed funds are repaid. At this time, Trust Stamp Malta does not have any revenue-generating contracts and therefore, we do not believe any amounts shall be classified as current. The Malta loan interest rate increased from 4.5% for the nine months ended September 30, 2023 to 6.5% for the nine months ended September 30, 2024 due to the increased interest rate noted by the ECB. The liability was paid in full on November 15, 2024. Subordinated Business Loans ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ ​ 2024 ​ ​ 2023 Agile loan agreement 1 - July 9, 2024 ​ $ 315,000 ​ $ — Agile loan agreement 2 - August 29,2024 ​ 530,000 ​ — Interest added to loan agreement 1 - July 9, 2024 ​ 54,450 ​ — Interest added to loan agreement 2 - August 29, 2024 ​ 33,314 ​ — Total principal and interest outstanding ​ 932,764 ​ — Less: loan repayments ​ 287,228 ​ — Total promissory notes payable ​ $ 645,536 ​ $ — ​ On July 9, 2024, the Company entered into a subordinated secured promissory note with Agile Lending, LLC as lead lender (“Agile”) and Agile Capital Funding, LLC as collateral agent, which provides for a term loan to the Company of $454 thousand with the principal amount of $315 thousand and interest of $139 thousand. Commencing July 18, 2024, the Company is required to make weekly payments of $16 thousand until the due date, January 23, 2025. The loan may be prepaid subject to a prepayment fee. An administrative agent fee of $15 thousand was paid on the loan. In connection with the loan, Agile was issued a subordinated secured promissory note, dated July 9, 2024, in the principal amount of $315 thousand which note is secured by all of the Borrower’s assets, including receivables. On August 29, 2024, the Company entered into another subordinated secured promissory note with Agile Lending, LLC as lead lender (“Agile”) and Agile Capital Funding, LLC as collateral agent, which provides for a term loan to the Company of $763 thousand with the principal amount of $530 thousand and interest of $233 thousand. Commencing September 6, 2024, the Company is required to make weekly payments of $27 thousand until the due date, March 14, 2025. The loan may be prepaid subject to a prepayment fee. An administrative agent fee of $27 thousand was paid on the loan. In connection with the loan, Agile was issued a subordinated secured promissory note, dated August 29, 2024, in the principal amount of $530 thousand which note is secured by all of the Borrower’s assets, including receivables.	2. Borrowings Promissory Notes Payable ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Malta loan receipt 3 – June 3, 2022 ​ $ 507,035 ​ $ 62,365 Malta loan receipt 2 – August 10, 2021 ​ ​ 313,063 ​ ​ 303,778 Malta loan receipt 1 – February 9, 2021 ​ 64,271 ​ 491,996 Interest added to principal ​ ​ 29,191 ​ ​ 11,551 Total principal outstanding ​ 913,560 ​ 869,690 Plus: accrued interest ​ 40,317 ​ 16,775 Total promissory notes payable ​ $ 953,877 ​ $ 886,465 ​ In May 2020, the Company formed a subsidiary in the Republic of Malta, Trust Stamp Malta Limited, with the intent to establish a research and development center with the assistance of potential grants and loans from the Maltese government. As part of the creation of this entity, we entered into an agreement with the government of Malta for a potentially repayable advance of up to €800 thousand or $858 thousand to assist in covering the costs of 75% of the first 24 months of payroll costs for any employee who begins 36 months from the execution of the agreement on July 8, 2020. On February 9, 2021, the Company began receiving funds and as of December 31, 2023 The Company will pay an annual interest rate of 2% over the European Central Banks (ECB) base rate as set on the beginning of the year in review. If the ECB rate is below negative 1%, the interest rate shall be fixed at 1%. The Company will repay a minimum of 10% of Trust Stamp Malta Limited’s pre - tax profits per annum capped at 15% of the amount due to the Corporation until the disbursed funds are repaid. At this time, Trust Stamp Malta Limited does not have any revenue - generating contracts and therefore, we do not believe any amounts shall be classified as current. The Malta loan interest rate increased from 2.5% for the year ended December 31, 2022 to 4.5% for the year ended December 31, 2023.

Warrants_2

Warrants	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Warrants
Warrants	3. Warrants Liability Classified Warrants The following table presents the change in the liability balance associated with the liability classified warrants, which are classified in Level 3 of the fair value hierarchy from January 1, 2023 to September 30, 2024: ​ ​ ​ ​ ​ ​ Warrants ($) Balance as of January 1, 2023 ​ $ 261,569 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,033) Balance as of December 31, 2023 ​ $ 256,536 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,842) Balance as of September 30, 2024 ​ $ 250,694 ​ As of September 30, 2024, the Company has issued a customer a warrant to purchase up to $1.00 million of capital stock in a future round of financing at a 20% discount of the lowest price paid by another investor. The warrant was issued on November 9, 2016. There is no vesting period, and the warrant expires on November 30, 2026. The Company evaluated the provisions of ASC 480, Distinguishing Liabilities from Equity, noting the warrant should be classified as a liability due to its settlement being for a variable number of shares and potentially for a class of shares not yet authorized. The warrant was determined to have a fair value of $250 thousand which was recorded as a Deferred contract acquisition asset and to a Warrant liability during the year ended December 31, 2016 and was amortized as a revenue discount prior to the current periods presented. The fair value of the warrant was estimated on the date of grant by estimating the warrant’s intrinsic value on issuance using the estimated fair value of the Company as a whole and has a balance of $250 thousand as of September 30, 2024. On December 16, 2016, the Company issued an investor warrant to purchase $50 thousand worth of shares of our Class A Common Stock. The warrants have no vesting period and expires on December 16, 2026. The warrant agreement states that the investor is entitled to the “number of shares of Common Stock with a Fair Market Value as of the Determination Date of The Company used a Black-Scholes-Merton pricing model to determine the fair value of the warrants and uses this model to assess the fair value of the warrant liability. As of September 30, 2024, the warrant liability is recorded at $1 thousand which is a $6 thousand decrease, recorded to Change in fair value of warrant liability, from the balance of $7 thousand as of December 31, 2023. The following assumptions were used to calculate the fair value of the warrant liability during the nine months ended September 30, 2024: ​ ​ ​ ​ ​ ​ Fair Value of Warrants $ 1.65 — $9.60 ​ Exercise price ​ $ 3.90 — $7.35 ​ Risk free interest rate ​ ​ 3.51%— 4.50 % Expected dividend yield ​ ​ — % Expected volatility ​ ​ 79.19% — 79.59 % Expected term ​ ​ 1 year - 3 years ​ Equity Classified Warrants ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, Warrant Issuance Date ​ Strike Price ​ 2024 ​ 2023 November 9, 2016 ​ $ 46.80 5,342 5,342 January 23, 2020 ​ $ 120.00 ​ 12,430 ​ 12,430 January 23, 2020 ​ $ 120.00 ​ 34,974 ​ 34,974 April 18, 2023 ​ $ 20.10 ​ — ​ 51,689 June 5, 2023 ​ $ 4.80 ​ — ​ 85,314 December 21, 2023 ​ $ 4.80 ​ 192,869 ​ 240,000 April 3, 2024 ​ $ 14.55 ​ — ​ — April 3, 2024 ​ $ 15.90 ​ — ​ — September 3, 2024 ​ $ 4.80 ​ 95,494 ​ — September 3, 2024 ​ $ 4.80 ​ 190,987 ​ — September 3, 2024 ​ $ 4.80 ​ 636,404 ​ — September 10, 2024 ​ $ 3.45 ​ 250,930 ​ — Total warrants outstanding ​ ​ ​ ​ 1,419,430 ​ 429,749 ​ November 9, 2016 The Company has issued a customer a warrant to purchase 5,342 shares of Class A Common Stock with an exercise price of $46.80 per share. The warrant was issued on November 9, 2016. There is no vesting period, and the warrant expires on November 30, 2026. January 23, 2020 In January 2020, the Company issued REach®, a related party, a warrant to purchase 12,430 shares of the Company’s Class A Common Stock at a strike price of $120.00 per share in exchange for the cancellation of a $100 thousand SAFE issued on August 18, 2017 by the Company’s affiliate Trusted Mail Inc. with a value of $125 thousand. The warrants were issued on January 23, 2020. There is no vesting period, and the warrants expire on December 20, 2024. January 23, 2020 In January 2020, the Company issued SCV, a related party, a warrant to purchase 62,141 shares of the Company’s Class A Common Stock at a strike price of $120.00 per share in exchange for $300 thousand in cash and “Premium” sponsorship status with a credited value of $100 thousand per year for 3 years totaling $300 thousand. This “premium” sponsorship status provides the Company with certain benefits in marketing and networking, such as the Company being listed on the investor’s website, as well as providing the Company certain other promotional opportunities organized by the investor. The warrants were issued on January 23, 2020. There is no vesting period, and the warrants expire on December 20, 2024. On December 21, 2021, SCV executed a Notice of Exercise for certain of its warrants to purchase 27,168 shares of Class A Common Stock at an exercise price of $120.00 per share for a total purchase price of $3.26 million. The closing occurred on January 10, 2022 and resulted in total cash proceeds of $3,260,000 to the Company for the warrant exercise. The warrants to purchase the remaining 34,974 shares of the Company’s Class A Common Stock remain outstanding as of September 30, 2024. April 18, 2023 On April 14, 2023, the Company entered into a securities purchase agreement (“SPA”) with Armistice Capital Master Fund Ltd. Pursuant to which the Company agreed to issue and sell to the investor (i) in a registered direct offering, 37,559 shares of Class A Common Stock, par value $0.01 per share of the Company at a price of $49.50 per share, and pre-funded warrants to purchase up to 67,330 shares of Class A Common Stock, at a price of $49.485 per prefunded warrant, at an exercise price of $0.015 per share of Class A Common Stock, and (ii) in a concurrent private placement, common stock purchase warrants, exercisable for an aggregate of up to 104,889 shares of Class A Common Stock, at an exercise price of $49.50 per share. On April 18, 2023, the Company sold 37,559 shares of Class A Common Stock to the institutional investor at a price of $49.50 per share for total proceeds $1,859,154. Additionally, on same date, the institutional investor purchased and exercised the 67,330 pre-funded warrants, for total proceeds to the Company of $3,332,835, resulting in an aggregate issuance by the Company of 104,889 shares of Class A Common Stock for net proceeds of $4,778,550 from the registered direct offering after deducting placement fee and legal expense of $363,439 and $50,000, respectively. On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the warrants to purchase the remaining 104,889 shares of Class A Common Stock of the Company was reduced to $20.10 for a total purchase price of $2,108,262. On December 21, 2023, the remaining 104,889 common stock purchase warrants to purchase shares of Class A Common Stock of the Company at a price of $20.10 per warrant were exercised for total proceeds of $2,108,262. As of December 31, 2023, the Company had received Notice to Exercise for 53,200 common stock purchase warrants resulting in an issuance by the Company of 53,200 shares of Class A Common Stock. Due to the beneficial ownership limitation provisions in the Inducement Agreement, as of December 31, 2023 the remaining 51,689 common stock purchase warrants exercised on December 21, 2023 were unissued and held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. On February 7, 2024 and February 27, 2024, the Company issued 21,334 and 30,356 shares, respectively. All warrants related to this investment have been exercised and are no longer outstanding as of September 30, 2024. June 5, 2023 On June 1, 2023, the Company entered into a securities purchase agreement (“SPA”) with an Armistice Capital Master Fund Ltd. Pursuant to which the Company agreed to issue and sell to the investor (i) in a registered direct offering, 49,094 shares of Class A Common Stock, par value $0.01 per share of the Company at a price of $34.50 per share, and pre-funded warrants to purchase up to 36,220 shares of Class A Common Stock, at a price of $34.485 per prefunded warrant, at an exercise price of $0.015 per share of Class A Common Stock, and (ii) in a concurrent private placement, common stock purchase warrants, exercisable for an aggregate of up to 85,314 shares of Class A Common Stock, at an exercise price of $34.50 per share. On June 5, 2023, the Company sold 49,094 shares of Class A Common Stock to the institutional investor at a price of $34.50 per share for total proceeds of $1,693,720. Additionally, on same date, the institutional investor purchased the 36,220 pre-funded warrants at a price of $34.485 per prefunded warrant, for total proceeds to the Company of $1,249,047, resulting in an issuance by the Company of 49,094 shares of Class A Common Stock for net proceeds of $2,686,773 from the registered direct offering after deducting placement fee and legal expense of $205,994 and $50,000, respectively. On June 12, 2023, the institutional investor exercised 21,487 pre-funded warrants at a price of $0.015 per prefunded warrant, resulting in an issuance by the Company of 21,487 shares of Class A Common Stock for total proceeds of $322. Additionally, on June 23, 2023, the institutional investor exercised 14,734 pre-funded warrants at a price of $0.015 per prefunded warrant, resulting in an issuance by the Company of 14,734 shares of Class A Common Stock for total proceeds of $221. On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the common stock purchase warrants to purchase the remaining 85,314 shares of Class A Common Stock of the Company was reduced to $20.10 for a total purchase price of $1,714,798. On December 21, 2023, the institutional investor exercised 7,112 warrants to purchase shares of Class A Common Stock of the Company at a price of $20.10 per warrant for total proceeds of $142,938. As of December 31, 2023, due to the beneficial ownership limitation provisions in the Inducement Agreement, the 7,112 warrants were unissued and held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. These shares were subsequently issued on February 27, 2024. On September 3, 2024, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the common stock purchase warrants to purchase the remaining 78,202 shares of Class A Common Stock of the Company was reduced to $4.8345. All of the 78,202 shares were exercised and issued on September 4, 2024. All warrants related to this investment have been exercised and are no longer outstanding as of September 30, 2024. December 21, 2023 On December 21, 2023, the Company entered into a warrant exercise agreement (the “WEA”) with a certain existing institutional investor, pursuant to which the institutional investor agreed to exercise (the “Exercise”) (i) a portion (7,112) of the warrants issued to the institutional investor on June 5, 2023, which, as of December 21, 2023, were exercisable for 85,314 shares of the Company’s Class A Common Stock, par value $0.01 per share (“Class A Common Stock”) with a current exercise price of $34.50 per share (the “June 2023 Warrants”), (ii) all of the warrants issued to the institutional investor on September 14, 2022, as amended on June 5, 2023, which are exercisable for 8,000 shares of Class A Common Stock, with a current exercise price of $34.50 per share (the “September 2022 Warrants”), and (iii) all of the warrants issued to the institutional investor on April 18, 2023, which are exercisable for 104,889 shares of Class A Common Stock, with a current exercise price of $49.50 per share (the “April 2023 Warrants” and collectively with all of the June 2023 Warrants and the September 2022 Warrants, the “Existing Warrants”). In consideration for the immediate exercise of 120,000 of the Existing Warrants for cash, the Company agreed to reduce the exercise price of all of the Existing Warrants, including any unexercised portion thereof, to $20.10 per share, which was equal to the most recent closing price of the Company’s Class A Common Stock on The Nasdaq Stock Market prior to the execution of the WEA. As of September 30, 2024, the institutional investor had submitted an Exercise Notice for all 120,000 Existing Warrants, in two batches, 61,200 and 58,800, respectively, and the shares of Class A Common Stock were issued to the warrant holders. In addition, in consideration for such Exercise, the Selling Stockholder received new unregistered warrants to purchase up to an aggregate of 240,000 shares of Class A Common Stock, equal to 200% of the shares of Class A Common Stock issued in connection with the Exercise, with an exercise price of $20.10 per share (the “New Warrants”) in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933 (the “Securities Act”). On September 3, 2024, the Company entered into an Inducement Agreement with an institutional investor. Pursuant to the terms of the Inducement Agreement, the exercise price for the common stock purchase warrants to purchase the remaining 240,000 shares of Class A Common Stock of the Company was reduced to $4.835. The 240,000 warrants were subsequently exercised resulting in the Company receiving $1,160,280 in cash proceeds. Due to the beneficial ownership limitation provisions in the Inducement Agreement, 47,132 shares were issued on September 4, 2024. The warrants to purchase the remaining 192,869 shares are held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. These shares were subsequently issued on November 5, 2024. April 3, 2024 On April 3, 2024, the Company closed a Securities Purchase Agreement with a certain institutional investor. Pursuant to the terms of the Securities Purchase Agreement, the investor agreed to purchase from the Company 33,333 shares of Class A Common Stock, par value $0.01 of the Company and pre-funded warrants to purchase 100,001 shares of Class A Common Stock of the Company (“Warrant A”) at a purchase price of $14.52 per share resulting in a total purchase price of $1,936,000. The Company paid offering costs of $245,520 resulting in net proceeds of $1,690,480. Additionally, pursuant to the Securities Purchase Agreement, as additional consideration for the share and Warrant A purchase described above, the Company agreed to issue to the Selling Stockholder a stock purchase warrant for the purchase of 133,334 shares of the Company’s Class A Common Stock at an exercise price of $14.52 per share (“Warrant B”), and a stock purchase warrant for the purchase of 106,667 shares of the Company’s Class A Common Stock at an exercise price of $15.90 per share (“Warrant C”). On May 24, 2024, the institutional investor exercised 36,140 pre-funded warrants from Warrant A to purchase shares of Class A Common Stock of the Company at an exercise price of $0.00 per warrant for total proceeds of $0. On July 26, 2024, the institutional investor exercised a further 53,273 pre-funded warrants from Warrant A to purchase shares of Class A Common Stock of the Company at an exercise price of $0.00 per warrant for total proceeds of $0. On August 20, 2024, the institutional investor exercised the remaining 10,588 pre-funded warrants from Warrant A to purchase shares of Class A Common Stock of the Company at an exercise price of $0.00 per warrant for total proceeds of $0. Subsequent to the August 20, 2024 exercise, there were no remaining securities in Warrant A. On September 3, 2024, the Company entered into a Termination and Release Agreement under which the transaction entered into between the Company and institutional investor that terminated the remaining 133,334 stock purchase warrants in Warrant B and 106,667 stock purchase warrants in Warrant C. In consideration of the termination of the Transaction Documents, the Company made a $1,650,000 payment to the institutional investor. All warrants related to this investment have been exercised or terminated and are no longer outstanding as of September 30, 2024. September 3, 2024 On September 3, 2024, the Company entered into a securities purchase agreement with a single institutional investor to purchase 95,494 shares of Class A Common Stock, par value $0.01 of the Company (or pre-funded warrants in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. The shares were purchased at $4.8195 resulting in proceeds of $460,230. In a concurrent private placement, the Company also agreed to issue and sell unregistered warrants to purchase up to an aggregate of 190,987 shares of Class A Common Stock, par value $0.01 of the Company. The exercise price for each share of common stock (or pre-funded warrant in lieu thereof) and accompanying warrant is $4.8345. The private placement warrants will be exercisable upon receipt of shareholder approval and will expire five years from the initial exercise date and will have an exercise price of $4.8345 per share. As of the date of this Quarterly Report on Form 10-Q, the Company has not received shareholder approval but will hold a vote on November 18, 2024. The warrants to purchase the remaining 95,494 shares of the Company’s Class A Common Stock are held in abeyance as of September 30, 2024 and 190,987 shares of the Company’s Class A Common Stock remain outstanding as of September 30, 2024. On November 6, 2024, the 95,494 shares were issued upon the exercise of the warrants for $0.015 per share resulting in $1,432 in proceeds. September 3, 2024 On September 3, 2024, the Company also entered into a warrant inducement agreement with a single institutional investor to exercise 78,202 outstanding warrants that the Company issued on June 5, 2023 (as amended on December 20, 2023) and 240,000 outstanding warrants that the Company issued on December 20, 2023. These warrant exercises are discussed under the June 5, 2023 and December 20, 2023 sections above. In consideration for the immediate exercise of the warrants, the Company also agreed to issue to the investor unregistered warrants to purchase an aggregate of 636,404 shares of the Company’s common stock. These warrants will have an exercise price of $4.835 per share, will be exercisable upon receipt of shareholder approval and will expire five years from the initial exercise date. As of the date of this Quarterly Report on Form 10-Q, the Company has not received shareholder approval but will hold a vote on November 18, 2024. In accordance with the Inducement Agreement we recognized a deemed dividend of $1.94 million calculated as the fair value of the warrants and reduction in exercise price of the warrants as described above immediately following the Inducement Agreement. The fair values were determined using the Black Sholes Model. This deemed dividend is added to net loss to arrive at net loss attributable to common stockholders on the statements of operations. The warrants to purchase the remaining 636,404 shares of the Company’s Class A Common Stock remain outstanding as of September 30, 2024. September 10, 2024 On September 10, 2024, T Stamp Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement the (“SPA”) with a certain institutional investor. The investor and the Company previously entered into that certain Securities Purchase Agreement dated July 13, 2024, in which the Company issued 306,514 shares of Class A Common Stock, par value $0.01 of the Company (the “Class A Common Stock”) in exchange for the issuance by the investor to the Company of (i) a $500,000 promissory note payable on July 31, 2024; (ii) a $500,000 promissory note payable on August 31, 2024; and (iii) a $1,000,000 promissory note payable within three (3) trading days of an effective resale registration statement. As of the date of this report, all promissory notes have been repaid. Pursuant to the terms of the SPA, the Company agreed, at the closing of the SPA and upon the terms and subject to the conditions set forth in the SPA, to issue certain shares warrants to purchase 250,930 shares of Class A Common Stock, with an exercise price equal to $3.41, subject to adjustment in certain circumstances. The warrants to purchase the remaining 250,930 shares of the Company’s Class A Common Stock remain outstanding as of September 30, 2024.	3. Warrants Liability Classified Warrants The following table presents the change in the liability balance associated with the liability classified warrants, which are classified in Level 3 of the fair value hierarchy from January 1, 2022 to December 31, 2023 ​ ​ ​ ​ ​ ​ Warrants ($) Balance as of January 1, 2022 ​ $ 374,694 Additional warrants issued ​ — Change in fair value ​ ​ (113,125) Balance as of December 31, 2022 ​ $ 261,569 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,033) Balance as of December 31, 2023 ​ $ 256,536 ​ As of December 31, 2023 December 31, 2023 On December 16, 2016, the Company issued an investor warrant to purchase $50 thousand worth of shares of our Class A Common Stock. The warrants have no vesting period and expires on December 16, 2026. The warrant agreement states that the investor is entitled to the “number of shares of Common Stock with a Fair Market Value as of the Determination Date of $50,000”. The determination date is defined as the “date that is the earlier of (A) the conversion of the investor’s Note into the equity interests of the Company or (B) the maturity date of the Note.” The investor converted the referenced Note on June 30, 2020, therefore, defining the determination date. The number of shares to be purchased is settled as 428 shares as of June 30, 2020. The exercise price of the warrants is variable until the exercise date. The Company used a Black-Scholes-Merton pricing model to determine the fair value of the warrants and uses this model to assess the fair value of the warrant liability. As of December 31, 2023 ​ ​ ​ ​ ​ ​ Fair Value of Warrants $ 13.95 – $30.15 ​ Exercise price ​ $ 7.95 – $14.40 ​ Risk free interest rate ​ 4.09% - 4.74 % Expected dividend yield ​ — % Expected volatility ​ 79.08% - 92.90 % Expected term ​ 3 years ​ Equity Classified Warrants ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, Warrant Issuance Date Strike Price 2023 2022 November 9, 2016 ​ $ 46.80 5,342 5,342 January 23, 2020 ​ $ 120.00 ​ 12,430 ​ 12,430 January 23, 2020 ​ $ 120.00 34,974 54,974 August – December 2021 ​ $ 300.00 — 17,917 January – February 2022 ​ $ 300.00 — 1,012 September 14, 2022 ​ $ 20.10 — 26,000 April 18, 2023 ​ $ 20.10 ​ 51,689 (1) — June 5, 2023 ​ $ 20.10 ​ 85,314 (1) — December 21, 2023 ​ $ 20.10 ​ 240,000 ​ — Total warrants outstanding ​ ​ ​ 429,749 97,675 (1) As of December 31, 2023, all 51,689 of the April 18, 2023 warrants and 7,112 of the June 5, 2023 warrants are held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. November 9, 2016 The Company has issued a customer a warrant to purchase 5,342 shares of Class A Common Stock with an exercise price of $46.80 per share. The warrant was issued on November 9, 2016. There is no vesting period, and the warrant expires on November 30, 2026. January 23, 2020 In January 2020, the Company issued REach®, a related party, a warrant to purchase 12,430 shares of the Company’s Class A Common Stock at an exercise of $120.00 per share in exchange for the cancellation of a $100 thousand SAFE issued on August 18, 2017 by the Company’s affiliate Trusted Mail Inc. with a value of $125 thousand. The warrants were issued on January 23, 2020. There is no vesting period, and the warrants expire on December 20, 2024. January 23, 2020 In January 2020, the Company issued SCV, a related party, a warrant to purchase 62,141 shares of the Company’s Class A Common Stock at a strike price of $120.00 per share in exchange for $300 thousand in cash and “Premium” sponsorship status with a credited value of $100 thousand per year for 3 years totaling $300 thousand. This “premium” sponsorship status provides the Company with certain benefits in marketing and networking, such as the Company being listed on the investor’s website, as well as providing the Company certain other promotional opportunities organized by the investor. The warrants were issued on January 23, 2020. There is no vesting period, and the warrants expire on December 20, 2024. On December 21, 2021, SCV executed a Notice of Exercise for certain of its warrants to purchase 27,168 shares of Class A Common Stock at an exercise price of $120.00 per share for a total purchase price of $3.26 million. The closing occurred on January 10, 2022 and resulted in total cash proceeds of $3.26 million to the Company for the warrant exercise. The warrants to purchase the remaining 34,974 shares of the Company’s Class A Common Stock remain outstanding as of December 31, 2023. August – December 2021 and January – February 2022 The Company issued 18,107 warrants from August 2021 to December 2021 and 1,028 warrants from January 2022 to February 2022 related to the Regulation CF, D, and S common stock and warrant offerings. These warrants became exercisable on January 26, 2022 when the Company received SEC qualification of its offering statement on Form 1-A. These warrants expire as of the earlier of: (a) January 26, 2023, (b) the acquisition of the Company by another entity, or (c) immediately prior to the closing of a firm commitment underwritten public offering. On August 25, 2022, we refunded $5,000 in units (comprised of common stock and warrants) sold in the Company’s Regulation CF offering to two investors resulting in the cancellation of 17 warrants. During the quarter ended December 31, 2022, investors exercised 190 warrants at an exercise price of $300.00 per share, resulting in total cash proceeds of $57 thousand to the Company for the warrant exercises. The warrants to purchase the remaining 18,928 shares of the Company’s Class A Common Stock expired on January 26, 2023 and are no longer outstanding as of December 31, 2023 September 14, 2022 On September 11, 2022, the Company entered into a Securities Purchase Agreement (the “SPA”) with Armistice Capital Master Fund Ltd. Pursuant to the terms of the SPA, the Company agreed, at the closing of the SPA, to sell and issue to the Armistice Capital Master Fund Ltd. in a private placement 13,000 shares of Class A Common Stock of the Company and warrants to purchase 26,000 shares of Class A Common Stock of the Company at an exercise price of $132.75 for a total purchase price of $1,511,250. The Company incurred offering costs of $90,675 from this transaction that were recorded as a reduction of the gross proceeds. The 26,000 warrants may be exercised at any time by Armistice Capital Master Fund Ltd. starting on the issuance date, September 14, 2022, until the five year and six-month anniversary thereafter. The warrants also allow for a “cashless exercise” if, at any time after the six (6) month anniversary of the issue date of the warrants there is no effective registration statement registering the resale of the Class A Common Stock issuable pursuant to the warrants. In such a case, then warrants may also be exercised, in whole or in part, by means of a cashless exercise in which Armistice Capital Master Fund Ltd. will be entitled to receive a number of shares of Class A Common Stock as described in the warrants. Trust Stamp filed the registration statement on September 30, 2022 and received the notice of effectiveness on January 26, 2023. On June 5, 2023, the Company entered into an Amendment to Existing Warrants agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Amendment to Existing Warrants, the exercise price for the warrants to purchase 26,000 shares of Class A Common Stock of the Company is reduced to $34.50 for a total purchase price of $897,000. In addition, the expiration date for the 26,000 warrants is amended allowing the exercise of the warrant at any time by Armistice Capital Master Fund Ltd. starting on the closing of the offering, June 5, 2023, until the five year anniversary thereafter. On August 18, 2023, the institutional investor exercised 18,000 warrants to purchase shares of Class A Common Stock of the Company at a price of $34.50 per warrant, resulting in an issuance by the Company of 18,000 shares of Class A Common Stock for total proceeds of $621,000. On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the warrants to purchase the remaining 8,000 shares of Class A Common Stock of the Company was reduced to $20.10 for a total purchase price of $160,800. On December 21, 2023, the remaining 8,000 common stock purchase warrants to purchase shares of Class A Common Stock of the Company at a price of $20.10 per warrant, resulting in an issuance by the Company of 8,000 shares of Class A Common Stock for total proceeds of $160,800. All warrants related to this investment have been exercised and are no longer outstanding as of December 31, 2023. April 18, 2023 On April 14, 2023, the Company entered into a securities purchase agreement (“SPA”) with Armistice Capital Master Fund Ltd. Pursuant to which the Company agreed to issue and sell to the investor (i) in a registered direct offering, 37,559 shares of Class A Common Stock, par value $0.01 per share of the Company at a price of $49.50 per share, and pre-funded warrants to purchase up to 67,330 shares of Class A Common Stock, at a price of $49.485 per prefunded warrant, at an exercise price of $0.015 per share of Class A Common Stock, and (ii) in a concurrent private placement, common stock purchase warrants, exercisable for an aggregate of up to 104,889 shares of Class A Common Stock, at an exercise price of $49.50 per share. On April 18, 2023, the Company sold 37,559 shares of Class A Common Stock to the institutional investor at a price of $49.50 per share for total proceeds $1,859,154. Additionally, on same date, the institutional investor purchased and exercised the 67,330 pre-funded warrants, for total proceeds to the Company of $3,332,835, resulting in an aggregate issuance by the Company of 104,889 shares of Class A Common Stock for net proceeds of $4,778,550 from the registered direct offering after deducting placement fee and legal expense of $363,439 and $50,000, respectively. On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the warrants to purchase the remaining 104,889 shares of Class A Common Stock of the Company was reduced to $20.10 for a total purchase price of $2,108,262. On December 21, 2023, the remaining 104,889 common stock purchase warrants to purchase shares of Class A Common Stock of the Company at a price of $20.10 per warrant were exercised for total proceeds of $2,108,262. As of December 31, 2023, the Company had received Notice to Exercise for 53,200 common stock purchase warrants resulting in an issuance by the Company of 53,200 shares of Class A Common Stock. Due to the beneficial ownership limitation provisions in the Inducement Agreement, as of December 31, 2023 the remaining 51,689 common stock purchase warrants exercised on December 21, 2023 were unissued and held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. On February 7, 2023 and February 27, 2023, the Company issued 21,334 and 30,356 shares, respectively. June 5, 2023 On June 1, 2023, the Company entered into a securities purchase agreement (“SPA”) with an Armistice Capital Master Fund Ltd. Pursuant to which the Company agreed to issue and sell to the investor (i) in a registered direct offering, 49,094 shares of Class A Common Stock, par value $0.01 per share of the Company at a price of $34.50 per share, and pre-funded warrants to purchase up to 36,220 shares of Class A Common Stock, at a price of $34.485 per prefunded warrant, at an exercise price of $0.015 per share of Class A Common Stock, and (ii) in a concurrent private placement, common stock purchase warrants, exercisable for an aggregate of up to 85,314 shares of Class A Common Stock, at an exercise price of $34.50 per share. On June 5, 2023, the Company sold 49,094 shares of Class A Common Stock to the institutional investor at a price of $34.50 per share for total proceeds of $1,693,720. Additionally, on same date, the institutional investor purchased the 36,220 pre-funded warrants at a price of $34.485 per prefunded warrant, for total proceeds to the Company of $1,249,047, resulting in an issuance by the Company of 49,094 shares of Class A Common Stock for net proceeds of $2,686,773 from the registered direct offering after deducting placement fee and legal expense of $205,994 and $50,000, respectively. On June 12, 2023, the institutional investor exercised 21,487 pre-funded warrants at a price of $0.015 per prefunded warrant, resulting in an issuance by the Company of 21,487 shares of Class A Common Stock for total proceeds of $322. Additionally, on June 23, 2023, the institutional investor exercised 14,734 pre-funded warrants at a price of $0.015 per prefunded warrant, resulting in an issuance by the Company of 14,734 shares of Class A Common Stock for total proceeds of $221. On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the common stock purchase warrants to purchase the remaining 85,314 shares of Class A Common Stock of the Company was reduced to $20.10 for a total purchase price of $1,714,798. On December 21, 2023, the institutional investor exercised 7,112 warrants to purchase shares of Class A Common Stock of the Company at a price of $20.10 per warrant for total proceeds of $142,938. As of December 31, 2023, due to the beneficial ownership limitation provisions in the Inducement Agreement, the 7,112 warrants were unissued and held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. These shares were subsequently issued on February 27, 2023. The common stock purchase warrants to purchase 85,314 shares of the Company’s Class A Common Stock remain outstanding as of December 31, 2023. December 21, 2023 On December 21, 2023, the Company entered into a warrant exercise agreement (the “WEA”) with a certain existing institutional investor, pursuant to which the institutional investor agreed to exercise (the “Exercise”) (i) a portion (7,112) of the warrants issued to the institutional investor on June 5, 2023, which are exercisable for 85,314 shares of the Company’s Class A Common Stock, par value $0.01 per share (“Class A Common Stock”) with a current exercise price of $34.50 per share (the “June 2023 Warrants”), (ii) all of the warrants issued to the institutional investor on September 14, 2022, as amended on June 5, 2023, which are exercisable for 8,000 shares of Class A Common Stock, with a current exercise price of $34.50 per share (the “September 2022 Warrants”), and (iii) all of the warrants issued to the institutional investor on April 18, 2023, which are exercisable for 104,889 shares of Class A Common Stock, with a current exercise price of $49.50 per share (the “April 2023 Warrants” and collectively with all of the June 2023 Warrants and the September 2022 Warrants, the “Existing Warrants”). In consideration for the immediate exercise of 120,000 of the Existing Warrants for cash, the Company agreed to reduce the exercise price of all of the Existing Warrants, including any unexercised portion thereof, to $20.10 per share, which is equal to the most recent closing price of the Company’s Class A Common Stock on The Nasdaq Stock Market prior to the execution of the WEA. As of December 31, 2023, Armistice had submitted an Exercise Notice for 61,200 Existing Warrants and the shares of Class A Common Stock were issued to the warrant holders. The remaining 58,800 Existing Warrants from this exercise are held in abeyance until the Company receives notice from the holders that the remaining shares may be issued in compliance with the beneficial ownership limitation. As of the date of this report, the remaining 58,800 Existing Warrants have been issued. In addition, in consideration for such Exercise, the Selling Stockholder received new unregistered warrants to purchase up to an aggregate of 240,000 shares of Class A Common Stock, equal to 200% of the shares of Class A Common Stock issued in connection with the Exercise, with an exercise price of $20.10 per share (the “New Warrants”) in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933 (the “Securities Act”). All 240,000 of the New Warrants remain outstanding as of December 31, 2023.

Balance Sheet Components_2

Balance Sheet Components	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Balance Sheet Components
Balance Sheet Components	5. Balance Sheet Components Prepaid expenses and other current assets Prepaid expenses and other current assets as of September 30, 2024 and December 31, 2023 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Prepaid operating expenses ​ $ 253,973 ​ $ 216,875 Rent deposit ​ ​ 27,458 ​ ​ 28,400 Value added tax receivable ​ ​ 48,177 ​ ​ 116,095 Tax credit receivable (short-term) ​ ​ 25,045 ​ ​ 102,151 Miscellaneous receivable ​ ​ 859,271 ​ ​ 363,260 Prepaid expenses and other current assets ​ $ 1,213,924 ​ $ 826,781 ​ Capitalized internal-use software, net Capitalized internal-use software, net as of as of September 30, 2024 and December 31, 2023 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Internally developed software ​ 5 Years ​ $ 4,363,338 ​ $ 3,901,801 Less: Accumulated depreciation ​ ​ ​ ​ (2,830,981) ​ ​ (2,429,427) Capitalized internal-use software, net ​ ​ ​ $ 1,532,357 ​ $ 1,472,374 ​ Amortization expense is recognized on a straight-line basis and during the three months ended September 30, 2024 and 2023 totaled $141 thousand and $140 thousand, respectively. Amortization expense during the nine months ended September 30, 2024 and 2023 totaled $419 thousand, respectively. As of September 30, 2024, the Company determined that $24 thousand of Capitalized internal-use software were impaired. The impaired Capitalized internal-use software was expensed to Research and development Property and equipment, net Property and equipment, net as of as of September 30, 2024 and December 31, 2023 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Computer equipment ​ 3-4 Years ​ $ 154,181 ​ $ 152,014 Furniture and fixtures ​ 10 Years ​ ​ 34,675 ​ ​ 28,052 Property and equipment, gross ​ ​ ​ ​ 188,856 ​ ​ 180,066 Less: Accumulated depreciation ​ ​ ​ ​ (149,031) ​ ​ (123,630) Property and equipment, net ​ ​ ​ $ 39,825 ​ $ 56,436 ​ Depreciation expense is recognized on a straight-line basis and during the three months ended September 30, 2024 and 2023 totaled $8 thousand and $10 thousand, respectively. Depreciation expense during the nine months ended September 30, 2024 and 2023 totaled $27 thousand and $62 thousand, respectively. ​ Accrued expenses Accrued expenses as of September 30, 2024 and December 31, 2023 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Compensation payable ​ $ 672,587 ​ $ 377,403 Commission liability ​ ​ 19,885 ​ ​ 26,863 Accrued employee taxes ​ ​ 890,411 ​ ​ 624,525 Other accrued liabilities ​ ​ 87,377 ​ ​ 115,099 Accrued expenses ​ $ 1,670,260 ​ $ 1,143,890 ​	4. Balance Sheet Components Prepaid expenses and other current assets Prepaid expenses and other current assets as of December 31, 2023 and 2022 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ 2023 2022 Prepaid operating expenses ​ $ 216,875 ​ $ 225,756 Rent deposit ​ 28,400 ​ 55,981 Value added tax receivable ​ 116,095 ​ 71,742 Tax credit receivable (short-term) ​ ​ 102,151 ​ ​ 218,239 Miscellaneous receivable ​ 363,260 ​ 8,368 Prepaid expenses and other current assets ​ $ 826,781 ​ $ 580,086 ​ Capitalized internal-use software, net Capitalized internal-use software, net as of December 31, 2023 and 2022 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Internally developed software 5 Years $ 3,901,801 ​ $ 3,314,450 Less: Accumulated depreciation ​ ​ (2,429,427) ​ (1,895,778) Capitalized internal-use software, net ​ ​ ​ $ 1,472,374 ​ $ 1,418,672 ​ Amortization expense is recognized on a straight-line basis and for the years ended December 31, 2023 and 2022 totaled $557 thousand and $517 thousand, respectively. ​ The Company determined that as of December 31, 2023, $19 thousand of Capitalized internal - use software was impaired. The impaired Capitalized internal - use software was expensed to Research and development during the year ended December 31, 2023. ​ Property and equipment, net Property and equipment, net as of December 31, 2023 and 2022 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Computer equipment 3-4 Years ​ $ 152,014 ​ $ 148,832 Furniture and fixtures 10 Years ​ 28,052 ​ 27,220 Mobile hardware ​ 2.5 years ​ ​ — ​ ​ 297,150 Property and equipment, gross ​ ​ ​ 180,066 ​ 473,202 Less: Accumulated depreciation ​ ​ ​ (123,630) ​ (172,538) Property and equipment, net ​ ​ ​ $ 56,436 ​ $ 300,664 ​ Depreciation expense is recognized on a straight-line basis and for the years ended December 31, 2023 and 2022 totaled $72 thousand and $136 thousand, respectively. On April 26, 2023, the Company sold a portion of the mobile hardware for a gross sales price of $180 thousand and a gain of $108 thousand. On May 26, 2023, the Company sold another portion of the mobile hardware for a gross sales price of $197 thousand and a gain of $108 thousand. Accrued expenses ​ Accrued expenses as of December 31, 2023 and 2022 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Compensation payable ​ $ 377,403 ​ $ 171,851 Commission liability ​ ​ 26,863 ​ ​ 58,771 Accrued employee taxes ​ 624,525 ​ 591,992 Accrued mobile expenses ​ ​ — ​ ​ 177,099 Other accrued liabilities ​ 115,099 ​ 100,111 Accrued expenses ​ $ 1,143,890 ​ $ 1,099,824 ​

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Goodwill and Intangible Assets
Goodwill and Intangible Assets, Net	6. Goodwill and Intangible Assets, Net There were no changes in the carrying amount of Goodwill for the nine months ended September 30, 2024. Intangible assets, net as of September 30, 2024 and December 31, 2023 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Patent application costs ​ 3 Years ​ $ 555,918 ​ $ 484,035 Trade name and trademarks ​ 3 Years ​ ​ 71,033 ​ ​ 70,446 Intangible assets, gross ​ ​ ​ ​ 626,951 ​ ​ 554,481 Less: Accumulated amortization ​ ​ ​ ​ (433,647) ​ ​ (330,791) Intangible assets, net ​ ​ ​ $ 193,304 ​ $ 223,690 ​ The Company added 6 new issued patents during the nine months ended September 30, 2024. The patents issued during the nine months ended September 30, 2024 increased our total number of patents to 23 and include: ● On January 2, 2024, the Company received Notice of Issuance for a patent that is a continuation of “Systems and Processes for Lossy Biometric Representation.” This patent is a continuation addresses a long-felt but unresolved need for a system or process that can transform size-variant, personally-identifying biometric templates into fixed-size, privacy-secured representations, while maintaining sufficiently accurate biometric matching capabilities. ● On January 30, 2024, the Company received Notice of Issuance for a patent that is a continuation of “Systems and Processes for Lossy Biometric Representation.” This technology provides a system or process that can transform size-variant, personally-identifying biometric templates into fixed-size, privacy-secured representations, while maintaining sufficiently accurate biometric matching capabilities. ● On March 19, 2024, the Company received Notice of Issuance for a patent entitled “Systems and Methods for Enhanced Hash Transforms.” Conventional cryptographic hashing techniques generally include functions that generate unique signatures given a piece of data, accepting binary strings of characters as an input, and producing a string (e.g., a digital signature) as an output. Our new patent addresses the need for improved techniques for securely handling sensitive data. ● On April 23, 2024, the Company received Notice of Issuance for a patent entitled “Face Cover-compatible Biometrics and Processes for Generating and Using Same.” which allows for enrollment of biometric information from individuals wearing face coverings such that subsequent biometric identification and verification processes may not require the individuals to remove their face coverings. ● On April 30, 2024, the Company received Notice of Issuance for a patent entitled “Systems and Methods for Liveness-verified, Biometric-based Encryption.” This patent fulfills a long-felt but unresolved need for a system or method that permits encryption/decryption based on liveness-verified biometric data that cannot be stolen or spoofed. ● On September 3, 2024 the Company received Notice of Issuance by the US Patent of Trademark Office of Patent No. 17/719,975 entitled, “Personal Identifiable Information Encoder.” This technology provides the means to maintain the essential utility of PII without storing highly sensitive data. Anyone processing or storing PII should embrace this technology to fulfill their data protection obligations and mitigate damage and losses in the event of a data breach.” Intangible asset amortization expense is recognized on a straight-line basis and during the three months ended September 30, 2024 and 2023 totaled $32 thousand and $40 thousand, respectively. Intangible asset amortization expense during the nine months ended September 30, 2024 and 2023 totaled $102 thousand and $115 thousand, respectively. Estimated future amortization expense of Intangible assets, net is as follows: ​ ​ ​ ​ ​ Years Ending December 31, Amount 2024 ​ $ 31,949 2025 ​ ​ 99,005 2026 ​ ​ 52,529 2027 ​ ​ 9,821 Total future amortization ​ $ 193,304 ​	5. Goodwill and Intangible Assets, Net There were no changes in the carrying amount of Goodwill for the years ended December 31, 2023 and 2022. Intangible assets, net as of December 31, 2023 and 2022 consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Patent application costs 3 Years ​ $ 484,035 ​ $ 382,285 Trade name and trademarks 3 Years ​ 70,446 ​ 68,356 Intangible assets, gross ​ ​ 554,481 ​ 450,641 Less: Accumulated amortization ​ ​ (330,791) ​ (198,955) Intangible assets, net ​ ​ ​ $ 223,690 ​ $ 251,686 ​ The Company determined that as of December 31, 2023, $12 thousand of Patent application costs were impaired. The impaired Patent application costs were expensed to Selling, general, and administrative expense during the year ended December 31, 2023. The Company added 4 patents and 1 trademark during the year ended December 31, 2023. The patents issued during the year ended December 31, 2023 increased our total number of patents to 17 and include: ● On August 29, 2023, the Company received Notice of Issuance together with a Notice of Allowance on August 17, 2023 both entitled “Systems and Processes for Lossy Biometric Representation.” These patents further expand our intellectual property portfolio related to the tokenization of biometric data and broaden our patent coverage by removing the necessity to use a neural network in our irreversible transformation process. ● On August 15, 2023, the Company received Notice of Issuance for a patent entitled “Systems and Methods for Identity Authentication via Third Party Accounts.” This technology, while leveraging our core privacy-first technologies, provides an optional interlock between different types of user accounts benefiting from the strengths that each can offer in terms of user authentication to produce a more resilient user-centric ecosystem. ● On July 25, 2023, the Company received Notice of Issuance for a patent entitled “Systems and Methods for Privacy-Secured Biometric Identification and Verification.” For the last six years we have invested heavily in research and development which has created a solid foundation for our current and future generations of cutting edge, privacy-first identity products and this patent reflects our systems and methods for matching an encrypted biometric input record with stored encrypted biometric record without data decryption of the input and at least one stored record. ● On June 20, 2023, the Company received Notice of Issuance for a patent entitled “Ownership Validation for Cryptographic Asset Contracts Using Irreversibly Transformed Identity Tokens.” This technology expands the range of use cases for the IT2 into NFT’s and the Metaverse by verifying the ownership of cryptographic asset contracts using embedded IT2 technology. Cryptographic assets are typically associated with a particular digital address (“digital wallet”) which are vulnerable to fraud, pilferage, and user errors. The new patent addresses the long-felt but unresolved need for improved systems and processes for validating ownership of cryptographic assets. Intangible asset amortization expense is recognized on a straight-line basis and for the years ended December 31, 2023 and 2022 totaled $160 thousand and $107 thousand, respectively. Estimated future amortization expense of Intangible assets, net is as follows: ​ ​ ​ ​ ​ Years Ending December 31, Amount 2024 ​ ​ 120,078 2025 ​ 75,043 2026 ​ ​ 28,569 ​ ​ $ 223,690 ​

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2023
Income Taxes
Income Taxes	6. Income Taxes Net loss before taxes consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 U.S. ​ $ (4,433,956) ​ $ (7,911,970) Non-U.S. ​ (3,217,171) ​ (4,158,494) Net loss before taxes ​ $ (7,651,127) ​ $ (12,070,464) ​ The components of income tax benefit (expense) are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Current: ​ ​ ​ ​ ​ ​ U.S. Federal ​ $ — ​ $ — U.S. State ​ 2,425 ​ 5,166 Non-U.S. ​ ​ (15,910) ​ ​ 15,910 ​ ​ $ (13,485) ​ $ 21,076 Deferred: ​ ​ ​ ​ ​ ​ U.S. Federal ​ $ — ​ $ — U.S. State ​ ​ — ​ ​ — Non-U.S. ​ ​ — ​ ​ — ​ ​ $ — ​ $ — Total income tax benefit (expense) ​ $ (13,485) ​ $ 21,076 ​ A reconciliation of the expected tax provision (benefit) at the statutory federal income tax rate to the Company’s recorded tax provision (benefit) consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Expected tax provision (benefit) at U.S. federal statutory rate ​ $ (1,606,737) ​ $ (2,534,797) State income taxes, net of federal benefit ​ 1,560 ​ 4,081 Foreign tax rate differential ​ (400,110) ​ (494,278) Change in valuation allowance ​ 1,869,814 ​ 3,146,272 Stock compensation ​ ​ 296,887 ​ ​ 19,730 Credits ​ ​ (181,270) ​ ​ (158,085) Prior year deferred tax adjustments ​ ​ (84,169) ​ ​ — Other ​ 90,540 ​ 38,153 Total provision (benefit) for income taxes ​ $ (13,485) ​ $ 21,076 ​ Temporary differences that give rise to significant portions of the deferred tax assets are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Deferred Tax Assets: ​ ​ Net operating losses ​ $ 8,330,939 ​ $ 7,082,125 Section 174 ​ ​ 943,401 ​ ​ 463,749 Tax credits ​ 516,330 ​ 335,060 Equity compensation ​ 1,476,296 ​ 1,660,684 Lease liability ​ ​ 3,934 ​ ​ 12,292 Other - accruals ​ ​ 17,448 ​ ​ 4,937 Other ​ 36,431 ​ 14,634 Total Deferred Tax Assets ​ 11,324,779 ​ 9,573,481 Deferred Tax Liabilities: ​ ​ ​ ​ Capitalized internal-use software, net ​ (88,041) ​ (198,051) Right-of-use asset ​ ​ (3,787) ​ ​ (12,082) Total Deferred Tax Liabilities ​ (91,828) ​ (210,133) Net Deferred Tax Assets ​ 11,232,951 ​ 9,363,348 Valuation allowance ​ (11,232,951) ​ (9,363,348) Deferred Tax Assets, Net ​ $ — ​ $ — ​ Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences are deductible. In making this determination, management considers all available positive and negative evidence affecting specific deferred tax assets, including the Company’s past and anticipated future performance, the reversal of deferred tax liabilities, the length of carry-back and carry-forward periods, and the implementation of tax planning strategies. Objective positive evidence is necessary to support a conclusion that a valuation allowance is not needed for all or a portion of deferred tax assets when significant negative evidence exists. The Company’s cumulative losses in recent years are the most compelling form of negative evidence considered by management in making this determination. For the years ended December 31, 2023 and 2022, the net increase in the total valuation allowance was $1,901,622 and $3,146,272, respectively, and management has determined that based on all available evidence, a valuation allowance of $11,232,951 and 9,363,348 is appropriate at December 31, 2023 and 2022, respectively. At December 31, 2023, the Company had Federal net operating loss carrying forwards of $19,127,170. Net operating losses generated for years ending December 31, 2017 and prior total $574,051 and will expire in 2037. Net operating losses generated beginning in 2018 total $18,553,119 and have an indefinite life. At December 31, 2023, the Company had state net operating loss carry forwards of $3,743,893. State net operating losses generated for years ending December 31, 2017 and prior total $574,051 and will expire in 2037. Net operating losses generated beginning in 2018 total $3,169,842 and have an indefinite life. At December 31, 2023, the Company had foreign net operating loss carry forwards of $11,859,008 with an indefinite carry forward period. Foreign net operating losses of $975,242 will begin to expire in 2026. Included in the balance of unrecognized tax benefit as of December 31, 2023 and December 31, 2022, are $129,082 and $83,765, respectively, of tax benefits that, if recognized, would affect the effective tax rate. The Company recognizes accrued interest related to unrecognized tax expenses and penalties as income tax expense. Related to the unrecognized tax benefits noted above, the Company accrued $0 of interest during 2023, and $0 of penalty, and in total, as of December 31, 2023 has recognized $0 of interest and penalty. The Company is subject to taxation in the US and various state jurisdictions. As of December 31, 2023 the Company’s tax returns for 2020, 2021, and 2022 are subject to full examination by the tax authorities. As of December 31, 2023, the Company is generally no longer subject to state or local examinations by tax authorities for years before 2020, except to the extent of NOLs generated in prior years claimed on a tax return.

Net Loss per Share Attributab_5

Net Loss per Share Attributable to Common Stockholders	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Net Loss per Share Attributable to Common Stockholders
Net Loss per Share Attributable to Common Stockholders	7 . Net Loss per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Numerator: ​ ​ ​ ​ ​ ​ ​ ​ Net loss attributable to common stockholders ​ $ (1,255,915) ​ $ (35,162) ​ $ (6,532,845) ​ $ (4,752,980) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares used in computing net loss per share attributable to common stockholders ​ ​ 1,181,150 ​ ​ 543,708 ​ 891,211 ​ 443,880 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net loss per share attributable to common stockholders ​ $ (1.06) ​ $ (0.06) ​ $ (7.33) ​ $ (10.71) ​ The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been anti-dilutive: ​ ​ ​ ​ ​ ​ ​ ​ As of September 30, ​ 2024 2023 Options, RSUs, and grants ​ 106,434 ​ 52,761 Warrants ​ 1,798,643 ​ 301,880 Total ​ 1,905,077 ​ 354,641 ​	7. Net Loss per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Numerator: ​ ​ ​ ​ ​ ​ Net loss attributable to common stockholders ​ $ (7,637,642) ​ $ (12,091,540) ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ Weighted average shares used in computing net loss per share attributable to common stockholders ​ 475,171 ​ ​ 315,518 ​ ​ ​ ​ ​ ​ ​ Net loss per share attributable to common stockholders ​ $ (16.07) ​ $ (38.32) ​ The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been anti-dilutive: ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Options, RSUs, and grants ​ 60,741 ​ 49,625 Warrants ​ 432,202 ​ 111,742 Total ​ 492,943 ​ 161,367 ​

Stock Awards and Stock-Based _8

Stock Awards and Stock-Based Compensation	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Stock Awards and Stock-Based Compensation
Stock Awards and Stock-Based Compensation	8. Stock Awards and Stock-Based Compensation From time to time, the Company may issue stock awards in the form of Class A Common Stock grants, Restricted Stock Units (RSUs), or Class A Common Stock options with vesting/service terms. Stock awards are valued on the grant date using the Company’s common stock share price quoted on an active market. Stock options are valued using the Black-Scholes-Merton pricing model to determine the fair value of the options. We generally issue our awards in terms of a fixed monthly value, resulting in a variable number of shares being issued, or in terms of a fixed monthly share number. Stock Options The following table summarizes stock option activity for the three and nine months ended September 30, 2024: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ Options Exercise Price Contractual Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2023 25,808 ​ $ 96.00 1.45 ​ $ — Options granted 793 ​ 34.20 — ​ — Options exercised (82) ​ 48.75 — ​ — Options canceled and forfeited ​ (280) ​ ​ 85.95 ​ — ​ ​ — Balance as of December 31, 2023 ​ 26,239 ​ ​ 94.05 ​ 1.95 ​ ​ — Options granted ​ 255 ​ ​ 23.55 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited (95) ​ 63.15 — ​ — Balance as of March 31, 2024 ​ 26,399 ​ ​ 93.60 ​ 1.72 ​ ​ — Options granted ​ 292 ​ ​ 20.55 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited (34) ​ 58.80 — ​ — Balance as of June 30, 2024 26,657 ​ 92.85 1.49 ​ — Options granted ​ 437 ​ ​ 13.80 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited ​ (102) ​ ​ 58.80 ​ — ​ ​ — Options vested and exercisable as of September 30, 2024 26,992 ​ $ 91.65 1.27 ​ ​ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ ​ Options ​ Exercise Price ​ Contractual ​ Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2024 ​ 26,239 ​ $ 94.05 1.95 ​ $ — Options granted ​ 984 ​ ​ 18.30 — ​ ​ — Options exercised ​ — ​ ​ — — ​ ​ — Options canceled and forfeited ​ (231) ​ ​ 60.30 — ​ ​ — Balance as of September 30, 2024 ​ 26,992 ​ ​ 91.65 1.27 ​ ​ — Options vested and exercisable as of September 30, 2024 ​ 26,992 ​ $ 91.65 ​ 1.27 ​ $ — ​ The aggregate intrinsic value of options outstanding, exercisable, and vested is calculated as the difference between the exercise price of the underlying options and the fair value of the Company’s common stock. The aggregate intrinsic value of options exercised during the nine months ended September 30, 2024 and 2023 was $0. The weighted average grant-date fair value of options granted during the nine months ended September 30, 2024 and 2023 was $4.35 and $18.75 per share, respectively. The total grant-date fair value of options that vested during the nine months ended September 30, 2024 and 2023 was $4 thousand and $10 thousand, respectively. The following assumptions were used to calculate the fair value of options granted during the nine months ended September 30, 2024: ​ ​ ​ ​ ​ ​ Fair value of Class A Common Stock $ 0.90 — 10.80 ​ Exercise price ​ $ 12.00 — 24.60 ​ Risk free interest rate ​ ​ 3.51 — 4.71 % Expected dividend yield ​ ​ 0.00 % Expected volatility ​ ​ 77.54 — 79.80 % Expected term ​ ​ 3 Years ​ As of September 30, 2024, the Company had 26,992 stock options outstanding of which all are fully vested options. Stock Grants As of September 30, 2024, the Company has 6,680 common stock grants outstanding of which 5,475 were vested but not issued and 1,205 were not yet vested. All granted and outstanding common stock grants will fully vest by September 30, 2025. The Company had unrecognized stock-based compensation related to common stock grants of $6 thousand as of September 30, 2024. RSU As of September 30, 2024, the Company had 72,762 RSUs outstanding of which 3,428 were vested but not issued and 69,335 were not yet vested. All granted and outstanding RSUs will fully vest by January 2, 2025. The Company had unrecognized stock-based compensation related to RSUs of $343 thousand as of September 30, 2024. During the nine months ended September 30, 2024 the Company issued 3,649 of Class A Common Stock to employees that were designated for employee stock awards and were previously recorded as treasury stock. A summary of outstanding RSU activity as of September 30, 2024 is as follows: ​ ​ ​ ​ ​ RSU Outstanding ​ ​ Number of Shares Balance as of January 1, 2023 19,505 Granted 27,368 Vested (issued) (10,652) Forfeited (6,481) Balance as of December 31, 2023 29,740 Granted 69,335 Vested (issued) (21,255) Forfeited (5,058) Balance as of September 30, 2024 72,762 ​ Stock-based compensation expense Our consolidated statements of operations include stock-based compensation expense as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Cost of services ​ $ 3,144 ​ $ 11,169 ​ $ 3,406 ​ $ 11,825 Research and development ​ ​ 23,878 ​ ​ 48,336 ​ 38,087 ​ 79,956 Selling, general, and administrative ​ ​ 324,571 ​ ​ 88,535 ​ 915,110 ​ 213,569 Total stock-based compensation expense ​ $ 351,593 ​ $ 148,040 ​ $ 956,603 ​ $ 305,350 ​	8. Stock Awards and Stock-Based Compensation From time to time, the Company may issue stock awards in the form of Class A Common Stock grants, Restricted Stock Units (RSUs), or Class A Common Stock options with vesting/service terms. Stock awards are valued on the grant date using the Company’s common stock share price quoted on an active market. Stock options are valued using the Black-Scholes-Merton pricing model to determine the fair value of the options. We generally issue our awards in terms of a fixed monthly value, resulting in a variable number of shares being issued, or in terms of a fixed monthly share number. During the years ended December 31, 2023 and 2022, the Company entered into agreements with advisory board members and other external advisors to issue cash payments and stock awards in exchange for services rendered to the Company monthly. The total granted stock-based awards to advisory board members and other external advisors during the years ended December 31, 2023 and 2022 included grants totaling, $6 thousand and $49 thousand, respectively, options totaling $0, and RSUs totaling $36 thousand and $190 thousand, respectively. In addition to issuing stock awards to advisory board members and other external advisors, during the years ended December 31, 2023 and 2022, the Company granted stock-based awards to multiple employees. The total granted stock-based awards to employees during the years ended December 31, 2023 and 2022 included grants totaling, $82 thousand and $307 thousand, respectively, options totaling $12 thousand and $57 thousand, respectively, and RSUs totaling $627 thousand and $1.80 million, respectively. The following table summarizes stock option activity for the years ended December 31, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ ​ Options ​ Exercise Price ​ Contractual ​ Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2023 ​ ​ 25,808 ​ $ 96.00 1.45 ​ $ — Options granted ​ ​ 793 ​ ​ 34.20 ​ ​ ​ ​ ​ Options exercised ​ ​ (82) ​ ​ 48.75 ​ ​ ​ ​ ​ Options canceled and forfeited ​ ​ (280) ​ ​ 85.95 ​ ​ ​ ​ ​ Balance as of December 31, 2023 ​ ​ 26,239 ​ ​ 94.05 ​ 1.95 ​ ​ — Options vested and exercisable as of December 31, 2023 ​ ​ 26,239 ​ $ 94.05 1.95 ​ ​ — ​ The aggregate intrinsic value of options outstanding, exercisable, and vested is calculated as the difference between the exercise price of the underlying options and the fair value of the Company’s common stock. The aggregate intrinsic value of options exercised during the years ended December 31, 2023 and 2022 was $0. The weighted average grant-date fair value of options granted during the years ended December 31, 2023 and 2022 was $16.20 and $ 114.75 per share, respectively. The total grant-date fair value of options that vested during the years ended December 31, 2023 and 2022 was $12 thousand and $57 thousand, respectively. The following assumptions were used to calculate the fair value of options granted during the year ended December 31, 2023: ​ ​ ​ ​ ​ Fair value of Class A Common Stock $ 5.70 – 25.05 ​ Exercise price ​ $ 26.70 – 46.35 ​ Risk free interest rate ​ 3.76 - 4.89 % Expected dividend yield ​ 0.00 % Expected volatility ​ 79.08– 96.45 % Expected term ​ 3 Years ​ As of December 31, 2023, the Company had 26,239 stock options outstanding of which all are fully vested options. As of December 31, 2023, the Company has 4,761 common stock grants outstanding of which 4,012 were vested but not issued and 750 were not yet vested. All granted and outstanding common stock grants will fully vest by December 31, 2024. The Company had unrecognized stock-based compensation related to common stock grants of $9 thousand as of December 31, 2023. As of December 31, 2023, the Company had 29,740 RSUs outstanding of which 3,187 were vested but not issued and 26,553 were not yet vested. All granted and outstanding RSUs will fully vest by August 1, 2024. The Company had unrecognized stock-based compensation related to RSUs of $25 thousand as of December 31, 2023. A summary of outstanding RSU activity as of December 31, 2023 is as follows: ​ ​ ​ ​ ​ RSU Outstanding ​ ​ Number of Shares Balance as of January 1, 2022 8,460 Granted 14,114 Vested (issued) (3,070) Forfeited — Balance as of December 31, 2022 19,504 Granted 27,368 Vested (issued) (10,652) Forfeited (6,480) Balance as of December 31, 2023 29,740 ​ Stock-based compensation expense Our consolidated statements of operations include stock-based compensation expense as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ ​ 2023 2022 Cost of services ​ $ 21,836 ​ $ 21,721 Research and development ​ 123,109 ​ 292,084 Selling, general, and administrative ​ 618,343 ​ 2,085,258 Total stock-based compensation expense ​ $ 763,288 ​ $ 2,399,063 ​

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2023
Stockholders' Equity
Stockholders' Equity	9. Stockholders’ Equity Common Stock The Class A Shares and Class B Shares are identical in all respects except as stated below. The holders of Class A Shares are entitled to one vote for each Class A Share held at all meetings of stockholders. Except as required by applicable law, the holders of Class B Shares shall have no voting rights with respect to such shares; provided, that the holders of Class B shares shall be entitled to vote (one vote for each Class B Share held) to the same extent that the holders of Class A Shares would be entitled to vote on matters as to which non-voting equity interests are permitted to vote. Preferred Stock Liquidation Rights Voting Rights Dividends

Related Party Transactions_2

Related Party Transactions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Related Party Transactions
Related Party Transactions	9. Related Party Transactions Related party payables of $48 thousand and $82 thousand as of September 30, 2024 and December 31, 2023, respectively, primarily relate to amounts owed to 10Clouds, the Company’s contractor for software development and investor in the Company, and smaller amounts payable to members of management as expense reimbursements. Total costs incurred in relation to 10Clouds for the three months ended September 30, 2024 and 2023, totaled approximately $1 thousand and $164 thousand, respectively. Total costs incurred in relation to 10Clouds for the nine months ended September 30, 2024 and 2023, totaled approximately $112 thousand and $699 thousand, respectively. Mutual Channel Agreement On November 15, 2020, the Company entered into a Mutual Channel Agreement with Vital4Data, Inc., a company at which one of our Directors serves as Chief Executive Officer. Pursuant to the agreement, the Company engaged Vita4Data, Inc. as a non-exclusive sales representative for the Company’s products and services. Vital4Data, Inc. is entitled to compensation in the form of commissions, receiving a 20% of commission-eligible on net revenue from sales generated by Vital4Data, Inc. in the first year of the contract term, which is reduced to 10% in the second year, and 5% in the third year. The Company has not earned or expensed any commissions pursuant to the Vital4Data, Inc. agreement to date. As of September 30, 2024 and December 31, 2023, the Vital4Data, Inc. commission due was $0.	10. Related Party Transactions Related party payables of $82 thousand and $273 thousand as of December 31, 2023 and 2022, respectively, primarily relate to amounts owed to 10Clouds, the Company’s contractor for software development and investor in the Company, and smaller amounts payable to members of management as expense reimbursements. Total costs incurred in relation to 10Clouds for the years ended December 31, 2023 and 2022, totaled approximately $816 thousand and $935 thousand, respectively. Legal Services A member of management provides legal services to the Company from a law firm privately owned and separate from the Company. Certain services are provided to the Company through this law firm. Total expenses incurred by the Company in relation to these services totaled $0 and $138 thousand during the years ended December 31, 2023 and 2022, respectively. Amounts payable as of December 31, 2023 and 2022 were $0. Options Agreement The Company has agreed, with effect from November 13, 2020, to grant a three-year loan in the amount of $335 thousand with an abated interest rate of 0.25% per annum to an advisory contractor to purchase 18,777 options. The options provide for the right to acquire shares of Class A Common Stock at a strike price of $ 90.00 per share. The options have no vesting period and will expire in November 2023. The loan was repaid with in-kind services from the contractor at a rate of $9 thousand per month for 36 months with the first payment receipt in April 2020 and the final payment received in February 2023. As of December 31, 2023 and 2022, the shareholder loan balances were $0 and $19 thousand, respectively. Mutual Channel Agreement On November 15, 2020, the Company entered into a Mutual Channel Agreement with Vital4Data, Inc., a company at which one of our Directors serves as Chief Executive Officer. Pursuant to the agreement, the Company engaged Vita4Data, Inc. as a non-exclusive sales representative for the Company’s products and services. Vital4Data, Inc. is entitled to compensation in the form of commissions, receiving a 20% of commission-eligible on net revenue from sales generated by Vital4Data, Inc. in the first year of the contract term, which is reduced to 10% in the second year, and 5% in the third year. The Company has not earned or expensed any commissions pursuant to the Vital4Data, Inc. agreement to date. As of December 31, 2023 and 2022, the Vital4Data, Inc. commission due was $0 .

Malta Grant_2

Malta Grant	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Malta Grant
Malta Grant	10 . Malta Grant During July 2020 the Company entered into an agreement with the Republic of Malta that would provide for a grant of up to €200 thousand or $251 thousand as reimbursement for operating expenses over the first twelve months following Trust Stamp Malta’s incorporation in the Republic of Malta. The Company must provide an initial capital amount of €50 thousand or $62 thousand, which is matched with a €50 thousand or $62 thousand grant. The remaining €150 thousand or $190 thousand are provided as reimbursement of operating expenses twelve months following incorporation. U.S. GAAP does not provide authoritative guidance regarding the receipt of economic benefits from government entities in return for compliance with certain conditions. Therefore, based on ASC 105-10-05-2, non-authoritative accounting guidance from other sources was considered by analogy in determining the appropriate accounting treatment, the Company elected to apply International Accounting Standards 20 – Accounting for Government Grants and Disclosure of Government Assistance and recognizes the expected reimbursements from the Republic of Malta as deferred income. As reimbursable operating expenses are incurred, a receivable is recognized (reflected within “Prepaid expenses and other current assets” in the consolidated balance sheets) and income is recognized in a similar systematic basis over the same periods in the consolidated statements of operations. During the nine months ended September 30, 2023, the Company incurred $0 in expenses that are reimbursable under the grant. As of September 30, 2024, all amounts provided for under this grant were received. On January 25, 2022, the Company entered into an additional agreement with the government of Malta for a grant of up to €100 thousand or $107 thousand, in terms of the ‘Investment Aid to produce the COVID-19 Relevant Product’ program, to support the proposed investment. The estimated value of the grant is €137 thousand or $146 thousand, at an aid intensity of 75% to cover eligible wage costs incurred after February 1, 2022 in relation to new employees engaged specifically for the implementation of the project. On September 22, 2022, the Company entered into an amendment agreement that enables the Company to submit eligible employee expenses for reimbursement by October 31, 2022. The grant was approved in January 2022, however, the request for payment was not approved and management abandoned the agreement. Hence, during the nine months ended September 30, 2024 and 2023, the Company incurred $0, respectively, in expenses that are reimbursable under the grant. As of September 30, 2024, no amounts provided under this grant were received.	11. Malta Grant During July 2020 the Company entered into an agreement with the Republic of Malta that would provide for a grant of up to €200 thousand or $251 thousand as reimbursement for operating expenses over the first twelve months following Trust Stamp Malta’s incorporation in the Republic of Malta. The Company must provide an initial capital amount of €50 thousand or $62 thousand, which is matched with a €50 thousand or $62 thousand grant. The remaining €150 thousand or $190 thousand are provided as reimbursement of operating expenses twelve months following incorporation. U.S. GAAP does not provide authoritative guidance regarding the receipt of economic benefits from government entities in return for compliance with certain conditions. Therefore, based on ASC 105-10-05-2, non-authoritative accounting guidance from other sources was considered by analogy in determining the appropriate accounting treatment, the Company elected to apply International Accounting Standards 20 – Accounting for Government Grants and Disclosure of Government Assistance and recognizes the expected reimbursements from the Republic of Malta as deferred income. As reimbursable operating expenses are incurred, a receivable is recognized (reflected within “Prepaid expenses and other current assets” in the consolidated balance sheets) and income is recognized in a similar systematic basis over the same periods in the consolidated statements of operations. During the years ended December 31, 2023 and 2022, the Company incurred $0 in expenses that are reimbursable under the grant. As of December 31, 2023, all amounts provided for under this grant were received. On January 25, 2022, the Company entered into an additional agreement with the government of Malta for a grant of up to €100 thousand or $107 thousand, in terms of the ‘Investment Aid to produce the COVID-19 Relevant Product’ program, to support the proposed investment. The estimated value of the grant is €136,568 or $146,493, at an aid intensity of 75% to cover eligible wage costs incurred after February 1, 2022 in relation to new employees engaged specifically for the implementation of the project. On September 22, 2022, the Company entered into an amendment agreement that enables the Company to submit eligible employee expenses for reimbursement by October 31, 2022. The grant was approved in January 2022, however, the request for payment was not approved and management abandoned the agreement. Hence, during the years ended December 31, 2023 and 2022, the Company incurred $0, respectively, in expenses that are reimbursable under the grant. As of December 31, 2023, no amounts provided under this grant were received.

Leases and Commitments_2

Leases and Commitments	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Leases and Commitments
Leases and Commitments	11. Leases and Commitments Operating Leases — Initial lease terms are determined at commencement date, the date the Company takes possession of the property, and the commencement date is used to calculate straight-line expense for operating leases. Certain leases contain renewal options for varying periods, which are at the Company’s sole discretion. For leases where the Company is reasonably certain to exercise a renewal option, such option periods have been included in the determination of the Company’s Operating lease right-of-use assets and Operating lease liabilities. The Company’s leases have remaining terms of 1 ​ ​ ​ ​ ​ ​ ​ September 30, ​ Lease term and discount rate 2024 ​ Weighted average remaining lease term ​ 1.88 years Weighted average discount rate ​ 5.0 % ​ During the nine months ended September 30, 2024, the Company did terminate one operating lease for office space located in the United States. The lease was terminated upon the conclusion of the agreed upon lease term, therefore, there were no termination fees, Right-of-use assets derecognized, Lease liabilities derecognized, or losses recognized. Balance sheet information related to leases as of as of September 30, 2024 and December 31, 2023 was as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Operating lease right-of-use assets ​ ​ ​ ​ ​ ​ Operating lease right-of-use assets ​ $ 198,634 ​ $ 164,740 ​ ​ ​ ​ ​ ​ ​ Operating lease liabilities ​ ​ ​ ​ ​ ​ Short-term operating lease liabilities ​ $ 95,367 ​ $ 81,236 Long-term operating lease liabilities ​ ​ 70,555 ​ ​ 53,771 Total operating lease liabilities ​ $ 165,922 ​ $ 135,007 ​ Future maturities of ASC 842 lease liabilities as of September 30, 2024 are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Imputed ​ ​ ​ ​ Principal ​ Interest ​ ​ ​ Years Ending December 31, ​ Payments ​ Payments ​ Total Payments 2024 ​ $ 36,976 ​ $ 1,921 ​ $ 38,897 2025 ​ ​ 88,889 ​ ​ 3,696 ​ ​ 92,585 2026 ​ ​ 22,735 ​ ​ 1,170 ​ ​ 23,905 2027 ​ ​ 8,831 ​ ​ 626 ​ ​ 9,457 2028 ​ ​ 8,491 ​ ​ 178 ​ ​ 8,669 Total future maturities ​ $ 165,922 ​ $ 7,591 ​ $ 173,513 ​ Total lease expense, under ASC 842, was included in Selling, general, and administrative expenses in our unaudited condensed consolidated statement of operations for the three and nine months ended September 30, 2024 and 2023 as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Operating lease expense – fixed payments ​ $ 39,368 ​ $ 40,060 ​ $ 117,221 ​ $ 169,496 Short term lease expense ​ ​ 10,710 ​ ​ 10,846 ​ ​ 34,929 ​ ​ 48,399 Total lease expense ​ $ 50,078 ​ $ 50,906 ​ $ 152,150 ​ $ 217,895 ​ Supplemental cash flows information related to leases was as follow: ​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended ​ September 30, ​ 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: ​ ​ ​ ​ ​ ​ Operating cash flows from operating leases ​ $ (111,277) ​ $ (145,483) ​ During the nine months ended September 30, 2024, the Company did not incur variable lease expense. Financial Liability Obligation — Litigation —	12. Leases and Commitments Operating Leases Initial lease terms are determined at commencement date, the date the Company takes possession of the property, and the commencement date is used to calculate straight-line expense for operating leases. Certain leases contain renewal options for varying periods, which are at the Company’s sole discretion. For leases where the Company is reasonably certain to exercise a renewal option, such option periods have been included in the determination of the Company’s Operating lease right-of-use assets and Operating lease liabilities. The Company’s leases have remaining terms of 1 to 5 years. As the Company’s leases do not provide an implicit rate, the present value of future lease payments is determined using the Company’s incremental borrowing rate based on information available at the commencement date. ​ ​ ​ ​ ​ Lease term and discount rate December 31, 2023 Weighted average remaining lease term 2.41 years Weighted average discount rate 5.0 % ​ During the year ended December 31, 2023, the Company terminated four leases including two offices in Malta and two vehicles in Malta. The terminated leases were operating leases. As a result of the terminations, the Company incurred $11 thousand in lease termination fees and recorded a loss of $669 related to this lease termination for the year ended December 31, 2023. ​ ​ ​ ​ ​ ​ December 31, ​ 2023 Leases terminated ​ 4 Lease termination fees ​ $ 10,932 Operating lease right-of-use assets derecognized upon lease termination ​ $ 96,639 Lease liabilities derecognized upon lease termination ​ $ 89,922 Loss recognized upon lease termination ​ $ 669 ​ On April 28, 2023, the Company extended the Malta office lease agreement, which would have ended on July 28, 2023, for a term of one On November 25, 2023, the Company entered into a new motor vehicle lease in Malta, which has term of 60 months. The new lease increased the Operating lease right-of-use asset by $47 thousand and the operating lease liability by $41 thousand. The Company classified the new lease as an operating lease under ASC 842. Balance sheet information related to leases as of December 31, 2023 and 2022 was as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Operating lease right-of-use assets ​ ​ ​ ​ ​ ​ Operating lease right-of-use assets ​ $ 164,740 ​ $ 315,765 ​ ​ ​ ​ ​ ​ ​ Operating lease liabilities ​ ​ ​ ​ Short-term operating lease liabilities ​ $ 81,236 ​ $ 177,795 Long-term operating lease liabilities ​ 53,771 ​ ​ 102,407 Total operating lease liabilities ​ $ 135,007 ​ $ 280,202 ​ Future maturities of ASC 842 lease liabilities as of December 31, 2023 are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Imputed ​ ​ ​ Principal ​ Interest ​ ​ ​ ​ Payments ​ Payments ​ Total Payments 2024 ​ $ 81,236 ​ $ 3,899 ​ $ 85,135 2025 ​ 27,655 ​ 1,802 ​ 29,457 2026 ​ 8,937 ​ 1,047 ​ 9,984 2027 ​ ​ 8,758 ​ ​ 621 ​ ​ 9,379 2028 ​ ​ 8,421 ​ ​ 176 ​ ​ 8,597 Total future maturities ​ $ 135,007 ​ $ 7,545 ​ $ 142,552 ​ Total lease expense, under ASC 842, was included in Selling, general, and administrative expenses in our consolidated statement of operations for the years ended December 31, 2023 and 2022 as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Operating lease expense – fixed payments ​ $ 209,577 ​ $ 276,562 Short term lease expense ​ 59,631 ​ ​ 90,159 Total lease expense ​ $ 269,208 ​ $ 366,721 ​ Supplemental cash flows information related to leases was as follow: ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: ​ ​ ​ ​ Operating cash flows from operating leases ​ $ (179,621) ​ $ (258,892) ​ During the year ended December 31, 2023, the Company did not incur variable lease expense. Financial Liability Obligation — 30-day Litigation —

Description of Business and S_2

Description of Business and Summary of Significant Accounting Policies And Going Concern (Policies)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Description of Business, Summary of Significant Accounting Policies, and Going Concern
Description of Business	Description of Business Trust Stamp primarily develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning artificial intelligence, including computer vision, cryptography, and data mining, to process and protect data and deliver insightful outputs that identify and defend against fraud, protect sensitive user information, facilitate automated processes, and extend the reach of digital services through global accessibility. We utilize the power and agility of technologies such as GPU processing, edge computing, neural networks, and large language models to process and protect data faster and more effectively than historically possible to deliver results at a disruptively low cost for usage across multiple industries. Our team has substantial expertise in the creation and development of AI-enabled software products. We license our technology and expertise in numerous fields, with an increasing emphasis on addressing diverse markets through established partners who will integrate our technology into field-specific applications.	Description of Business — Trust Stamp develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning, artificial intelligence, biometric science, cryptography, and data mining, to deliver insightful identity and trust predictions that identify and defend against fraudulent identity attacks, protect sensitive user information, and extend the reach of digital services through global accessibility. We utilize the power and agility of technologies such as GPU processing, edge-computing, neural networks, and large language models to process and protect data faster and more effectively than has ever previously been possible in order to deliver results at a disruptively low cost for usage across multiple industries, including: ● Banking/FinTech ● KYC/AML Compliance ● Humanitarian and Development Services ● Government and Law Enforcement, including Alternative to Detention programs ● Cryptocurrency and Digital Assets ● Biometrically Secured Email and Digital Communications ● P2P Transactions, Social Media, and Sharing Economy ● Real Estate, Travel, and Healthcare
Reverse Split	Reverse Split — one 1A. Reverse Stock Split Reverse Split — December 30, 2024, the Company filed a Certificate of Amendment to the Company’s Third Amended and Restated Certificate of Incorporation, which was previously approved by the Company’s stockholders at the special meeting held on November 18, 2024 and described in the Company’s definitive proxy statement filed with the SEC on September 30, 2024, to effectuate a reverse stock split at a ratio of one (1) share of Common Stock for every fifteen (15) shares of Common Stock (the “ Reverse Stock Split ”) which became effective as of the opening of business on January 6, 2024 (the “ Effective Time ”). Accordingly, all share and per share amounts for all periods presented in the accompanying financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the reverse stock split.	Reverse Split — Amended and Restated Certificate of Incorporation 1A. Reverse Stock Split Reverse Split — Reverse Stock Split Effective Time
Going Concern	Going Concern The Company’s ability to continue as a going concern in the next twelve months following the date the unaudited condensed consolidated financial statements were available to be issued is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to generate revenue and raise capital as needed to satisfy the Company’s capital needs. While the negotiation of significant additional revenue is well advanced, it has not reached a stage that allows it to be factored into a going concern evaluation. In addition, although the Company has previously been successful in raising capital as needed and has already made plans to do so as well as restructuring expenses to meet the Company’s cash needs, no assurance can be given that the Company will be successful in its capital raising efforts. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period.	Going Concern The Company’s ability to continue as a going concern in the next twelve months following the date the consolidated financial statements were available to be issued is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to generate revenue and raise capital as needed to satisfy the Company’s capital needs. While the negotiation of significant additional revenue is well advanced, it has not reached a stage that allows it to be factored into a going concern evaluation. In addition, although the Company has previously been successful in raising capital as needed and has already made plans to do so as well as restructuring expenses to meet the Company’s cash needs, no assurance can be given that the Company will be successful in its capital raising efforts. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period.
Basis of Presentation	Basis of Presentation —	Basis of Presentation
Basis of Consolidation	Basis of Consolidation — The Company has completed the process of administratively dissolving AIID Payments Limited and the dissolution was effective October 29, 2024. Further, we continue to consolidate Tstamp Incentive Holdings (“TSIH”) which we consider to be a variable interest entity. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments necessary (which adjustments are of a normal and recurring nature) for the fair presentation of the Company’s financial position as of September 30, 2024 and December 31, 2023, and the results of operations for the three and nine months ended September 30, 2024 and 2023. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of results expected for the full year. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to the rules and regulations of the SEC. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The accounting policies employed are substantially the same as those shown in note 1 of the notes to consolidated financial statements included therein.	Basis of Consolidation On February 28, 2023, the Company received the Certificate of Termination from the State of Georgia, which represents the completion of administratively dissolving T Avatar LLC. As there were no operations established under the entity, there is a limited impact to Trust Stamp. The dissolution of T Avatar LLC was effective February 28, 2023. On June 2, 2023, the Company received the termination resolution from the Polish National Court Register, which represents the completion of administratively dissolving Sunflower AI Technologies (“SAIT”). As there were no operations established under the entity, there is a limited impact to Trust Stamp. The dissolution of SAIT was effective May 10, 2023. Further, we continue to consolidate Tstamp Incentive Holdings (“TSIH”) which we consider to be a variable interest entity.
Variable Interest Entity	Variable Interest Entity The Company considers this entity to be a variable interest entity (“VIE”) because it is thinly capitalized and holds no cash. Because the Company does not own shares in TSIH, management believes that this gives the Company a variable interest. Further, management of the Company also acts as management of TSIH and is the decision-maker as management grants shares held by TSIH to employees of the Company. As this VIE’s primary purpose is to hold shares in the Company from time to time and holds no other liabilities or assets, the Company is the primary beneficiary of TSIH and will consolidate the VIE.	Variable Interest Entity The Company does not own any of the shares of Class A Common Stock of the Company held by TSIH. The Company considers this entity to be a variable interest entity (“VIE”) because it is thinly capitalized and holds no cash. Because the Company does not own shares in TSIH, management believes that this gives the Company a variable interest. Further, management of the Company also acts as management of TSIH and is the decision-maker as management grants shares held by TSIH to employees of the Company. As this VIE owns only shares in the Company and no other liabilities or assets, the Company is the primary beneficiary of TSIH and will consolidate the VIE.
Use of Estimates		Use of Estimates
Segment Information		Segment Information —
Risks and Uncertainties		Risks and Uncertainties
Major Customers and Concentration of Risks	Major Customers and Concentration of Risks — For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures. Three customers represented 86.87% or 65.12%, 17.12%, and 4.63% of the balance of total Accounts receivable as of September 30, 2024 and three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. As of September 30, 2024 and December 31, 2023, the Company had not experienced any significant losses on its Accounts receivable. During the three months ended September 30, 2024, the Company sold to primarily three customers which made up approximately 93.24% of total Net revenue, and consisted of 66.34%, 17.60%, and 9.30% from an S&P 500 Bank, Mastercard, and Triton, respectively. Additionally, during the three months ended September 30, 2023, the Company sold to primarily three customers which made up approximately 95.85% of total Net revenue, and consisted of 81.87%, 7.91%, and 6.07% from IGS, Mastercard, and an S&P 500 Bank, respectively. During the nine months ended September 30, 2024, the Company sold to primarily three customers which made up approximately 94.68% of total Net revenue, and consisted of 63.66%, 21.07%, and 9.95% from an S&P 500 Bank, Mastercard, and Triton, respectively. Additionally, during the nine months ended September 30, 2023, the Company sold to primarily three customers which made up approximately 90.53% of total Net revenue, and consisted of 62.98%, 14.95%, and 12.60% from IGS, an S&P 500 Bank, and Mastercard, respectively.	Major Customers and Concentration of Risks For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures. Three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023 and three customers represented 95.37% or 36.90%, 32.69%, and 25.78% of the balance of total Accounts receivable as of December 31, 2022. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. As of December 31, 2023 and 2022, the Company had not experienced any significant losses on its Accounts receivable. During the year ended December 31, 2023, the Company sold to primarily three customers which made up approximately 89.75% of total Net revenue, and consisted of 55.04%, 17.77%, and 16.94% from IGS, an S&P 500 Bank, and Mastercard, respectively. Additionally, during the year ended December 31, 2022, the Company sold to primarily three customers which made up approximately 93.60% of total Net revenue, and consisted of 61.01%, 18.36%, and 14.23% from ICE, an S&P 500 Bank, and Mastercard.
Foreign Currencies		Foreign Currencies
Cash and Cash Equivalents		Cash and Cash Equivalents
Accounts Receivable and Allowance for Credit Losses		Accounts Receivable and Allowance for Credit Losses The Company maintains an allowance for credit losses, which represents an estimate of expected losses over the remaining contractual life of its receivables considering current market conditions and estimates for supportable forecasts when appropriate. The Company measures expected credit losses on its trade receivables on a customer basis. The estimate of expected credit losses considers any historical losses, delinquency trends, collection experience, and/or economic risk where appropriate. Additionally, management develops a specific allowance for trade receivables known to have a high risk of expected future credit loss. The Company has historically experienced immaterial write-offs given the nature of the customers and contracts. As of December 31, 2023, the Company had gross receivables (including unbilled receivables) of $694 thousand and an allowance for credit losses of $8 thousand. As of December 31, 2022, the Company had gross receivables of $1.01 million and no allowance for credit losses. As of December 31, 2023 and 2022, Accounts receivable includes unbilled receivables of $143 thousand and $109 thousand, respectively.
Property and Equipment, Net	Property and Equipment, Net —	Property and Equipment, Net
Capitalized Internal-Use Software, Net		Capitalized Internal-Use Software, Net Capitalized Internal-Use Software, Net is a combination of c
Accounting for Impairment of Long-Lived Assets	Accounting for Impairment of Long-Lived Assets — As of September 30, 2024, the Company determined that $24 thousand of Capitalized internal-use software were impaired .	Accounting for Impairment of Long-Lived Assets As of December 31, 2023, the Company determined that $19 thousand of Capitalized internal-use software and $12 thousand of Intangible assets was impaired. The impaired Capitalized internal-use software was expensed to Research and development during the year ended December 31, 2023.. As of December 31, 2022, the Company determined that no long-lived assets with finite lives were impaired.
Goodwill	Goodwill — Intangibles—Goodwill and Other financial performance and other relevant entity-specific events in determining whether it is more likely than not that the fair value of the reporting unit is less than the carrying amount. Should the Company conclude that it is more likely than not that the recorded Goodwill amounts have been impaired, the Company would perform the impairment test. Goodwill impairment exists when a reporting unit’s carrying value exceeds its fair value. Significant judgment is applied when Goodwill is assessed for impairment. There were no impairment charges to Goodwill as of September 30, 2024 and December 31, 2023.	Goodwill Intangibles—Goodwill and Other
Fair Value of Assets and Liabilities		Fair Value of Assets and Liabilities — Level 1 Level 2 Level 3 A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The estimated fair values of Cash and cash equivalents, Accounts receivable, Related party receivables, Prepaid expenses and other current assets, Other assets, Accounts payable, Related party payables, Accrued expenses, Deferred revenue, Customer deposit liabilities, and Notes payable approximate their carrying values. The fair values of warrant liabilities issued in connection with equity or debt issuance are determined using the Black-Scholes valuation model, a “Level 3” fair value measurement, based on the estimated fair value of the underlying common stock, volatility based on the historical volatility data of similar companies, considering the industry, products and market capitalization of such other entities, the expected life based on the remaining contractual term of the conversion option and warrant liabilities and the risk free interest rate based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrant liability’s contractual life. The Company accounts for its financial assets and liabilities at fair value regularly. The Company evaluates the fair value of its non-financial assets and liabilities on a nonrecurring basis.
Revenue Recognition	Remaining Performance Obligations — Disaggregation of Revenue ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Professional services (over time) ​ $ 424,831 ​ $ 2,990,804 ​ $ 1,326,403 ​ $ 3,760,242 License fees (over time) ​ ​ 86,250 ​ ​ 75,000 ​ ​ 258,750 ​ 225,000 Total Revenue ​ $ 511,081 ​ $ 3,065,804 ​ $ 1,585,153 ​ $ 3,985,242	Revenue Recognition — ● Identification of the contract, or contracts with a customer; ● Identification of the performance obligations in the contract; ● Determination of the transaction price; ● Allocation of the transaction price to the performance obligations in the contract; and ● Recognition of revenue when or as the Company satisfies the performance obligations. At contract inception, the Company will assess the services agreed upon within each contract and assess whether each service is distinct and determine those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In general, each contract with a customer consists of a single performance obligation to perform services in which revenue is recognized when the service has been delivered. Remaining Performance Obligations considered a remaining performance obligation. As of December 31, 2023 and 2022, the Company did not have any related performance obligations for contracts with terms exceeding twelve months. Disaggregation of Revenue ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Professional services (over time) ​ $ 4,260,275 ​ $ 4,415,512 Termination expense reimbursement (one time) ​ — ​ 719,565 License fees (over time) ​ 300,000 ​ 250,000 Total Revenue ​ $ 4,560,275 ​ $ 5,385,077 ​ Contract Balances — . The payment terms and conditions vary by contract; however, the Company’s terms generally require payment within 30 to 60 days from the invoice date. In instances where the timing of revenue recognition differs from the timing of payment, the Company elected to apply the practical expedient in accordance with ASC 606 to not adjust contract consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when promised goods and services are transferred to the customer and when the customer pays for those goods and services will be one year or less. As such, the Company determined its contracts do not generally contain a significant financing component. Costs to Obtain and Fulfill Contracts —
Warrants		Warrants —
Cost of Services Provided		Cost of Services Provided —
Research and Development		Research and Development —
Advertising		Advertising —
Stock- Based Compensation		Stock- Based Compensation — input of highly subjective assumptions, including the fair value of the underlying common shares, the expected term of the share option, the expected volatility of the price of our common shares, risk-free interest rates, and the expected dividend yield of common shares. The assumptions used to determine the fair value of the option awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment. The calculated fair value is recognized as expense over the requisite service period using the straight-line method. Forfeitures are accounted for in the period in which they occur. Trust Stamp offers the indirect repurchase of shares through a net-settlement feature upon the vesting of RSU awards to satisfy minimum statutory tax-withholding requirements for the recipient.
Income Taxes		Income Taxes — A valuation allowance is established if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income in assessing the need for a valuation allowance. The Company’s tax positions are subject to income tax audits by multiple tax jurisdictions. The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not the position will be sustainable upon examination by the taxing authority, including resolution of any related appeals or litigation processes. This evaluation is based on all available evidence and assumes that the tax authorities have full knowledge of all relevant information concerning the tax position. The tax benefit recognized is measured as the largest amount of benefit which is more likely than not (greater than 50% likely) to be realized upon ultimate settlement with the taxing authority. The Company recognizes interest accrued and penalties related to unrecognized tax benefits in Income tax benefit (expense). The Company adjusts these reserves in accordance with the income tax guidance when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may affect the provision for income taxes in the period in which such determination is made and could have a material impact on the Company’s financial condition and operating results. The Company computes its tax provision for interim periods by applying the estimated annual effective tax rate to year-to-date pre-tax income from recurring operations and adjusting for discrete tax items arising in that quarter. There were no discrete items that impacted the effective tax rate for the years ended December 31, 2023 and 2022, respectively. The rate remained consistent over the period due to the full valuation allowance recorded in the period. The Company had an effective tax rate of 0% for the years ended December 31, 2023 and 2022, respectively. The Company has incurred U.S. operating losses and has minimal profits in foreign jurisdictions. Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences are deductible. In making this determination, management considers all available positive and negative evidence affecting specific deferred tax assets, including the Company’s past and anticipated future performance, the reversal of deferred tax liabilities, the length of carry-back and carry-forward periods, and the implementation of tax planning strategies. The Company had no unrecognized tax benefits as of December 31, 2023 and 2022. It is the Company’s policy to recognize interest and penalties related to income tax matters in Income tax benefit (expense). The Company has not accrued any penalties related to uncertain tax positions due to offsetting tax attributes as of December 31, 2023 and 2022. The Company files U.S. federal, state, and foreign income tax returns in jurisdictions with varying statutes of limitation. The only material jurisdiction where the Company is subject to potential examination by tax authorities is the U.S. (federal and state) for tax years 2020 through 2022.
Leases		Leases — Lessors—Certain Leases with Variable Lease Payments Operating lease right-of-use assets represent the Company’s right to use an underlying asset during a lease term and are included in non-current assets on our consolidated balance sheet. Operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease liabilities are divided into two classifications on our consolidated balance sheet as a current liability, Short-term operating lease liabilities, and a non-current liability, Long-term operating lease liabilities. The Company does not have any finance lease right-of-use assets or finance lease liabilities. The Company’s operating lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. The interest rate implicit in the lease is not readily determinable, therefore, the Company uses an estimated incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s Operating lease right-of-use assets are also recognized at the applicable lease commencement date. The Operating lease right-of-use asset equals the carrying amount of the related operating lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable Operating lease right-of-use asset or operating lease liability. The term of our leases equals the non-cancellable period of the lease, including any rent-free periods provided by the lessor, and also include options to renew or extend the lease (including by not terminating the lease) that we are reasonably certain to exercise. We establish the term of each lease at lease commencement and reassess that term in subsequent periods if a triggering event occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term. Some lease contracts include lease and non-lease components. Trust Stamp elected the practical expedient offered by ASC 842 to not separate the lease components from non-lease components. As a result, the Company accounts for leases as a single lease component. In addition, the Company elected not to recognize right-of-use assets and lease liabilities for leases term of twelve months or less. The short-term lease expenses are recognized on a straight-line basis over the lease term.
Commitments and Contingencies		Commitments and Contingencies -
Treasury Stock		Treasury Stock -
Net Loss per Share Attributable to Common Stockholders		Net Loss per Share Attributable to Common Stockholders —
Recent Accounting Pronouncements Not Yet Adopted	Recent Accounting Pronouncements Not Yet Adopted — , Income Taxes (Topic 740) – Improvements to Income Tax Disclosures In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions . The amendments in this ASU clarify that an entity should measure the fair value of an equity security subject to contractual sale restriction the same way it measures an identical equity security that is not subject to such a restriction. The FASB said the contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, should not affect its fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect this guidance to have a material impact to its unaudited condensed consolidated financial statements or related disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures . ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption of the amendments is permitted. The Company is currently evaluating the impacts of the new standard but does not expect a material impact to its unaudited condensed consolidated financial statements or related disclosures.	Recent Accounting Pronouncements Not Yet Adopted — In December 2023, the FASB issued ASU 2023-09 , Income Taxes – Improvements to Income Tax Disclosures . ASU 2023-09 requires enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impacts of the new standard but does not expect a material impact to its consolidated financial statements or related disclosures. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions . The amendments in this ASU clarify that an entity should measure the fair value of an equity security subject to contractual sale restriction the same way it measures an identical equity security that is not subject to such a restriction. The FASB said the contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, should not affect its fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect this guidance to have a material impact to its consolidated financial statements or related disclosures.
Recently Adopted Accounting Pronouncement		Recently Adopted Accounting Pronouncement — In June 2016, the FASB issued Accounting Standards Update No. 2016-13, “Financial Instruments - Credit Losses (Topic 326)” (“ASU 2016-13”). ASU 2016-13 revises the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. In November 2019, FASB issued ASU 2019-10, “ Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842 ). ” This ASU defers the effective date of ASU 2016-13 for public companies that are considered smaller reporting companies as defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted this standard as of January 1, 2023, and the guidance did not have a material impact on its consolidated financial statements or related disclosures.

Description of Business and S_3

Description of Business and Summary of Significant Accounting Policies And Going Concern (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Description of Business, Summary of Significant Accounting Policies, and Going Concern
Schedule of Disaggregation of Revenue	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Professional services (over time) ​ $ 424,831 ​ $ 2,990,804 ​ $ 1,326,403 ​ $ 3,760,242 License fees (over time) ​ ​ 86,250 ​ ​ 75,000 ​ ​ 258,750 ​ 225,000 Total Revenue ​ $ 511,081 ​ $ 3,065,804 ​ $ 1,585,153 ​ $ 3,985,242	​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Professional services (over time) ​ $ 4,260,275 ​ $ 4,415,512 Termination expense reimbursement (one time) ​ — ​ 719,565 License fees (over time) ​ 300,000 ​ 250,000 Total Revenue ​ $ 4,560,275 ​ $ 5,385,077

Borrowings (Tables)_2

Borrowings (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Borrowings
Summary of Non-Convertible Promissory Notes Payable	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Malta loan receipt 3 – June 3, 2022 ​ $ 511,262 ​ $ 507,035 Malta loan receipt 2 – August 10, 2021 ​ ​ 315,673 ​ ​ 313,063 Malta loan receipt 1 – February 9, 2021 ​ ​ 64,807 ​ ​ 64,271 Interest added to principal ​ ​ 70,088 ​ ​ 29,191 Total principal outstanding ​ ​ 961,830 ​ ​ 913,560 Plus: accrued interest ​ ​ 45,383 ​ ​ 40,317 Total promissory notes payable ​ $ 1,007,213 ​ $ 953,877	​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Malta loan receipt 3 – June 3, 2022 ​ $ 507,035 ​ $ 62,365 Malta loan receipt 2 – August 10, 2021 ​ ​ 313,063 ​ ​ 303,778 Malta loan receipt 1 – February 9, 2021 ​ 64,271 ​ 491,996 Interest added to principal ​ ​ 29,191 ​ ​ 11,551 Total principal outstanding ​ 913,560 ​ 869,690 Plus: accrued interest ​ 40,317 ​ 16,775 Total promissory notes payable ​ $ 953,877 ​ $ 886,465

Warrants (Tables)_2

Warrants (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Warrants
Schedule of Changes in Warrant Liability	​ ​ ​ ​ ​ ​ Warrants ($) Balance as of January 1, 2023 ​ $ 261,569 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,033) Balance as of December 31, 2023 ​ $ 256,536 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,842) Balance as of September 30, 2024 ​ $ 250,694	​ ​ ​ ​ ​ ​ Warrants ($) Balance as of January 1, 2022 ​ $ 374,694 Additional warrants issued ​ — Change in fair value ​ ​ (113,125) Balance as of December 31, 2022 ​ $ 261,569 Additional warrants issued ​ ​ — Change in fair value ​ ​ (5,033) Balance as of December 31, 2023 ​ $ 256,536
Schedule of Fair Value of Warrants Liabilities	​ ​ ​ ​ ​ ​ Fair Value of Warrants $ 1.65 — $9.60 ​ Exercise price ​ $ 3.90 — $7.35 ​ Risk free interest rate ​ ​ 3.51%— 4.50 % Expected dividend yield ​ ​ — % Expected volatility ​ ​ 79.19% — 79.59 % Expected term ​ ​ 1 year - 3 years	​ ​ ​ ​ ​ ​ Fair Value of Warrants $ 13.95 – $30.15 ​ Exercise price ​ $ 7.95 – $14.40 ​ Risk free interest rate ​ 4.09% - 4.74 % Expected dividend yield ​ — % Expected volatility ​ 79.08% - 92.90 % Expected term ​ 3 years
Schedule of Warrant Issuance Date	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, Warrant Issuance Date ​ Strike Price ​ 2024 ​ 2023 November 9, 2016 ​ $ 46.80 5,342 5,342 January 23, 2020 ​ $ 120.00 ​ 12,430 ​ 12,430 January 23, 2020 ​ $ 120.00 ​ 34,974 ​ 34,974 April 18, 2023 ​ $ 20.10 ​ — ​ 51,689 June 5, 2023 ​ $ 4.80 ​ — ​ 85,314 December 21, 2023 ​ $ 4.80 ​ 192,869 ​ 240,000 April 3, 2024 ​ $ 14.55 ​ — ​ — April 3, 2024 ​ $ 15.90 ​ — ​ — September 3, 2024 ​ $ 4.80 ​ 95,494 ​ — September 3, 2024 ​ $ 4.80 ​ 190,987 ​ — September 3, 2024 ​ $ 4.80 ​ 636,404 ​ — September 10, 2024 ​ $ 3.45 ​ 250,930 ​ — Total warrants outstanding ​ ​ ​ ​ 1,419,430 ​ 429,749	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, Warrant Issuance Date Strike Price 2023 2022 November 9, 2016 ​ $ 46.80 5,342 5,342 January 23, 2020 ​ $ 120.00 ​ 12,430 ​ 12,430 January 23, 2020 ​ $ 120.00 34,974 54,974 August – December 2021 ​ $ 300.00 — 17,917 January – February 2022 ​ $ 300.00 — 1,012 September 14, 2022 ​ $ 20.10 — 26,000 April 18, 2023 ​ $ 20.10 ​ 51,689 (1) — June 5, 2023 ​ $ 20.10 ​ 85,314 (1) — December 21, 2023 ​ $ 20.10 ​ 240,000 ​ — Total warrants outstanding ​ ​ ​ 429,749 97,675 (1) As of December 31, 2023, all 51,689 of the April 18, 2023 warrants and 7,112 of the June 5, 2023 warrants are held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation.

Balance Sheet Components (Tab_2

Balance Sheet Components (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Balance Sheet Components
Schedule of Prepaid Expenses and Other Current Assets	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Prepaid operating expenses ​ $ 253,973 ​ $ 216,875 Rent deposit ​ ​ 27,458 ​ ​ 28,400 Value added tax receivable ​ ​ 48,177 ​ ​ 116,095 Tax credit receivable (short-term) ​ ​ 25,045 ​ ​ 102,151 Miscellaneous receivable ​ ​ 859,271 ​ ​ 363,260 Prepaid expenses and other current assets ​ $ 1,213,924 ​ $ 826,781	​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ 2023 2022 Prepaid operating expenses ​ $ 216,875 ​ $ 225,756 Rent deposit ​ 28,400 ​ 55,981 Value added tax receivable ​ 116,095 ​ 71,742 Tax credit receivable (short-term) ​ ​ 102,151 ​ ​ 218,239 Miscellaneous receivable ​ 363,260 ​ 8,368 Prepaid expenses and other current assets ​ $ 826,781 ​ $ 580,086
Schedule of Capitalized Internal-Use Software, Net	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Internally developed software ​ 5 Years ​ $ 4,363,338 ​ $ 3,901,801 Less: Accumulated depreciation ​ ​ ​ ​ (2,830,981) ​ ​ (2,429,427) Capitalized internal-use software, net ​ ​ ​ $ 1,532,357 ​ $ 1,472,374	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Internally developed software 5 Years $ 3,901,801 ​ $ 3,314,450 Less: Accumulated depreciation ​ ​ (2,429,427) ​ (1,895,778) Capitalized internal-use software, net ​ ​ ​ $ 1,472,374 ​ $ 1,418,672
Schedule of Property and Equipment, Net	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Computer equipment ​ 3-4 Years ​ $ 154,181 ​ $ 152,014 Furniture and fixtures ​ 10 Years ​ ​ 34,675 ​ ​ 28,052 Property and equipment, gross ​ ​ ​ ​ 188,856 ​ ​ 180,066 Less: Accumulated depreciation ​ ​ ​ ​ (149,031) ​ ​ (123,630) Property and equipment, net ​ ​ ​ $ 39,825 ​ $ 56,436	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Computer equipment 3-4 Years ​ $ 152,014 ​ $ 148,832 Furniture and fixtures 10 Years ​ 28,052 ​ 27,220 Mobile hardware ​ 2.5 years ​ ​ — ​ ​ 297,150 Property and equipment, gross ​ ​ ​ 180,066 ​ 473,202 Less: Accumulated depreciation ​ ​ ​ (123,630) ​ (172,538) Property and equipment, net ​ ​ ​ $ 56,436 ​ $ 300,664
Schedule of Accrued Expenses	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Compensation payable ​ $ 672,587 ​ $ 377,403 Commission liability ​ ​ 19,885 ​ ​ 26,863 Accrued employee taxes ​ ​ 890,411 ​ ​ 624,525 Other accrued liabilities ​ ​ 87,377 ​ ​ 115,099 Accrued expenses ​ $ 1,670,260 ​ $ 1,143,890 ​	​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Compensation payable ​ $ 377,403 ​ $ 171,851 Commission liability ​ ​ 26,863 ​ ​ 58,771 Accrued employee taxes ​ 624,525 ​ 591,992 Accrued mobile expenses ​ ​ — ​ ​ 177,099 Other accrued liabilities ​ 115,099 ​ 100,111 Accrued expenses ​ $ 1,143,890 ​ $ 1,099,824 ​

Goodwill and Intangible Asset_7

Goodwill and Intangible Assets, Net (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Goodwill and Intangible Assets
Schedule of Intangible Assets, Net	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ Useful Lives ​ 2024 ​ 2023 Patent application costs ​ 3 Years ​ $ 555,918 ​ $ 484,035 Trade name and trademarks ​ 3 Years ​ ​ 71,033 ​ ​ 70,446 Intangible assets, gross ​ ​ ​ ​ 626,951 ​ ​ 554,481 Less: Accumulated amortization ​ ​ ​ ​ (433,647) ​ ​ (330,791) Intangible assets, net ​ ​ ​ $ 193,304 ​ $ 223,690	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ ​ Useful Lives ​ 2023 2022 Patent application costs 3 Years ​ $ 484,035 ​ $ 382,285 Trade name and trademarks 3 Years ​ 70,446 ​ 68,356 Intangible assets, gross ​ ​ 554,481 ​ 450,641 Less: Accumulated amortization ​ ​ (330,791) ​ (198,955) Intangible assets, net ​ ​ ​ $ 223,690 ​ $ 251,686
Schedule of Estimated Future Amortization Expense of Intangible Assets, Net	​ ​ ​ ​ ​ Years Ending December 31, Amount 2024 ​ $ 31,949 2025 ​ ​ 99,005 2026 ​ ​ 52,529 2027 ​ ​ 9,821 Total future amortization ​ $ 193,304 ​	​ ​ ​ ​ ​ Years Ending December 31, Amount 2024 ​ ​ 120,078 2025 ​ 75,043 2026 ​ ​ 28,569 ​ ​ $ 223,690 ​

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2023
Income Taxes
Schedule of Net Loss Before Taxes	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 U.S. ​ $ (4,433,956) ​ $ (7,911,970) Non-U.S. ​ (3,217,171) ​ (4,158,494) Net loss before taxes ​ $ (7,651,127) ​ $ (12,070,464)
Schedule of Components of Income Tax Expense	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Current: ​ ​ ​ ​ ​ ​ U.S. Federal ​ $ — ​ $ — U.S. State ​ 2,425 ​ 5,166 Non-U.S. ​ ​ (15,910) ​ ​ 15,910 ​ ​ $ (13,485) ​ $ 21,076 Deferred: ​ ​ ​ ​ ​ ​ U.S. Federal ​ $ — ​ $ — U.S. State ​ ​ — ​ ​ — Non-U.S. ​ ​ — ​ ​ — ​ ​ $ — ​ $ — Total income tax benefit (expense) ​ $ (13,485) ​ $ 21,076
Schedule of Reconciliation of the Federal Income Tax Rate	​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Expected tax provision (benefit) at U.S. federal statutory rate ​ $ (1,606,737) ​ $ (2,534,797) State income taxes, net of federal benefit ​ 1,560 ​ 4,081 Foreign tax rate differential ​ (400,110) ​ (494,278) Change in valuation allowance ​ 1,869,814 ​ 3,146,272 Stock compensation ​ ​ 296,887 ​ ​ 19,730 Credits ​ ​ (181,270) ​ ​ (158,085) Prior year deferred tax adjustments ​ ​ (84,169) ​ ​ — Other ​ 90,540 ​ 38,153 Total provision (benefit) for income taxes ​ $ (13,485) ​ $ 21,076
Schedule of Net Deferred Tax Assets (Liability)	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Deferred Tax Assets: ​ ​ Net operating losses ​ $ 8,330,939 ​ $ 7,082,125 Section 174 ​ ​ 943,401 ​ ​ 463,749 Tax credits ​ 516,330 ​ 335,060 Equity compensation ​ 1,476,296 ​ 1,660,684 Lease liability ​ ​ 3,934 ​ ​ 12,292 Other - accruals ​ ​ 17,448 ​ ​ 4,937 Other ​ 36,431 ​ 14,634 Total Deferred Tax Assets ​ 11,324,779 ​ 9,573,481 Deferred Tax Liabilities: ​ ​ ​ ​ Capitalized internal-use software, net ​ (88,041) ​ (198,051) Right-of-use asset ​ ​ (3,787) ​ ​ (12,082) Total Deferred Tax Liabilities ​ (91,828) ​ (210,133) Net Deferred Tax Assets ​ 11,232,951 ​ 9,363,348 Valuation allowance ​ (11,232,951) ​ (9,363,348) Deferred Tax Assets, Net ​ $ — ​ $ —

Net Loss per Share Attributab_6

Net Loss per Share Attributable to Common Stockholders (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Net Loss per Share Attributable to Common Stockholders
Schedule of Basic and Diluted Loss Per Share Attributable to Common Stockholders	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Numerator: ​ ​ ​ ​ ​ ​ ​ ​ Net loss attributable to common stockholders ​ $ (1,255,915) ​ $ (35,162) ​ $ (6,532,845) ​ $ (4,752,980) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares used in computing net loss per share attributable to common stockholders ​ ​ 1,181,150 ​ ​ 543,708 ​ 891,211 ​ 443,880 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net loss per share attributable to common stockholders ​ $ (1.06) ​ $ (0.06) ​ $ (7.33) ​ $ (10.71)	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Numerator: ​ ​ ​ ​ ​ ​ Net loss attributable to common stockholders ​ $ (7,637,642) ​ $ (12,091,540) ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ Weighted average shares used in computing net loss per share attributable to common stockholders ​ 475,171 ​ ​ 315,518 ​ ​ ​ ​ ​ ​ ​ Net loss per share attributable to common stockholders ​ $ (16.07) ​ $ (38.32) ​
Schedule of Anti-Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share	​ ​ ​ ​ ​ ​ ​ ​ As of September 30, ​ 2024 2023 Options, RSUs, and grants ​ 106,434 ​ 52,761 Warrants ​ 1,798,643 ​ 301,880 Total ​ 1,905,077 ​ 354,641 ​	​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Options, RSUs, and grants ​ 60,741 ​ 49,625 Warrants ​ 432,202 ​ 111,742 Total ​ 492,943 ​ 161,367 ​

Stock Awards and Stock-Based _9

Stock Awards and Stock-Based Compensation (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Stock Awards and Stock-Based Compensation
Schedule of Stock Options Activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ Options Exercise Price Contractual Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2023 25,808 ​ $ 96.00 1.45 ​ $ — Options granted 793 ​ 34.20 — ​ — Options exercised (82) ​ 48.75 — ​ — Options canceled and forfeited ​ (280) ​ ​ 85.95 ​ — ​ ​ — Balance as of December 31, 2023 ​ 26,239 ​ ​ 94.05 ​ 1.95 ​ ​ — Options granted ​ 255 ​ ​ 23.55 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited (95) ​ 63.15 — ​ — Balance as of March 31, 2024 ​ 26,399 ​ ​ 93.60 ​ 1.72 ​ ​ — Options granted ​ 292 ​ ​ 20.55 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited (34) ​ 58.80 — ​ — Balance as of June 30, 2024 26,657 ​ 92.85 1.49 ​ — Options granted ​ 437 ​ ​ 13.80 ​ — ​ ​ — Options exercised ​ — ​ ​ — ​ — ​ ​ — Options canceled and forfeited ​ (102) ​ ​ 58.80 ​ — ​ ​ — Options vested and exercisable as of September 30, 2024 26,992 ​ $ 91.65 1.27 ​ ​ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ ​ Options ​ Exercise Price ​ Contractual ​ Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2024 ​ 26,239 ​ $ 94.05 1.95 ​ $ — Options granted ​ 984 ​ ​ 18.30 — ​ ​ — Options exercised ​ — ​ ​ — — ​ ​ — Options canceled and forfeited ​ (231) ​ ​ 60.30 — ​ ​ — Balance as of September 30, 2024 ​ 26,992 ​ ​ 91.65 1.27 ​ ​ — Options vested and exercisable as of September 30, 2024 ​ 26,992 ​ $ 91.65 ​ 1.27 ​ $ — ​	The following table summarizes stock option activity for the years ended December 31, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ ​ Options ​ Exercise Price ​ Contractual ​ Aggregate ​ ​ Outstanding ​ Per Share ​ Life (years) ​ Intrinsic Value Balance as of January 1, 2023 ​ ​ 25,808 ​ $ 96.00 1.45 ​ $ — Options granted ​ ​ 793 ​ ​ 34.20 ​ ​ ​ ​ ​ Options exercised ​ ​ (82) ​ ​ 48.75 ​ ​ ​ ​ ​ Options canceled and forfeited ​ ​ (280) ​ ​ 85.95 ​ ​ ​ ​ ​ Balance as of December 31, 2023 ​ ​ 26,239 ​ ​ 94.05 ​ 1.95 ​ ​ — Options vested and exercisable as of December 31, 2023 ​ ​ 26,239 ​ $ 94.05 1.95 ​ ​ — ​
Schedule of Stock Options Valuation Assumptions	​ ​ ​ ​ ​ ​ Fair value of Class A Common Stock $ 0.90 — 10.80 ​ Exercise price ​ $ 12.00 — 24.60 ​ Risk free interest rate ​ ​ 3.51 — 4.71 % Expected dividend yield ​ ​ 0.00 % Expected volatility ​ ​ 77.54 — 79.80 % Expected term ​ ​ 3 Years	The following assumptions were used to calculate the fair value of options granted during the year ended December 31, 2023: ​ ​ ​ ​ ​ Fair value of Class A Common Stock $ 5.70 – 25.05 ​ Exercise price ​ $ 26.70 – 46.35 ​ Risk free interest rate ​ 3.76 - 4.89 % Expected dividend yield ​ 0.00 % Expected volatility ​ 79.08– 96.45 % Expected term ​ 3 Years
Schedule of Outstanding RSU Activity	​ ​ ​ ​ ​ RSU Outstanding ​ ​ Number of Shares Balance as of January 1, 2023 19,505 Granted 27,368 Vested (issued) (10,652) Forfeited (6,481) Balance as of December 31, 2023 29,740 Granted 69,335 Vested (issued) (21,255) Forfeited (5,058) Balance as of September 30, 2024 72,762	A summary of outstanding RSU activity as of December 31, 2023 is as follows: ​ ​ ​ ​ ​ RSU Outstanding ​ ​ Number of Shares Balance as of January 1, 2022 8,460 Granted 14,114 Vested (issued) (3,070) Forfeited — Balance as of December 31, 2022 19,504 Granted 27,368 Vested (issued) (10,652) Forfeited (6,480) Balance as of December 31, 2023 29,740
Schedule of Stock-Based Compensation Expense	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Cost of services ​ $ 3,144 ​ $ 11,169 ​ $ 3,406 ​ $ 11,825 Research and development ​ ​ 23,878 ​ ​ 48,336 ​ 38,087 ​ 79,956 Selling, general, and administrative ​ ​ 324,571 ​ ​ 88,535 ​ 915,110 ​ 213,569 Total stock-based compensation expense ​ $ 351,593 ​ $ 148,040 ​ $ 956,603 ​ $ 305,350 ​	​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ ​ 2023 2022 Cost of services ​ $ 21,836 ​ $ 21,721 Research and development ​ 123,109 ​ 292,084 Selling, general, and administrative ​ 618,343 ​ 2,085,258 Total stock-based compensation expense ​ $ 763,288 ​ $ 2,399,063 ​

Leases and Commitments (Table_2

Leases and Commitments (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Leases and Commitments
Summary of Lease Term and Discount Rate	​ ​ ​ ​ ​ ​ ​ September 30, ​ Lease term and discount rate 2024 ​ Weighted average remaining lease term ​ 1.88 years Weighted average discount rate ​ 5.0 %	​ ​ ​ ​ ​ Lease term and discount rate December 31, 2023 Weighted average remaining lease term 2.41 years Weighted average discount rate 5.0 %
Summary of Lease Termination		​ ​ ​ ​ ​ ​ December 31, ​ 2023 Leases terminated ​ 4 Lease termination fees ​ $ 10,932 Operating lease right-of-use assets derecognized upon lease termination ​ $ 96,639 Lease liabilities derecognized upon lease termination ​ $ 89,922 Loss recognized upon lease termination ​ $ 669
Summary of Balance Sheet Information Related to Leases	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2024 ​ 2023 Operating lease right-of-use assets ​ ​ ​ ​ ​ ​ Operating lease right-of-use assets ​ $ 198,634 ​ $ 164,740 ​ ​ ​ ​ ​ ​ ​ Operating lease liabilities ​ ​ ​ ​ ​ ​ Short-term operating lease liabilities ​ $ 95,367 ​ $ 81,236 Long-term operating lease liabilities ​ ​ 70,555 ​ ​ 53,771 Total operating lease liabilities ​ $ 165,922 ​ $ 135,007	​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Operating lease right-of-use assets ​ ​ ​ ​ ​ ​ Operating lease right-of-use assets ​ $ 164,740 ​ $ 315,765 ​ ​ ​ ​ ​ ​ ​ Operating lease liabilities ​ ​ ​ ​ Short-term operating lease liabilities ​ $ 81,236 ​ $ 177,795 Long-term operating lease liabilities ​ 53,771 ​ ​ 102,407 Total operating lease liabilities ​ $ 135,007 ​ $ 280,202
Summary of Future Maturities of ASC 842 Lease Liabilities	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Imputed ​ ​ ​ ​ Principal ​ Interest ​ ​ ​ Years Ending December 31, ​ Payments ​ Payments ​ Total Payments 2024 ​ $ 36,976 ​ $ 1,921 ​ $ 38,897 2025 ​ ​ 88,889 ​ ​ 3,696 ​ ​ 92,585 2026 ​ ​ 22,735 ​ ​ 1,170 ​ ​ 23,905 2027 ​ ​ 8,831 ​ ​ 626 ​ ​ 9,457 2028 ​ ​ 8,491 ​ ​ 178 ​ ​ 8,669 Total future maturities ​ $ 165,922 ​ $ 7,591 ​ $ 173,513	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Imputed ​ ​ ​ Principal ​ Interest ​ ​ ​ ​ Payments ​ Payments ​ Total Payments 2024 ​ $ 81,236 ​ $ 3,899 ​ $ 85,135 2025 ​ 27,655 ​ 1,802 ​ 29,457 2026 ​ 8,937 ​ 1,047 ​ 9,984 2027 ​ ​ 8,758 ​ ​ 621 ​ ​ 9,379 2028 ​ ​ 8,421 ​ ​ 176 ​ ​ 8,597 Total future maturities ​ $ 135,007 ​ $ 7,545 ​ $ 142,552
Summary of Total Lease Expense, Under ASC 842, was Included in Selling, General, and Administrative Expenses in Consolidated Statement of Operations	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended For the nine months ended ​ ​ September 30, ​ September 30, ​ 2024 2023 2024 2023 Operating lease expense – fixed payments ​ $ 39,368 ​ $ 40,060 ​ $ 117,221 ​ $ 169,496 Short term lease expense ​ ​ 10,710 ​ ​ 10,846 ​ ​ 34,929 ​ ​ 48,399 Total lease expense ​ $ 50,078 ​ $ 50,906 ​ $ 152,150 ​ $ 217,895	​ ​ ​ ​ ​ ​ ​ ​ ​ For the years ended December 31, ​ 2023 2022 Operating lease expense – fixed payments ​ $ 209,577 ​ $ 276,562 Short term lease expense ​ 59,631 ​ ​ 90,159 Total lease expense ​ $ 269,208 ​ $ 366,721
Summary of Supplemental Cash Flows Information Related to Leases	​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended ​ September 30, ​ 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: ​ ​ ​ ​ ​ ​ Operating cash flows from operating leases ​ $ (111,277) ​ $ (145,483)	​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, ​ 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: ​ ​ ​ ​ Operating cash flows from operating leases ​ $ (179,621) ​ $ (258,892)

Description of Business and S_4

Description of Business and Summary of Significant Accounting Policies And Going Concern - Narrative (Details) - USD ($)			3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 08, 2021	Apr. 25, 2019	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Jul. 06, 2023	Feb. 15, 2023	Dec. 31, 2021
Disaggregation of Revenue
Common stock, shares authorized (in shares)			50,000,000		50,000,000		50,000,000	50,000,000	50,000,000
Net loss attributable to T Stamp Inc.			$ 1,255,915	$ 35,162	$ 6,532,845	$ 4,752,980	$ 7,637,642	$ 12,091,540
Operating cash outflows					6,183,158	5,884,123	7,852,546	6,337,386
Working capital			(1,450,000)		(1,450,000)		(1,980,000)
Accumulated deficit			$ 55,446,691		$ 55,446,691		$ 50,853,285	$ 39,299,726
Treasury stock, at cost, shares held (in shares)			0		0		3,649	3,768
Common stock, shares issued (in shares)			1,254,650		1,254,650		613,206	327,389
Cash and cash equivalents			$ 598,031	$ 3,182,503	$ 598,031	$ 3,182,503	$ 3,140,747	$ 1,254,494			$ 3,475,695
Gross receivables							694,000	1,010,000
Goodwill, Impairment Loss					0		0	0
Allowance for credit losses							(8,000)	0
Unbilled receivables			$ 4,463		4,463		143,219	109,475
Impaired capitalized internal-use software					24,000		19,000
Impairment on finite-lived assets					$ 24,000		12,000	0
Advertising and marketing expense							$ 224,000	217,000
Effective tax rate							0%
Unrecognized tax benefits							$ 0	$ 0
Third Restated Certificate
Disaggregation of Revenue
Common stock, shares authorized (in shares)									50,000,000
Top Three Customers | Accounts receivable | Customer Concentration Risk
Disaggregation of Revenue
Concentration Risk, Percentage					86.87%		91.11%	95.37%
Top Three Customers | Sales revenue net | Customer Concentration Risk
Disaggregation of Revenue
Concentration Risk, Percentage			93.24%	95.85%	94.68%	90.53%
Customer One | Accounts receivable | Customer Concentration Risk
Disaggregation of Revenue
Concentration Risk, Percentage					65.12%		53.55%	36.90%
Customer Two | Accounts receivable | Customer Concentration Risk
Disaggregation of Revenue
Concentration Risk, Percentage					17.12%		30.43%	32.69%
Customer Three | Accounts receivable | Customer Concentration Risk
Disaggregation of Revenue
Concentration Risk, Percentage					4.63%		7.13%	25.78%
Customer | Sales revenue net | Customer Concentration Risk
Disaggregation of Revenue
Concentration Risk, Percentage							89.75%	93.60%
IGS | Sales revenue net | Customer Concentration Risk
Disaggregation of Revenue
Concentration Risk, Percentage							55.04%
S And P 500 Bank | Sales revenue net | Customer Concentration Risk
Disaggregation of Revenue
Concentration Risk, Percentage			66.34%	81.87%	63.66%	14.95%	17.77%	18.36%
Mastercard | Sales revenue net | Customer Concentration Risk
Disaggregation of Revenue
Concentration Risk, Percentage			17.60%	6.07%	21.07%		16.94%	14.23%
ICE | Sales revenue net | Customer Concentration Risk
Disaggregation of Revenue
Concentration Risk, Percentage				7.91%		62.98%		61.01%
Bank Time Deposits
Disaggregation of Revenue
Cash and cash equivalents			$ 30,342		$ 30,342		$ 2,620,765	$ 71,000
Common Class A
Disaggregation of Revenue
Treasury stock, at cost, shares held (in shares)		21,368					13,736
Common stock, shares issued (in shares)										13,736
Common stock, shares held (in shares)							3,649
Common Class A | Various employees
Disaggregation of Revenue
Number of shares transferred (in shares)	17,600	17,600

Description of Business and S_5

Description of Business and Summary of Significant Accounting Policies And Going Concern - Schedule of Disaggregation of Revenue (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue
Total Revenue	$ 511,081	$ 3,065,804	$ 1,585,153	$ 3,985,242	$ 4,560,275	$ 5,385,077
Professional services (over time)
Disaggregation of Revenue
Total Revenue					4,260,275	4,415,512
Termination expense reimbursement (one time)
Disaggregation of Revenue
Total Revenue					0	719,565
License fees (over time)
Disaggregation of Revenue
Total Revenue					$ 300,000	$ 250,000

Borrowings - Summary of Non-Con

Borrowings - Summary of Non-Convertible Promissory Notes Payable (Details) - Non-Convertible Promissory Notes Payable - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Borrowings
Total principal outstanding	$ 961,830	$ 913,560	$ 869,690
Interest added to principal	70,088	29,191	11,551
Plus: accrued interest	45,383	40,317	16,775
Total promissory notes payable	1,007,213	953,877	886,465
Malta loan receipt 3
Borrowings
Total principal outstanding	511,262	507,035	62,365
Malta loan receipt 2
Borrowings
Total principal outstanding	315,673	313,063	303,778
Malta loan receipt 1
Borrowings
Total principal outstanding	$ 64,807	$ 64,271	$ 491,996

Borrowings - Narrative (Detai_2

Borrowings - Narrative (Details) € in Thousands			1 Months Ended	9 Months Ended		12 Months Ended
	Jul. 08, 2020 EUR (€)	May 01, 2020	May 31, 2020 EUR (€)	Sep. 30, 2024 USD ($)	Sep. 30, 2023	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jul. 08, 2020 USD ($)	May 31, 2020 USD ($)
Borrowings
Proceeds from non-convertible notes						$ 0	$ 61,361
Minimum base rate for interest			1%
Fixed interest rate percentage			1%						1%
Base Rate
Borrowings
Minimum base rate for interest			1%
Fixed interest rate percentage			1%						1%
Loans from Maltese government | Trust Stamp Malta Limited
Borrowings
Potential repayable advance	€ 800		€ 800					$ 858,000	$ 858,000
Percentage of payroll cost covered by advance	75%	75%
Term of payroll costs covered by advance	24 months	24 months
Employment term for receiving advances	36 months	36 months
Proceeds from non-convertible notes				$ 892,000		$ 884,000
Spread on variable rate			2%
Loan interest rate				6.50%	4.50%	4.50%	2.50%
Loans from Maltese government | Trust Stamp Malta Limited | Minimum
Borrowings
Percentage of pre-tax profits per annum to be repaid			10%
Loans from Maltese government | Trust Stamp Malta Limited | Maximum
Borrowings
Percentage of pre-tax profits per annum to be repaid			15%
Loans from Maltese government | Trust Stamp Malta Limited | Base Rate
Borrowings
Spread on variable rate			2%
Loans from Maltese government | Trust Stamp Malta Limited | Base Rate | Minimum
Borrowings
Percentage of pre-tax profits per annum to be repaid			10%
Loans from Maltese government | Trust Stamp Malta Limited | Base Rate | Maximum
Borrowings
Percentage of pre-tax profits per annum to be repaid			15%

Warrants - Schedule of Change_2

Warrants - Schedule of Changes in Warrant Liability (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Change In Financial Instruments [Roll Forward]
Balance, beginning of period	$ 256,536	$ 261,569
Balance, end of period	250,694	256,536	$ 261,569
Fair Value, Inputs, Level 3
Change In Financial Instruments [Roll Forward]
Balance, beginning of period	256,536	261,569	374,694
Additional warrants issued	0	0
Change in fair value	(5,842)	(5,033)	(113,125)
Balance, end of period	$ 250,694	$ 256,536	$ 261,569

Warrants - Narrative (Details_2

Warrants - Narrative (Details)																	1 Months Ended	3 Months Ended			9 Months Ended		12 Months Ended
	Aug. 20, 2024 USD ($) $ / shares shares	Jul. 26, 2024 USD ($) $ / shares shares	May 24, 2024 USD ($) $ / shares shares	Apr. 03, 2024 USD ($) $ / shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 21, 2023 USD ($) $ / shares shares	Aug. 18, 2023 USD ($) $ / shares shares	Jun. 23, 2023 USD ($) $ / shares shares	Jun. 12, 2023 USD ($) $ / shares shares	Jun. 05, 2023 USD ($) $ / shares shares	Jun. 01, 2023 $ / shares shares	Apr. 18, 2023 USD ($) $ / shares shares	Apr. 14, 2023 $ / shares shares	Sep. 11, 2022 USD ($) $ / shares shares	Dec. 21, 2021 USD ($) $ / shares shares	Dec. 16, 2016 USD ($)	Jan. 31, 2020 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Sep. 03, 2024 USD ($) $ / shares	Aug. 06, 2024 $ / shares	Jul. 13, 2024 $ / shares	Feb. 27, 2024 shares	Feb. 07, 2024 shares	Feb. 27, 2023 shares	Feb. 15, 2023 shares	Feb. 07, 2023 shares	Aug. 25, 2022 USD ($) item shares	Feb. 28, 2022 shares	Dec. 31, 2021 shares	Jun. 30, 2020 shares	Nov. 09, 2016 $ / shares shares
Warrants
Maximum number of warrants issued to purchase common stock in future | $					$ 1,000,000													$ 1,000,000			$ 1,000,000		$ 1,000,000
Percentage of discount of future issuance of preferred stock																					20%		20%
Fair value of warrants | $					$ 250,000											$ 50,000		$ 250,000			$ 250,000		$ 250,000
Proceeds from issuance of Common Stock warrants | $																							$ 0	$ 667,290
Number of warrants exercised for issuance of shares (in shares)					429,749													1,419,430		97,675	1,419,430		429,749	97,675												428
Warrant liabilities | $					$ 256,536													$ 250,694		$ 261,569	$ 250,694		$ 256,536	$ 261,569
Change in fair value of warrant liability | $																		$ (974)	$ 2,142		$ (5,842)	$ (3,473)	$ (5,033)	$ (113,125)
Exercise price of warrants (in dollars per share) | $ / shares														$ 132.75												$ 1
Number of warrants cancelled (in shares)														26,000
Common stock, shares issued (in shares)					613,206													1,254,650		327,389	1,254,650		613,206	327,389
Common stock, par value (in dollars per share) | $ / shares					$ 0.01													$ 0.01		$ 0.01	$ 0.01		$ 0.01	$ 0.01
Shares issued upon exercise of warrants (in shares)						104,889		47,132			85,314
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees | $																					$ 3,985,795	$ 7,464,312	$ 7,464,312	$ 983,195
Investors Exercised
Warrants
Proceeds from issuance of Common Stock warrants | $																				$ 57,000
Number of warrants exercised for issuance of shares (in shares)																				190				190
Exercise price of warrants (in dollars per share) | $ / shares																				$ 300				$ 300
Institutional Investor
Warrants
Proceeds from issuance of Common Stock warrants | $							$ 621,000,000
Number of warrants exercised for issuance of shares (in shares)							18,000
Exercise price of warrants (in dollars per share) | $ / shares							$ 34.50
Warrants exercised (in shares)					7,112																		7,112
September 14, 2022
Warrants
Number of warrants exercised for issuance of shares (in shares)					0															26,000			0	26,000
Exercise price of warrants (in dollars per share) | $ / shares					$ 20.10																		$ 20.10
April 18, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)					51,689													0		0	0		51,689	0
Exercise price of warrants (in dollars per share) | $ / shares					$ 20.10													$ 20.10			$ 20.10		$ 20.10
Warrants, held in abeyance (in shares)					51,689																		51,689
Pre Funded Warrants
Warrants
Proceeds from issuance of Common Stock warrants | $	$ 0	$ 0	$ 0
Exercise price of warrants (in dollars per share) | $ / shares	$ 0	$ 0	$ 0					$ 0.015	$ 0.015
Shares issued upon exercise of warrants (in shares)								14,734	21,487
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees | $								$ 221	$ 322
Warrants exercised (in shares)	10,588	53,273	36,140					14,734	21,487
December 21, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)					240,000													192,869		0	192,869		240,000	0
Exercise price of warrants (in dollars per share) | $ / shares					$ 20.10													$ 4.80			$ 4.80		$ 20.10
Warrants exercised (in shares)						(7,112)
June 5, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)					85,314													0		0	0		85,314	0
Exercise price of warrants (in dollars per share) | $ / shares					$ 20.10													$ 4.80			$ 4.80		$ 20.10
Warrants, held in abeyance (in shares)					7,112																		7,112
Regulation CF, D, and S Common Stock And Warrant Offering
Warrants
Number of warrants exercised for issuance of shares (in shares)																																		1,028	18,107
Notice to Exercise | April 18, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)					53,200																		53,200
Securities Purchase Agreement With Armistice Capital Master Fund Ltd. | Private Placement
Warrants
Number of warrants exercised for issuance of shares (in shares)														13,000
Securities purchase agreement
Warrants
Number of warrants exercised for issuance of shares (in shares)								14,734	21,487	36,220		67,330
Exercise price of warrants (in dollars per share) | $ / shares								$ 0.015	$ 0.015
Number of shares agreed to issue and sell (in shares)									21,487	49,094		37,559
Common stock, par value (in dollars per share) | $ / shares										$ 34.50		$ 49.50
Share issue price (in dollars per share) | $ / shares										34.50		$ 49.50
Price per warrant (in dollars per share) | $ / shares										$ 34.485
Shares issued upon exercise of warrants (in shares)										49,094		104,889
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees | $								$ 14,734	$ 322	$ 1,693,720		$ 1,859,154
Proceeds from warrant exercises | $								$ 221		1,249,047		3,332,835
Proceeds from offering after deducting placement fee and legal expense | $										2,686,773		4,778,550
Placement fee | $										205,994		363,439
Legal expense | $										$ 50,000		$ 50,000
Securities purchase agreement | Private Placement
Warrants
Exercise price of warrants (in dollars per share) | $ / shares						$ 34.50					$ 34.50		$ 49.50
Shares issued upon exercise of warrants (in shares)											85,314		104,889
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees | $				$ 1,690,480
Securities purchase agreement | Private Placement | April 18, 2023
Warrants
Proceeds from issuance of Common Stock warrants | $						$ 2,108,262
Common stock, par value (in dollars per share) | $ / shares						$ 20.10
Shares issued upon exercise of warrants (in shares)						104,889
Securities purchase agreement | Private Placement | December 21, 2023
Warrants
Shares issued upon exercise of warrants (in shares)						85,314
Securities purchase agreement | Private Placement | June 5, 2023
Warrants
Proceeds from issuance of Common Stock warrants | $						$ 142,938
Common stock, par value (in dollars per share) | $ / shares						$ 20.10
Securities purchase agreement | Registered direct offering
Warrants
Exercise price of warrants (in dollars per share) | $ / shares											$ 0.015		$ 0.015
Number of shares agreed to issue and sell (in shares)											49,094		37,559
Common stock, par value (in dollars per share) | $ / shares						0.01					$ 0.01		$ 0.01
Share issue price (in dollars per share) | $ / shares						34.50					$ 34.50		$ 49.50
Warrants to purchase shares of common stock agreed to issue and sell (in shares)											36,220		67,330
Price per warrant (in dollars per share) | $ / shares						$ 49.50				$ 34.485	$ 34.485		$ 49.485
Second Century Ventures, LLC | January 2020 Warrant Purchase Agreement
Warrants
Proceeds from issuance of Common Stock warrants | $						$ 160,800									$ 3,260,000
Number of warrants exercised for issuance of shares (in shares)						8,000
Exercise price of warrants (in dollars per share) | $ / shares						$ 20.10
Armistice Capital Master Fund Ltd.
Warrants
Exercise price of warrants (in dollars per share) | $ / shares										$ 34.50
Armistice Capital Master Fund Ltd. | September 14, 2022
Warrants
Exercise price of warrants (in dollars per share) | $ / shares						20.10
Armistice Capital Master Fund Ltd. | April 18, 2023
Warrants
Exercise price of warrants (in dollars per share) | $ / shares						20.10
Armistice Capital Master Fund Ltd. | December 21, 2023
Warrants
Exercise price of warrants (in dollars per share) | $ / shares						$ 20.10																			$ 4.835
Warrants exercised (in shares)						120,000
Armistice Capital Master Fund Ltd. | June 5, 2023
Warrants
Exercise price of warrants (in dollars per share) | $ / shares						$ 20.10																			$ 4.8345
Trusted Mail
Warrants
Cancellation of shares | $																	$ 100,000
Exchange of SAFEs for warrants | $																	$ 125,000
Trusted Mail | Second Century Ventures, LLC | January 2020 Warrant Purchase Agreement
Warrants
Proceeds from issuance of Common Stock warrants | $															$ 3,260,000
Common Class A
Warrants
Maximum number of warrants issued to purchase common stock in future | $														$ 1,511,250
Proceeds from issuance of Common Stock warrants | $														$ 90,675		$ 50,000
Number of warrants exercised for issuance of shares (in shares)					18,928									26,000			62,141						18,928														5,342
Exercise price of warrants (in dollars per share) | $ / shares																	$ 120																				$ 46.80
Fair value of consideration received from warrants | $																	$ 300,000
Credited value over three years | $																	$ 100,000
Threshold period after which cashless exercise of warrants																							6 months
Common stock, shares issued (in shares)																															13,736
Common Class A | Institutional Investor
Warrants
Number of warrants exercised for issuance of shares (in shares)																		192,869			192,869
Common stock, shares issued (in shares)							18,000
Common Class A | September 14, 2022
Warrants
Number of warrants exercised for issuance of shares (in shares)						8,000
Common stock, shares issued (in shares)						8,000
Common Class A | April 18, 2023
Warrants
Common stock, shares issued (in shares)					53,200																		53,200					30,356	21,334	30,356		21,334
Common Class A | Securities purchase agreement | Private Placement
Warrants
Common stock, par value (in dollars per share) | $ / shares																											$ 0.01
Common Class A | Securities purchase agreement | Private Placement | December 21, 2023
Warrants
Shares issued upon exercise of warrants (in shares)						240,000
Percentage of shares issued						200%
Common Class A | Securities purchase agreement | Registered direct offering
Warrants
Common stock, par value (in dollars per share) | $ / shares				$ 0.01
Common Class A | Second Century Ventures, LLC
Warrants
Number of warrants exercised for issuance of shares (in shares)					34,974													34,974			34,974		34,974
Common Class A | Second Century Ventures, LLC | January 2020 Warrant Purchase Agreement
Warrants
Number of warrants exercised for issuance of shares (in shares)															27,168
Exercise price of warrants (in dollars per share) | $ / shares															$ 120
Common Class A | Armistice Capital Master Fund Ltd.
Warrants
Maximum number of warrants issued to purchase common stock in future | $										$ 897,000
Number of warrants exercised for issuance of shares (in shares)										26,000
Expiration period										5 years
Common Class A | Armistice Capital Master Fund Ltd. | September 14, 2022
Warrants
Maximum number of warrants issued to purchase common stock in future | $						$ 160,800
Common Class A | Armistice Capital Master Fund Ltd. | April 18, 2023
Warrants
Maximum number of warrants issued to purchase common stock in future | $						$ 2,108,262
Number of warrants exercised for issuance of shares (in shares)						2,108,262
Common Class A | Armistice Capital Master Fund Ltd. | December 21, 2023
Warrants
Maximum number of warrants issued to purchase common stock in future | $																									$ 1,160,280
Number of warrants exercised for issuance of shares (in shares)						8,000
Common Class A | Armistice Capital Master Fund Ltd. | June 5, 2023
Warrants
Maximum number of warrants issued to purchase common stock in future | $						$ 1,714,798
Common Class A | Armistice Capital Master Fund Ltd. | Notice to Exercise | December 21, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)						61,200
Common Class A | Trusted Mail
Warrants
Number of warrants exercised for issuance of shares (in shares)																	12,430
Fair Value of Warrant Liability
Warrants
Warrant liabilities | $					$ 7,000													$ 1,000			$ 1,000		$ 7,000
Change in fair value of warrant liability | $																					$ 6,000		$ 5,000	$ 12,000
CF Common stock
Warrants
Units refunded | $																																	$ 5,000,000
Number of investors refunded | item																																	2
Number of warrants cancelled (in shares)																																	17
Existing Warrants | Armistice Capital Master Fund Ltd. | December 21, 2023
Warrants
Warrants exercised (in shares)						58,800

Warrants - Schedule of Fair V_2

Warrants - Schedule of Fair Value of Warrants Liabilities (Details)	Sep. 30, 2024 $ / shares Y	Dec. 31, 2023 $ / shares Y
Fair Value of Warrants | Minimum
Warrants
Warrants measurement input	1.65	13.95
Fair Value of Warrants | Maximum
Warrants
Warrants measurement input	9.60	30.15
Exercise price | Minimum
Warrants
Warrants measurement input	3.90	7.95
Exercise price | Maximum
Warrants
Warrants measurement input	7.35	14.40
Risk free interest rate | Minimum
Warrants
Warrants measurement input	0.0351	0.0409
Risk free interest rate | Maximum
Warrants
Warrants measurement input	0.0450	0.0474
Expected dividend yield
Warrants
Warrants measurement input	0	0
Expected volatility | Minimum
Warrants
Warrants measurement input	0.7919	0.7908
Expected volatility | Maximum
Warrants
Warrants measurement input	0.7959	0.9290
Expected term
Warrants
Warrants measurement input | Y		3
Expected term | Minimum
Warrants
Warrants measurement input | Y	1
Expected term | Maximum
Warrants
Warrants measurement input | Y	3

Warrants - Schedule of Warran_2

Warrants - Schedule of Warrant Issuance Date (Details) - $ / shares	Sep. 30, 2024	Aug. 06, 2024	Dec. 31, 2023	Dec. 31, 2022	Sep. 11, 2022	Jun. 30, 2020
Warrants
Exercise price of warrants (in dollars per share)		$ 1			$ 132.75
Number of warrants exercised for issuance of shares (in shares)	1,419,430		429,749	97,675		428
November 9, 2016
Warrants
Exercise price of warrants (in dollars per share)	$ 46.80		$ 46.80
Number of warrants exercised for issuance of shares (in shares)	5,342		5,342	5,342
January 23, 2020
Warrants
Exercise price of warrants (in dollars per share)	$ 120		$ 120
Number of warrants exercised for issuance of shares (in shares)	12,430		12,430	12,430
Second Warrant Issuance January 23 2020
Warrants
Exercise price of warrants (in dollars per share)	$ 120		$ 120
Number of warrants exercised for issuance of shares (in shares)	34,974		34,974	54,974
August - December 2021
Warrants
Exercise price of warrants (in dollars per share)			$ 300
Number of warrants exercised for issuance of shares (in shares)			0	17,917
January - February 2022
Warrants
Exercise price of warrants (in dollars per share)			$ 300
Number of warrants exercised for issuance of shares (in shares)			0	1,012
September 14, 2022
Warrants
Exercise price of warrants (in dollars per share)			$ 20.10
Number of warrants exercised for issuance of shares (in shares)			0	26,000
April 18, 2023
Warrants
Exercise price of warrants (in dollars per share)	$ 20.10		$ 20.10
Number of warrants exercised for issuance of shares (in shares)	0		51,689	0
Warrants, held in abeyance (in shares)			51,689
June 5, 2023
Warrants
Exercise price of warrants (in dollars per share)	$ 4.80		$ 20.10
Number of warrants exercised for issuance of shares (in shares)	0		85,314	0
Warrants, held in abeyance (in shares)			7,112
December 21, 2023
Warrants
Exercise price of warrants (in dollars per share)	$ 4.80		$ 20.10
Number of warrants exercised for issuance of shares (in shares)	192,869		240,000	0

Balance Sheet Components - Sc_5

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Balance Sheet Components
Prepaid operating expenses	$ 253,973	$ 216,875	$ 225,756
Rent deposit	27,458	28,400	55,981
Value added tax receivable	48,177	116,095	71,742
Tax credit receivable (short-term)	25,045	102,151	218,239
Miscellaneous receivable	859,271	363,260	8,368
Prepaid expenses and other current assets	$ 1,213,924	$ 826,781	$ 580,086

Balance Sheet Components - Sc_6

Balance Sheet Components - Schedule of Capitalized Internal-Use Software, Net (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Balance Sheet Components
Useful Lives	5 years	5 years
Internally developed software	$ 4,363,338	$ 3,901,801	$ 3,314,450
Less: Accumulated depreciation	(2,830,981)	(2,429,427)	(1,895,778)
Capitalized internal-use software, net	$ 1,532,357	$ 1,472,374	$ 1,418,672

Balance Sheet Components - Na_2

Balance Sheet Components - Narrative (Details) - USD ($)			3 Months Ended		9 Months Ended		12 Months Ended
	May 26, 2023	Apr. 26, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Balance Sheet Components
Amortization of capitalized Internal-use Software			$ 141,000	$ 140,000	$ 419,000	$ 419,000	$ 557,000	$ 517,000
Impaired capitalized internal-use software					24,000		19,000
Depreciation			$ 8,000	$ 10,000	27,000	62,000	72,000	136,000
Proceeds from sale of property and equipment	$ 197,000	$ 180,000			$ 0	$ 377,360	$ 377,360	$ 0
Gain on property and equipment	$ 108,000	$ 108,000

Balance Sheet Components - Sc_7

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Property and Equipment, Net
Property and equipment, gross	$ 188,856	$ 180,066	$ 473,202
Less accumulated depreciation	(149,031)	(123,630)	(172,538)
Property and equipment, net	39,825	56,436	300,664
Computer equipment
Property and Equipment, Net
Property and equipment, gross	$ 154,181	$ 152,014	148,832
Computer equipment | Minimum
Property and Equipment, Net
Useful Lives	3 years	3 years
Computer equipment | Maximum
Property and Equipment, Net
Useful Lives	4 years	4 years
Furniture and fixtures
Property and Equipment, Net
Useful Lives	10 years	10 years
Property and equipment, gross	$ 34,675	$ 28,052	27,220
Mobile hardware
Property and Equipment, Net
Useful Lives		2 years 6 months
Property and equipment, gross		$ 0	$ 297,150

Balance Sheet Components - Sc_8

Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Balance Sheet Components
Compensation payable	$ 672,587	$ 377,403	$ 171,851
Commission liability	19,885	26,863	58,771
Accrued employee taxes	890,411	624,525	591,992
Accrued mobile expenses		0	177,099
Other accrued liabilities	87,377	115,099	100,111
Accrued expenses	$ 1,670,260	$ 1,143,890	$ 1,099,824

Goodwill and Intangible Asset_8

Goodwill and Intangible Assets, Net - Schedule of Intangible Assets, Net (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) patent	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) patent item	Dec. 31, 2022 USD ($)
Intangible assets
Intangible assets, gross	$ 626,951		$ 626,951		$ 554,481	$ 450,641
Less: Accumulated amortization	(433,647)		(433,647)		(330,791)	(198,955)
Intangible assets, net	193,304		193,304		223,690	251,686
Impairment on finite-lived assets			$ 24,000		$ 12,000	0
Number of intangible assets added | patent			23		17
Amortization expense	$ 32,000	$ 40,000	$ 102,000	$ 115,000	$ 160,000	107,000
Patents
Intangible assets
Useful Lives	3 years		3 years		3 years
Intangible assets, gross	$ 555,918		$ 555,918		$ 484,035	382,285
Number of intangible assets added | patent			6		4
Trade name and trademarks
Intangible assets
Useful Lives	3 years		3 years		3 years
Intangible assets, gross	$ 71,033		$ 71,033		$ 70,446	$ 68,356
Trademarks
Intangible assets
Number of intangible assets added | item					1

Goodwill and Intangible Asset_9

Goodwill and Intangible Assets, Net - Schedule of Estimated Future Amortization Expense of Intangible Assets, Net (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Estimated future amortization expense of intangible assets
2024	$ 99,005	$ 120,078
2025	52,529	75,043
2026	9,821	28,569
Total	$ 193,304	$ 223,690	$ 251,686

Income Taxes - Schedule of Net

Income Taxes - Schedule of Net Loss Before Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Taxes
U.S.	$ (4,433,956)	$ (7,911,970)
Non-U.S.	(3,217,171)	(4,158,494)
Net Loss before Taxes	$ (7,651,127)	$ (12,070,464)

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Income Tax Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Current:
U.S. Federal	$ 0	$ 0
U.S. State	2,425	5,166
Non-U.S.	(15,910)	15,910
Current Income Tax	(13,485)	21,076
Deferred:
U.S. Federal	0	0
U.S. State	0	0
Non-U.S.	0	0
Deferred Income Tax	0	0
Total income tax benefit (expense)	$ (13,485)	$ 21,076

Income Taxes - Federal Income T

Income Taxes - Federal Income Tax Rate (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Taxes
Expected tax provision (benefit) at U.S. federal statutory rate	$ (1,606,737)	$ (2,534,797)
State income taxes, net of federal benefit	1,560	4,081
Foreign tax rate differential	(400,110)	(494,278)
Change in valuation allowance	1,869,814	3,146,272
Stock compensation	296,887	19,730
Credits	(181,270)	(158,085)
Prior year deferred tax adjustments	(84,169)	0
Other	90,540	38,153
Total provision (benefit) for income taxes	$ (13,485)	$ 21,076

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Deferred Tax Assets:
Net operating losses	$ 8,330,939	$ 7,082,125
Section 174	943,401	463,749
Tax credits	516,330	335,060
Equity compensation	1,476,296	1,660,684
Lease liability	3,934	12,292
Other - accruals	17,448	4,937
Other	36,431	14,634
Total Deferred Tax Assets	11,324,779	9,573,481
Deferred Tax Liabilities:
Capitalized internal-use software, net	(88,041)	(198,051)
Right-of-use asset	(3,787)	(12,082)
Total Deferred Tax Liabilities	(91,828)	(210,133)
Net Deferred Tax Assets	11,232,951	9,363,348
Valuation allowance	(11,232,951)	(9,363,348)
Deferred Tax Assets, Net	$ 0	$ 0

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Jan. 01, 2018
Income Taxes
Net increase in valuation allowance	$ 1,901,622	$ 3,146,272
Valuation allowance	11,232,951	9,363,348
Unrecognized tax benefits that would impact effective tax rate	129,082	$ 83,765
Unrecognized tax benefits, Interest on income taxes accrued	0
Unrecognized tax benefits, Income tax penalties accrued	0
Unrecognized tax benefits, Income tax penalties and interest accrued	0
Federal
Income Taxes
Operating loss carryovers	19,127,170		$ 18,553,119
Operating loss carryforwards subject to expire	574,051
State
Income Taxes
Operating loss carryovers	3,743,893		$ 3,169,842
Operating loss carryforwards subject to expire	574,051
Foreign
Income Taxes
Operating loss carryovers	11,859,008
Operating loss carryforwards subject to expire	$ 975,242

Net Loss per Share Attributab_7

Net Loss per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Loss Per Share Attributable to Common Stockholders (Details) - USD ($)		3 Months Ended		9 Months Ended		12 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Numerator:
Net income (loss) attributable to T Stamp Inc.		$ (1,255,915)	$ (35,162)	$ (6,532,845)	$ (4,752,980)	$ (7,637,642)	$ (12,091,540)
Denominator:
Weighted average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	[1]	1,181,150	543,708	891,211	443,880	475,171	315,518
Weighted average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	[1]	1,181,150	543,708	891,211	443,880	475,171	315,518
Net loss per share attributable to common stockholders, basic (in dollars per share)	[1]	$ (1.06)	$ (0.06)	$ (7.33)	$ (10.71)	$ (16.07)	$ (38.32)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	[1]	$ (1.06)	$ (0.06)	$ (7.33)	$ (10.71)	$ (16.07)	$ (38.32)
[1] After giving effect to the 15 for 1 reverse stock split effected on January 6, 2025.

Net Loss per Share Attributab_8

Net Loss per Share Attributable to Common Stockholders - Schedule of Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share (Details) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Net Loss per Share Attributable to Common Stockholders
Total	$ 1,905,077	$ 354,641	$ 492,943	$ 161,367
Options, RSUs, and grants
Net Loss per Share Attributable to Common Stockholders
Total	106,434	52,761	60,741	49,625
Warrants
Net Loss per Share Attributable to Common Stockholders
Total	$ 1,798,643	$ 301,880	$ 432,202	$ 111,742

Stock Awards and Stock-Based_10

Stock Awards and Stock-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2024	Mar. 31, 2023	Dec. 31, 2021
Stock Awards and Stock-Based Compensation
Aggregate intrinsic value of options exercised	$ 0		$ 0	$ 0
Weighted average grant-date fair value of options granted per share	$ 4.35	$ 18.75	$ 16.20	$ 114.75
Weighted average grant-date fair value of options granted amount	$ 4	$ 10	$ 12	$ 57
Stock options outstanding (in shares)	26,992		26,239	25,808	26,657	26,399	25,808
Share-Based Payment Arrangement, Option
Stock Awards and Stock-Based Compensation
Stock options outstanding (in shares)	26,992		26,239
Restricted stock units, outstanding	6,680		4,761
Stock not yet issued	5,475		4,012
Stock granted not yet vested	1,205		750
Unrecognized stock-based compensation related to common stock grants	$ 6		$ 9
Restricted Stock Units (RSUs)
Stock Awards and Stock-Based Compensation
Restricted stock units, outstanding	72,762		29,740
Stock not yet issued	3,428		3,187
Restricted stock units ("RSUs") granted but not yet vested	69,335		26,553
Unrecognized stock compensation related to the RSUs	$ 343		$ 25
Management | Grants
Stock Awards and Stock-Based Compensation
Stock based awards granted			6	$ 49
Management | Share-Based Payment Arrangement, Option
Stock Awards and Stock-Based Compensation
Stock based awards granted			0
Management | Restricted Stock Units (RSUs)
Stock Awards and Stock-Based Compensation
Stock based awards granted			36	190
Various employees | Grants
Stock Awards and Stock-Based Compensation
Stock based awards granted			82	307
Various employees | Share-Based Payment Arrangement, Option
Stock Awards and Stock-Based Compensation
Stock based awards granted			12	57
Various employees | Restricted Stock Units (RSUs)
Stock Awards and Stock-Based Compensation
Stock based awards granted			$ 627	$ 1,800

Stock Awards and Stock-Based_11

Stock Awards and Stock-Based Compensation - Schedule of Stock Options Activity (Details) - $ / shares	3 Months Ended				9 Months Ended	12 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Options Outstanding
Beginning balance (in shares)	26,657		26,399	25,808	26,239	25,808	25,808
Options granted (in shares)	437	292		255	984	793
Options exercised (in shares)	0			0	0	(82)
Options canceled and forfeited (in shares)	(102)		(34)	(95)	(231)	(280)
Ending balance (in shares)	26,992	26,657		26,399	26,992	26,239	25,808	25,808
Options vested and exercisable (in shares)	26,992				26,992	26,239
Weighted Average Exercise Price Per Share
Beginning balance (in dollars per share)	$ 92.85		$ 93.60	$ 96	$ 94.05	$ 96	$ 96
Options granted (in dollars per share)	13.80	$ 20.55		23.55	18.30	34.20
Options exercised (in dollars per share)	0			0	0	48.75
Options canceled and forfeited (in dollars per share)	58.80		$ 58.80	63.15	60.30	85.95
Ending balance (in dollars per share)	91.65	$ 92.85		$ 93.60	91.65	94.05	$ 96	$ 96
Options vested and exercisable (in dollars per share)	$ 91.65				$ 91.65	$ 94.05
Weighted Average Remaining Contractual Life (years)
Outstanding		1 year 5 months 26 days		1 year 8 months 19 days	1 year 3 months 7 days	1 year 11 months 12 days	1 year 5 months 12 days	1 year 5 months 12 days
Options vested and exercisable	1 year 3 months 7 days				1 year 3 months 7 days	1 year 11 months 12 days

Stock Awards and Stock-Based_12

Stock Awards and Stock-Based Compensation - Schedule of Stock Options Valuation Assumptions (Details) - Share-Based Payment Arrangement, Option - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Stock Awards and Stock-Based Compensation
Expected dividend yield	0%	0%
Expected term	3 years	3 years
Minimum
Stock Awards and Stock-Based Compensation
Fair value of Class A Shares of Common Stock (in dollars per share)	$ 0.90	$ 5.70
Exercise Price (in dollars per share)	$ 12	$ 26.70
Risk free interest rate	3.51%	3.76%
Expected volatility	77.54%	79.08%
Maximum
Stock Awards and Stock-Based Compensation
Fair value of Class A Shares of Common Stock (in dollars per share)	$ 10.80	$ 25.05
Exercise Price (in dollars per share)	$ 24.60	$ 46.35
Risk free interest rate	4.71%	4.89%
Expected volatility	79.80%	96.45%

Stock Awards and Stock-Based_13

Stock Awards and Stock-Based Compensation - Schedule of Outstanding RSU Activity (Details) - Restricted Stock Units (RSUs) - shares	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
RSU Outstanding Number of Shares
Balance at the beginning (in shares)	29,740	19,505	8,460
Granted (in shares)	69,335	27,368	14,114
Vested (issued) (in shares)	(21,255)	(10,652)	(3,070)
Forfeited (in shares)	(5,058)	(6,481)	0
Balance at the end (in shares)	72,762	29,740	19,505

Stock Awards and Stock-Based_14

Stock Awards and Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	$ 351,593	$ 148,040	$ 956,603	$ 305,350	$ 763,288	$ 2,399,063
Cost of services
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	3,144	11,169	3,406	11,825	21,836	21,721
Research and development
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	23,878	48,336	38,087	79,956	123,109	292,084
Selling, general, and administrative
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	$ 324,571	$ 88,535	$ 915,110	$ 213,569	$ 618,343	$ 2,085,258

Stockholders' Equity (Details)

Stockholders' Equity (Details)	12 Months Ended
	Dec. 31, 2023 Vote shares	Sep. 30, 2024 shares	Jul. 06, 2023 shares	Dec. 31, 2022 shares
Stockholders Equity
Number of shares authorized (in shares) | shares	50,000,000
Common stock, shares authorized (in shares) | shares	50,000,000	50,000,000	50,000,000	50,000,000
Common Class A
Stockholders Equity
Number of votes | Vote	1
Common Class B
Stockholders Equity
Number of votes | Vote	1

Related Party Transactions (D_2

Related Party Transactions (Details) - USD ($)			3 Months Ended				9 Months Ended		12 Months Ended
	Nov. 15, 2020	Nov. 13, 2020	Sep. 30, 2024	Jun. 30, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Related Party Transactions
Related party receivables			$ 23,781				$ 23,781		$ 44,087	$ 31,446
Cost of Revenue, Related Party, Type [Extensible Enumeration]										Related Party	Related Party
Number of stock options purchased (in shares)			437	292		255	984		793
Stock options expiration period		36 months
Related Party
Related Party Transactions
Related party receivables			$ 48,000				$ 48,000		$ 82,000	$ 273,000
Related party cost			$ 1,000		$ 164,000		$ 112,000	$ 699,000	816,000	935,000
Expenses incurred in relation to legal services									0	138,000
Amounts payable										0	$ 0
Percentage of commission received, first year	20%
Percentage of commission received, second year	10%
Percentage of commission received, third year	5%
Payment of commission									0	0
Related Party | Options Agreement
Related Party Transactions
Loans receivable term		3 years
Loans receivable carrying amount		$ 335,000
Abated interest rate		0.25%
Number of stock options purchased (in shares)		18,777
Share issue price (in dollars per share)		$ 90
Loans receivable amount kind in services per month		$ 9,000
Shareholder loan balances totaled									$ 0	$ 19,000

Malta Grant (Details)_2

Malta Grant (Details) - Malta Grant Agreement		9 Months Ended		12 Months Ended
	Jan. 25, 2022 EUR (€)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jan. 25, 2022 USD ($)	Jul. 31, 2020 EUR (€)	Jul. 31, 2020 USD ($)
Malta Grant
Maximum amount grant	€ 100,000					$ 107,000	€ 200,000	$ 251,000
Requirement of initial capital amount							50,000	62,000
Reimbursement of grant for initial capital amount							50,000	62,000
Remaining reimbursement amount of grant for operating expenses incurred up to 12 Months from incorporation							€ 150,000	$ 190,000
Expenses incurred for grant		$ 0	$ 0	$ 0	$ 0
Estimated amount of grant	€ 136,568					$ 146,493
Percentage of aid intensity to cover eligible wage cost	75%
Amounts received from grants		$ 0		$ 0

Leases and Commitments - Narr_2

Leases and Commitments - Narrative (Details)		9 Months Ended		12 Months Ended
	Mar. 03, 2023	Sep. 30, 2024 USD ($) lease	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) lease	Dec. 31, 2022 USD ($)	Nov. 25, 2023 USD ($)
Leases and Commitments
Minimum lease commitments related to month-to-month lease arrangements		$ 0		$ 0
Remaining lease term				1 year
Number of leases terminated		1		4
Number of office lease terminated | lease				2
Number of vehicle lease terminated | lease				2
Lease termination fees				$ 10,932
Loss related to lease termination				669
Adjustment to operating lease right-of-use assets related to renewed leases		$ 143,594	$ 82,185	82,185	$ 259,292
Adjustment to operating lease operating lease liabilities related to renewed leases		142,192	$ 83,298	83,298	236,521
Operating lease right of use assets		198,634		164,740	315,765
Operating lease liabilities		165,922		135,007	$ 280,202
Purchase obligation		$ 0		$ 162,000
Termination notice term	30 days
Vehicles
Leases and Commitments
Operating lease term						60 months
Operating lease right of use assets						$ 47,000
Operating lease liabilities						$ 41,000
Minimum
Leases and Commitments
Remaining lease term		1 year		1 year
Maximum
Leases and Commitments
Remaining lease term		4 years		5 years

Leases and Commitments - Summ_5

Leases and Commitments - Summary of Lease Term and Discount Rate (Details)	Sep. 30, 2024	Dec. 31, 2023
Leases and Commitments
Weighted average remaining lease term	1 year 10 months 17 days	2 years 4 months 28 days
Weighted average discount rate	5%	5%

Leases and Commitments - Summ_6

Leases and Commitments - Summary of Lease Termination (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2024 lease	Dec. 31, 2023 USD ($) lease
Leases and Commitments
Leases terminated	1	4
Lease termination fees		$ 10,932
Operating lease right-of-use assets derecognized upon lease termination		96,639
Lease liabilities derecognized upon lease termination		89,922
Loss recognized upon lease termination		$ 669

Leases and Commitments - Summ_7

Leases and Commitments - Summary of Balance Sheet Information Related to Leases (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Balance sheet information related to leases
Operating lease right of use assets	$ 198,634	$ 164,740	$ 315,765
Operating lease liabilities
Short-term operating lease liabilities	95,367	81,236	177,795
Long-term operating lease liabilities	70,555	53,771	102,407
Total operating lease liabilities	$ 165,922	$ 135,007	$ 280,202

Leases and Commitments - Summ_8

Leases and Commitments - Summary of Future Maturities of ASC 842 Lease Liabilities (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Principal Payments
2024	$ 36,976	$ 81,236
2025	88,889	27,655
2026	22,735	8,937
2027	8,831	8,758
2028	8,491	8,421
Total operating lease liabilities	165,922	135,007	$ 280,202
Imputed Interest Payments
2024	1,921	3,899
2025	3,696	1,802
2026	1,170	1,047
2027	626	621
2028	178	176
Total future maturities	7,591	7,545
Total Payments
2024	38,897	85,135
2025	92,585	29,457
2026	23,905	9,984
2027	9,457	9,379
2028	8,669	8,597
Total future maturities	$ 173,513	$ 142,552

Leases and Commitments - Summ_9

Leases and Commitments - Summary of Total Lease Expense, Under ASC 842, was Included in Selling, General, and Administrative Expenses in Consolidated Statement of Operations (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Total lease expense
Operating lease expense - fixed payments	$ 39,368	$ 40,060	$ 117,221	$ 169,496	$ 209,577	$ 276,562
Short term lease expense	10,710	10,846	34,929	48,399	59,631	90,159
Total lease expense	$ 50,078	$ 50,906	152,150	217,895	269,208	366,721
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases			$ (111,277)	$ (145,483)	$ (179,621)	$ (258,892)